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Abstract 
CD4+CD8+ double positive (DP) precursors undergo positive selection in the 
thymus, and subsequently commit to either the CD4 or CD8 single positive (SP) 
lineage.  Mice lacking Zap70, a crucial kinase involved in T-cell receptor (TCR) 
signal transduction are developmentally arrested at the DP stage, showing that 
this  process  depends  on  TCR  signalling.    Furthermore,  the  resultant  SP 
populations are major histocompatibility (MHC) matched, as CD4 lineage cells 
recognise MHC-II whereas CD8 lineage T cells recognise MHC-I.   
There are currently two favoured models describing how the MHC restriction of 
the TCR correlates with lineage choice.  These suggest that differences in either 
the TCR signalling strength or signalling length underlie the CD4/CD8 lineage 
decision during the DP stage.  Both models posit that differences in signalling 
strength/length  are  properties  that  are  conferred  by  the  different  signalling 
capacities of the CD4/CD8 coreceptors.  However, questions remain over the 
mechanisms behind this process, including how the selecting cell interprets the 
proximal differences in TCR activation and whether the quality of this signal 
impacts  on  its  future  homeostatic  survival  potential.    A  major  obstacle  in 
addressing these questions is the lack of tools to facilitate understanding of the 
kinetic  regulation  of  positive  selection.    We  therefore  sought  to  examine  the 
kinetics  of  T-cell  development  using  a  tetracycline  inducible  Zap70  mouse 
model (TetZap70 hereon).          
  5 
In  the  absence  of  the  tetracycline  derivative  doxycycline  (dox),  T-cells  were 
arrested  at  the  DP  stage,  prior  to  positive  selection.    However,  the 
administration  of  dox  induced  positive  selection  of  a  synchronized  wave  of 
positively  selecting  thymocytes,  enabling  the  resolution  of  intermediate 
populations of positively selecting DPs.  We found that CD4 and CD8 lineage 
development occurred with temporal distinction, from phenotypically disparate 
populations of DP thymocytes.  Furthermore, we found that endogenous Zap70 
was developmentally regulated in different DP populations of WT mice, and loss 
of  this  regulation  in  TetZap70  mice  corresponded  to  an  impairment  in  CD8 
lineage  generation.    Thus  we  suggest  that  temporal  regulation  of  T-cell 
signalling  sensitivity  during  thymic  development  facilitates  the  resolution  of 
strong/consistent  signals  versus  weak/intermittent  signals.    Finally  we  find 
evidence that the quality of the positive selection signal not only controls the 
CD4/CD8 lineage decision, but also impacts on the future homeostatic survival 
potential of T-cells by influencing levels of the prosurvival interleukin-7 receptor 
alpha chain (IL7r ). 
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Chapter 1  
Introduction 
1.1 The immune system 
The immune system refers to integrated cellular and molecular mechanisms by 
which a host protects itself from pathogens.  That such protective mechanisms 
are beneficial is highlighted by the diversity of organisms exhibiting elements of 
immunity.    For  example,  bacteria  possess  mechanisms  to  prevent 
bacteriophage entry at both a cellular and population level (reviewed in (Labrie 
et  al.,  2010)).    In  addition,  the  secretion  of  antimicrobial  factors  facilitates 
competition with microbial rivals (reviewed in (Hibbing et al., 2010).  With the 
development and diversification of multicellular organisms over one billion years 
ago  (reviewed  in (Kaiser,  2001)),  shifting  evolutionary  pressure  favoured  the 
development of increasingly complex and diverse immunological mechanisms.  
This  is  typified  in  placental  mammals,  which  evolved  recently  in  the  early 
cretaceous period (approximately 145-65 million years ago) (reviewed in (Luo, 
2007)), and boast a highly complex immune system, consisting of organs, cells 
and molecular responses.  Thus it appears to be an evolutionarily favourable 
trait to have resistance against disease causing organisms.  Furthermore, whilst 
lower  evolved  invertebrates  largely  possess  non-specific  innate  immune 
mechanisms,  the  immune  system  in  higher  evolved  vertebrate  species  is 
comprised of both innate and adaptive components.        
 28 
1.1.1 Innate immunity 
Innate immunity refers to a non-specific response to pathogen challenge that 
does not confer immunological memory.  At a most basic level, this can refer to 
physical  barriers  including  epithelial  cells  that  prevent  access  of  bacteria  to 
internal host environments.  In mice and humans, barriers including skin, lung 
and  gut  epithelia  represent  the  first  line  of  defence  against  pathogens.  
Epithelial  cells  also  secrete  mucus  containing  antibacterial  peptides  such  as 
defensins, further limiting the potential for microbial colonisation (reviewed in 
(Ganz, 2003)).  Nevertheless, mechanical damage to the physical barriers can 
enable microbial entry.  Viral or toxin-mediated injury of lung epithelia can also 
facillitate this process (reviewed in (Evans et al., 2010).  Furthermore, in an 
experimental system the disruption of gut epithelial membrane by administration 
of dextran sodium sulphate (DSS) leads to chronic colitis in mice (Okayasu et 
al.,  1990).    Thus  physical  barriers  can  be  overcome,  either  by  inadvertent 
damage,  or  directed  pathogenic  mechanisms.    Damage  to  epithelial  barriers 
induces  immediate  and  non-specific  release  of  pro-inflammatory  mediators 
including  eicosanoids  (leukotrienes  and  prostaglandins)  and  nitrous  oxide 
(NOS)  (reviewed  in  (Bogdan,  2001;  Funk,  2001)).    These  pro-inflammatory 
molecules  induce  recruitment  of  innate  immune  cells  to  the  site  of  infection.  
Subsequent microbial invasion results in the activation of a vast array of innate 
immune cells, which function to control the spread of infection.  Innate immune 
cells  function  cooperatively  with  the  complement  system,  a  biochemical 
cascade of blood proteins that can result in agglutination, lysis or opsonisation 
of bacteria (reviewed in (Frank & Fries, 1991)).          
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Cells  of  the  innate  immune  system  are  largely  myeloid-derived  including 
monocytes,  neutrophils,  macrophages,  dendritic  cells  (DCs),  mast  cells, 
granulocytes,  basophils  and  eosinophils.    These  cells  largely  function  to 
phagocytose  foreign  microbes,  or  to  release  inflammatory  mediators  that 
augment the immune response.  In addition the innate immune system also 
encompasses lymphoid-derived cells, such as natural killer (NK) cells.  These 
cells are involved in tumour and viral surveillance, as well as in the recognition 
of invariant major histocompatibility complex (MHC) associated antigen.  Such a 
variety of cell types underscore the variation in evasion strategies utilised by 
microorganisms.  Although each cell type has a slightly divergent cellular role, 
there is also considerable redundancy in function, ensuring a robust response 
against pathogens. 
Innate  immune  cells  commonly  recognise  pathogen-associated  molecular 
patterns  (PAMPs).    They  do  so  by  expressing  a  diverse  array  of  germline 
encoded  pattern-recognition  receptors  (PRRs).    PRRs  including  the 
Lipopolysaccharide (LPS) receptor, mannose receptor, scavenger receptor and 
N-formyl-methionyl  receptor  aid  in  the  binding  of  phagocytic  immune  cells 
(macrophages and DCs) to microbes (reviewed in (Gordon, 2002)).  In addition, 
macrophage  complement  receptors  are  involved  in  the  phagocytosis  of 
opsonised  pathogens  (reviewed  in  (van  Lookeren  Campagne  et  al.,  2007)).  
Alternatively  PRRs  can  signal  to  induce  cellular  release  of  proinflammatory 
cytokines,  further  upregulating  an  immune  response.    The  most 
well-characterised  of  the  signalling  PRRs  are  Toll-like  receptors  (TLRs),        
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discovered in 1997 as the mammalian homologue to the Drosophila protein Toll 
(Medzhitov et al., 1997).  Subsequently, a family of 10 related TLR proteins 
have been identified in mice.  TLR signalling leads to the activation of c-jun 
NH2-terminal  kinase  (JNK)  and  nuclear  factor  kappa-light-chain-enhancer  of 
activated B-cells (NF B), resulting in the release of proinflammatory signalling 
molecules (reviewed in (Akira & Takeda, 2004; Takeda et al., 2003)).  However, 
despite the wide variety of innate cellular responses, the PAMPs recognised are 
limited by the diversity of germline-encoded receptors.  Not all microorganisms 
exhibit  the  same  common  PAMPs,  and  thus  an  ability  to  recognise  rare 
antigens is essential, particularly in the clearance of infections.  The ability of 
higher  organisms  to  alter  genetic  material  through  somatic  diversification 
permits  development  of  an  adaptive  immune  response  tailored  to  specific 
pathogens. 
1.1.2 Adaptive immunity 
Adaptive immunity refers to an antigen-specific response generated by the host, 
that confers long-lasting and protective immunological memory.  Such a system 
was thought to have arisen in gnathostomes (jawed vertebrates), although the 
agnathan (jawless) sea lamprey also exhibits somatic diversification though a 
disparate  mechanism  (Pancer  et  al.,  2004).    Thus  convergent  evolution  of 
adaptive  immunity  highlights  its  importance  in  higher  vertebrates.    Adaptive 
immune cells are lymphoid-derived and in mice and humans consist of B and 
T-lymphocytes.  B-cells predominately play a role in the recognition of soluble 
antigens  (referred  to  as  humoral  immunity),  whereas  T-cells  can  recognise        
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either intracellular antigen or extracellular antigen taken up and presented by 
antigen presenting cells (APCs) (referred to as cell-mediated immunity). 
Activation  of  B  and  T-lymphocytes  is  mediated  by  stimulation  of  polyclonal 
antigen receptors known as the B-cell receptor (BCR) (also referred to as the 
immunoglobulin (Ig) receptor) and T-cell receptor (TCR) respectively.  This is a 
temporally  late  event  during  the  course of  an  infection,  due  to  an  additional 
requirement  for  costimulatory  signals  from  innate  immune  cells  (reviewed  in 
(Lenschow  et  al.,  1996)).    Once  activated  lymphocytes  undergo  clonal 
expansion and effector cell differentiation.  B-cells secrete a soluble form of their 
Ig-receptor,  referred  to  as  antibody.    The  binding  of  antibodies  functions  to 
agglutinate or neutralise soluble particles, in addition to acting as an opsonin.  
Phagocytes  interact  with  the  fragment-crystallisable  (Fc)  domain  of  bound 
antibody,  thus  enhancing  phagocytosis  (reviewed  in  (Daeron,  1997)).    This 
represents an example of crosstalk between cells of the innate and adaptive 
immune system.  In contrast to B-cells, T-cells recognise processed oligomer 
peptides,  complexed  with  major  histocompatibility  proteins  on  the  surface  of 
APCs  (Zinkernagel  &  Doherty,  1974)  (reviewed  in  (Madden,  1995)).    The 
cognate recognition of peptide complexed with MHC (pMHC) by the TCR, in the 
context  of  costimulation  mediated  by  proinflammatory  cytokines  and 
costimulatory cell:cell interactions with APCs, results in T-cell activation.  If the 
APC is infected by an intracellular pathogen T-cells exhibit cytolytic activity, thus 
killing the target cell (Lowin et al., 1994).  In contrast, activation of T-cells by 
 professional APCs  can lead to cytokine production (Lassila et al., 1988), and        
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thus modulation of the immune response (reviewed in (O'Garra, 1998)).  Upon 
clearance of a pathogen lymphocyte effector cells largely die, although some 
give rise to long-lived memory cells.  These memory cells are readily reactivated 
during a secondary immune response, conferring long lasting protection to the 
host (reviewed in (Freitas & Rocha, 2000)). 
An essential requirement of adaptive immunity is the generation of a diverse 
repertoire  of  immune  cell  antigen  receptors.    Clonal  diversification  of  both 
B-cells  and  T-cells  occurs  through  the  somatic  recombination  of  antigen 
receptor gene loci, so that components of each antigen receptor are arranged 
contiguously (Brack et al., 1978; Chien et al., 1984).  This is mediated by the 
V(D)J  recombinase  enzyme  complex,  consisting  of  recombination  activating 
gene  (Rag)1  and  Rag2,  which  act  in  concert  to  cut  antigen  receptor  genes 
between antigen receptor coding subunits and recombination signal sequences 
(RSS) (Oettinger et al., 1990; Schatz et al., 1989).  In addition, non-homologous 
end joining (NHEJ) components join RSS to form functioning antigen receptor 
chains (reviewed in (Fugmann et al., 2000)).  Thus, combinatorial diversity is 
generated through different combinations of antigen receptor gene segments.  
Furthermore  N  and  P  nucleotide  addition  at  recombination  sites  mediates 
further  junctional  diversity  (reviewed  in  (Schatz  et  al.,  1992)).    Together, 
combinatorial and junctional diversity mechanisms permit the generation of a 
large  polyclonal  repertoire  of  lymphocyte  clones,  each  expressing  a  distinct 
lymphocyte receptor, which potentially recognise an equally diverse range of 
pathogens.        
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The  requirement  for  an  optimally  functioning  adaptive  immune  system  is 
highlighted in human patients lacking the Rag1/Rag2 genes.  These patients 
lack circulating T and B-cells but have normal NK-cells (reviewed in (Villa et al., 
2001)).    This
  severe  combined  immunodeficiency  (SCID)  phenotype  typically 
results in opportunistic infections during early childhood (Sadeghi-Shabestari et 
al., 2009; Yeganeh et al., 2008) (reviewed in (Sobacchi et al., 2006)).  Similarly 
Rag1 and Rag2 knockout mice exhibit a similar T-cell
- B-cell
- NK-cell
+ SCID 
phenotype (Mombaerts et al., 1992b; Shinkai et al., 1992).   
In addition to the Rag1/Rag2 genes, a multitude of factors have been implicated 
in  a  loss  of  lymphocyte  development  and/or  function  (reviewed  in  (Fischer, 
2007)).  Furthermore, the dysregulation of lymphocyte homeostasis has also 
been  linked  to  autoimmunity  (reviewed  in (Vyse  &  Todd,  1996))  and  cancer 
(reviewed in (Siegel et al., 2000)).  Therefore, understanding the mechanisms of 
lymphocyte  development  and  function  in  experimental  systems  is  of  clinical 
significance,  with  regards  to  understanding  and  potentially  treating  human 
disease. 
1.2 T-cell biology 
T-cells  are  constantly  generated  throughout  life  in  the  thymus;  a  specialised 
organ situated in the anterior superior mediastinum (Miller, 1961).  The majority 
of  T-cells  express  TCR   and  TCR   chains,  which  together  form  the  mature 
TCR  (Kappler  et  al.,  1983).    Recognition  of  pMHC  also  depends  on  the 
presence on either CD4 or CD8, which function as TCR coreceptors (Doyle &        
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Strominger, 1987; Norment et al., 1988).  Expression of CD4 or CD8 is mutually 
exclusive on mature T-cells and is determined during thymic selection. 
1.2.1 CD4 T-cells 
CD4 lineage T-cells are referred to as T-helper (TH) cells, as they commonly 
secrete cytokines that modulate the immune response upon activation.  The 
CD4 lineage comprises CD4
+CD8
- cells that specifically recognise antigen in a 
complex with MHC-II molecules (Doyle & Strominger, 1987).  MHC-II is a dimer 
consisting of   and  -chains, and is expressed in  professional APCs , which 
include  DCs,  macrophages  and  activated  B-cells.    These  cells  take  up  and 
degrade extracellular antigen to 10-12mer peptides in endosomal compartments 
(Hunt et al., 1992; Lassila et al., 1988).  Endosomes subsequently fuse with 
vesicles containing empty MHC-II molecules and peptides are loaded through 
the action of the peptide exchange catalyst H2-M in mice (HLA-DM in humans) 
(reviewed in (Watts, 1997)).  Thus CD4 T-cells generally recognise extracellular 
antigens and produce cytokines to modulate the immune response. 
1.2.2 CD8 T-cells 
The CD8 T-cell lineage is referred to as cytotoxic, as upon activation by pMHC 
these cells exhibit cytolytic activity and kill their target cell.  The CD8 coreceptor 
confers  specificity  to  MHC-I  molecules  (Norment  et  al.,  1988),  which  are 
expressed  on  the  majority  of  somatic  cells.    MHC-I  consists  of  an   -chain 
ionically bonded to a  2-microglobulin ( 2m) subunit (reviewed in (Ploegh et al., 
1981)).  Internal peptides are constantly turned over, through the process of        
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ubiquitination  and  proteosomal  degradation.    Degraded  peptides  are 
transported into the endoplasmic reticulum (ER), a process that depends on 
transporters associated with antigen processing (Tap)1 and Tap2 (reviewed in 
(York  &  Rock,  1996)).    Here  they  undergo  further  degradation  to  8-10mer 
peptides (Hunt et al., 1992), before being loaded onto MHC-I molecules.  The 
recognition  of  foreign  antigen  occurs  when  cells  are  infected  by  intracellular 
pathogens, and the cytotoxic activity of CD8 lineage cells results in target cell 
lysis.  This exposes intracellular antigens to humoral or phagocytic responses 
and kills obligate intracellular pathogens that cannot survive outside of a host 
cell. 
Therefore CD4 and CD8 lineage cells have different functions and recognise 
different types of APC.  The mutually exclusive expression of the CD4 or CD8 
coreceptor facilitates the unique recognition of either MHC-II or MHC-I by the 
corresponding  lineage.    Thus  such  a  mechanism  permits  the  independent 
development  and  function  of  two  cellular  lineages  utilising  the  same  antigen 
receptor. 
1.3 Differentiation of mature T-cells 
Following development, T-cells emigrate from the thymus and reside primarily in 
the lymph nodes (LN), spleen and bone marrow (BM), or recirculate in the blood 
(reviewed  in  (Butcher  &  Picker,  1996)).    T-cells  express  polyclonal  TCRs, 
conferring clonal-specific avidity for both self and foreign peptides (reviewed in 
(Freitas & Rocha, 2000)).  A T-cell clone will undergo further differentiation upon        
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activation by a specific pMHC complex.  Furthermore, some activated T-cells 
will  go  on  to  form  long  lived  memory  cells,  facilitating  protective  immunity 
following  antigen  re-exposure.    Hence,  there  exist  multiple  subsets  of 
phenotypically  distinct  mature  T-cells  that  are  in  disparate  states  of 
differentiation. 
1.3.1 Naïve T-cells 
Mature T-cells are referred to as naïve prior to stimulation with pMHC and these 
cells make up the majority of the peripheral T-lymphocyte pool.  Naive cells are 
phenotypically characterised by low expression of CD44 and CD25 (reviewed in 
(Harty  &  Badovinac,  2008)).    In  addition,  they  express  intermediate  to  high 
levels of the interleukin-7 receptor alpha subunit (IL7r ) (Sudo et al., 1993). 
1.3.2 Effector T-cells 
Upon  stimulation  T-cells  undergo  clonal  expansion,  and  differentiation  to  a 
number of different effector subsets.  Effector T-cell fate depends largely on the 
context  of  activation  and  the  number  of  effector  subsets  has  been  much 
expanded in recent years.  Originally the TH1/TH2 paradigm was established to 
distinguish two functional outcomes in CD4 lineage cells (Mosmann et al., 1986) 
(reviewed in (Mosmann & Coffman, 1989)).  Activation of T-cells in the presence 
of  interleukin  (IL)4  results  in  TH2  cell  differentiation,  a  common  occurrence 
during  infection  by  extracellular  parasites.    In  contrast,  activation  in  the 
presence  of  interferon-   (IFN )  and  IL12  results  in  TH1  polarisation,  which 
commonly  occurs  during  bacterial  infections  (reviewed  in  (O'Garra,  1998)).         
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More  recently,  further  subdivisions  of  T-effector  populations  have  been 
described, for example the TH17 and TH9 effector states, based on associated 
cytokine secretion (IL17 and IL9 for respectively) (reviewed in (Zhu et al., 2010). 
In  contrast,  CD8  lineage  cells  primarily  perform  a  cytotoxic  function  in  the 
immune system.  However, CD8 cells also function to produce cytokines, and 
can be classified in terms of their cytokine expression profiles.  For example 
T-cytotoxic (TC)1, TC2 and TC17 cell subsets have been identified, expressing 
TH1,  TH2  and  TH17-associated  cytokines,  whilst  retaining  cytotoxic  activity 
(Hamada et al., 2009; Li et al., 1997).  Therefore, in addition to developmentally 
instructed differences between the CD4 and CD8 lineages, the context of the 
T-cell activation signal triggers a specified effector response for cells within both 
CD4 and CD8 T-cells.  This has functional implications, as the type of effector 
response elicited can result in different outcomes following infection.  A classic 
example  is  the  finding  that  decreases  in  TH1  polarizing  cytokines  underlie  a 
genetic susceptibility to the obligate intracellular pathogen Leishmania major, 
which is thought to be cleared by a TH1 response in mice (Guler et al., 1996)).  
In humans, TH1 versus TH2 responses define the outcome of Mycobacterium 
leprae infection (reviewed in (Modlin, 1994)). 
Activated T-cells are further characterised by an increase in cell size, production 
of  large  amount  of  cytokines  and  changes  in  surface  phenotype.    Cells 
upregulate  the  activation  markers  CD69,  CD25  and  CD44,  whereas  IL7r  
expression is downregulated.  Following clearance of a pathogen, up to 95% of        
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effector T-cells undergo apoptosis, whilst some survive to become long-lived 
memory cells (reviewed in (Harty & Badovinac, 2008)). 
1.3.3 Memory T-cells 
The generation of immunological memory is the hallmark of adaptive immunity.  
Memory cells are rapidly activated during the secondary immune response, if an 
antigenic  stimulus  is  re-encountered.    Memory  cells  can  be  subdivided  into 
effector memory T-cells (TEM) and central memory T-cells (TCM).  Whereas TEM 
cells  confer  protective  immunity,  TCM  cells  are  rapidly  reactive  following 
antigenic re-stimulation, ensuring a more rapid adaptive immune response to a 
secondary  challenge.    Memory  T-cells  can  be  defined  by  high  surface 
expression of CD44 and IL7r .  In addition, TCM express L-selectin and C-C 
motif chemokine receptor (CCR)7, which are not present on TEM cell subsets 
(reviewed in (Sallusto et al., 2004; Surh & Sprent, 2008)). 
Thus T-cells can potentially exist in a number of differentiated states throughout 
their lifespan.  Whereas the naïve T-cell pool favours diversity of receptors that 
have  the  potential  to  recognise  wide  ranges  of  antigens,  activation  leads  to 
rapid  clonal  expansion,  effector  differentiation  and  elimination  of  pathogens.  
The memory T-cell pool contains a restricted polyclonal repertoire, as cells have 
previously received antigenic stimulation.  These memory cells confer protective 
immunity, or are poised to respond rapidly upon reinfection.          
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1.3.4 Regulatory T-cells 
The regulatory T-cells (Tregs) comprise a T-cell sub-lineage, that functions to 
suppress  immune  responses  against  both  self  and  foreign  antigens,  thus 
maintaining T-cells in a non-activated state (Sakaguchi et al., 1985) (reviewed in 
(Sakaguchi,  2004)).    These  cells  can  either  develop  intrathymically,  or  arise 
during  the  activation  of  naive  T-cells  (reviewed  in  (Sakaguchi,  2004)).    The 
absence of Treg cells results in severe multi-organ autoimmune disease in both 
humans  and  mice  (reviewed  in  (Wildin  et  al.,  2002)).    Murine  Tregs 
constitutively express the lineage defining transcription factor Forkhead box P3 
(Foxp3) (Hori et al., 2003), and also express high levels of CD25 (Sakaguchi et 
al.,  1995).    Conditional  deletion  of  Foxp3  in  mature  Treg  cells  using  cre-lox 
technology  ablated  their  suppressive  function,  showing  that  constitutive 
expression of Foxp3 is required for maintenance of Treg function (Williams & 
Rudensky, 2007).  Thus Treg differentiation represents a control mechanism 
whereby  an  excessive  immune  response  can  be  dampened.    Critically,  the 
various T-cell pools are subject to additional homeostatic constraints to ensure 
they  are  optimized  for  their  divergent  functions,  within  the  limited  physical 
constraints of the host body. 
1.4 T-cell homeostasis 
Metazoan tissues and organs remain stable and constant in size, but consist of 
cells that constantly turnover.  Older differentiated cells are lost by apoptosis 
and are replaced by cell division or stem cell differentiation.  The various inputs        
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and outputs to a pool of cells depend on environmental factors.  For example, 
during wound healing cellular input outpaces output (reviewed in (Pellettieri & 
Sanchez  Alvarado,  2007)).    Similarly,  T-lymphocyte  cell  numbers  are  also 
maintained at a constant size throughout life, despite their constant turnover.  
As T-cells are dispersed in the circulatory and lymphatic systems, mechanisms 
have  evolved  to  sense  the  surrounding  space  and  to  keep  cell  numbers 
constant.  The disruption of the homeostatic control mechanisms are associated 
with immunopathology, including but not limited to SCID (Peschon et al., 1994; 
von Freeden-Jeffry et al., 1995), arthritis (Sakaguchi et al., 2003) and cancer 
(Bain et al., 1997).  Thus maintenance the T-cell population size and cell density 
is essential to maintain the health of a host. 
1.4.1 How do T-cells sense space? 
Lymphocyte homeostasis depends on the integration of signals from a multitude 
of soluble survival factors in addition to signals mediated by cell:cell contact. 
The frequency and intensity of these homeostatic survival signals can result 
various homeostatic outcomes (reviewed in (Freitas & Rocha, 2000)).  If cell 
numbers  are  low,  there  is  less  competition  for  homeostatic  survival  factors, 
resulting in increased homeostatic signalling.  In contrast, if cell numbers are 
high, homeostatic survival factors become rate-limiting, thus limiting lymphocyte 
population size (reviewed in (Seddon & Zamoyska, 2003)). 
This is the case for B-cells, which require survival signals mediated by both the 
BCR  and  soluble  B-cell  activating  factor  (BAFF)  (reviewed  in  (Stadanlick  &        
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Cancro,  2008).    In  contrast,  for  both  naïve  and  memory  T-lymphocytes,  the 
required soluble factors include common gamma chain ( c) (CD132) cytokine 
signals mediated predominantly by IL7, whereas cell:cell survival signals are 
transduced  through  the  TCR.    Whereas  pMHC  complexes  result  in  the 
activation of T-cells, homeostatic TCR survival signalling is mediated by weaker 
recognition of self-peptide antigen displayed in the context of MHC (spMHC) 
(reviewed in (Jameson, 2002)). 
1.4.1.1 IL7 signalling 
An overview of IL7-mediated signalling pathways is shown in Figure 1.1.  IL7 
was first identified as a 25 kilodalton (kDa) growth factor that could promote 
growth of murine B-cell precursors in vitro (Namen et al., 1988b).  IL7 mRNA 
was identified in the thymus (Namen et al., 1988a), and recombinant IL7 was 
subsequently found to promote growth and survival of thymocytes (Murray et 
al.,  1989).    Depletion  of  IL7  or  blocking  IL7-receptor  (IL7R)  activity  through 
injection of neutralising monoclonal antibodies (mAbs) severely reduces thymic 
and  peripheral  T-cell  numbers  (Grabstein  et  al.,  1993;  Sudo  et  al.,  1993).  
Furthermore,  the  generation  of  IL7  and  IL7r   knockout  mice  confirmed  the 
essential role of IL7 in both T-cell and B-cell development (Peschon et al., 1994; 
von Freeden-Jeffry et al., 1995).  In addition, IL7 gene transcripts have been 
identified in a variety of lymphoid tissues (reviewed in (Hofmeister et al., 1999)), 
and it is appreciated that IL7 is also required for mature T-cell survival (Schluns 
et al., 2000).        
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Stimulation by IL7 induces the heterodimerization of the  c and the IL7r  chain 
(Kondo et al., 1994; Noguchi et al., 1993).  Janus kinase (JAK)3 is constitutively 
associated with the  c, whereas JAK1 is constitutively associated with IL7r  
(reviewed in (Jiang et al., 2005)).  Heterodimerization brings JAK1 and JAK3 in 
close  proximity  with  one  another,  resulting  in  their  mutual  phosphorylation 
(Foxwell et al., 1995).  The essential role of JAKs in transducing  c cytokine 
signals is evidenced in the JAK3-deficient mice, which exhibit a similar SCID 
phenotype  to  the   c-deficient  mice  (Cao  et  al.,  1995;  DiSanto  et  al.,  1995; 
Nosaka  et  al.,  1995;  Park  et  al.,  1995).    Activated  JAK1  and  JAK3 
phosphorylate  the  IL7R,  providing  docking  sites  for  Signal  transducer  and 
activator of transcription (STAT) proteins (reviewed in (Jiang et al., 2005)).   
The predominant STAT activated by the IL7R is STAT5, which is encoded by 
two genes: Stat5a and Stat5b (Johnston et al., 1995; Lin et al., 1995).  These 
isoforms are thought to play redundant roles within the lymphoid lineage, as a 
deficiency in either gene does not block lymphocyte development (Imada et al., 
1998; Nakajima et al., 1997).  In contrast, mice deficient in both STAT5a and 
STAT5b proteins exhibit a T-cell lymphopenic phenotype, showing that STAT5 
signals are essential for lymphocyte homeostasis (Yao et al., 2006).  Indeed a 
primary  function  of  STAT5  signalling  is  the  upregulation  of  pro-survival 
molecules including B-cell leukaemia/lymphoma 2 (Bcl2) (Jiang et al., 2004; von 
Freeden-Jeffry et al., 1997).  Furthermore, STAT5 has been implicated in the 
transcription of genes involved in cell cycle entry proteins including CyclinD1        
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(encoding  cyclin  D)  and  Myc  proto-oncogene  protein  (Myc,  encoding  c-Myc) 
(reviewed in (Jiang et al., 2005)). 
Phenotypic  differences  in  the  composition  of  T-cell  progenitor  populations  in 
STAT5a/STAT5b-deficient mice compared to IL7r -deficient mice led authors to 
conclude that IL7 also signals though additional non-redundant pathways (Yao 
et al., 2006).  This conclusion is supported by the findings that in addition to 
STATs, IL7R activates the phosphatidylinositide-3-kinase (PI3K) pathway (Dadi 
et  al.,  1994;  Dadi  &  Roifman,  1993).    The  p85   -subunit  of  PI3K  bound  to 
phosphorylated tyrosine (Y)449 of the IL7r  chain via its Src homology 2 (SH2) 
domain,  and  subsequently  led  to  activation  of  the  PI3K  catalytic  subunit 
(Venkitaraman & Cowling, 1994).  PI3K can activate Akt, and this signalling 
pathway  has  been  suggested  to  facillitate  cell  cycle  entry,  and  lead  to 
inactivation  of  the  pro-apoptotic  molecule  Bcl-xL/Bcl-2-associated  death 
promotor (BAD) (reviewed in (Jiang et al., 2005)).  However, mice deficient in 
PI3K  p85  -subunit  show  no  defect  in  T-cell  development  or  proliferation 
(Fruman et al., 1999).  Thus the physiological role of PI3K activation by IL7 
remains  unclear  and  highlights  the  lack  of  understanding  of  the  precise 
downstream targets of IL7 signalling. 
1.4.1.2 TCR signalling 
A schematic overview of TCR signalling is shown in Figure 1.3.  The TCR is 
composed  of  heterodimerized     and   -chains  and  recognises  antigen 
complexed with MHC molecules.  TCR signalling is conferred by two associated        
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CD3 molecules, which form a complex consisting of the   -TCR, CD3   and 
CD3   heterodimers and a CD3  homodimer.  Mice deficient in any of these 
subunits  show  perturbed    -TCR  signalling  and  fail  to  develop  mature 
  -T-cells (Dave et al., 1998b; Haks et al., 1998; Liu et al., 1993; Malissen et 
al.,  1995),  showing  their  important  role  in  TCR  assembly  and/or  signal 
transduction.    The  presence  of  either  the  CD4  or  CD8  coreceptor  is  also 
essential  for  TCR  signalling.    The  extracellular  domains  of  the  CD4/CD8 
coreceptors  interact  with  invariant  regions  on  the  MHC-II/MHC-I  molecules, 
conferring TCR:ligand specificity for the CD4 and CD8 SP lineages (Doyle & 
Strominger, 1987; Norment et al., 1988).  In addition, the cytoplasmic tails of 
CD4/CD8  associate  with  the  Src  family  kinase  Leukocyte-specific  protein 
tyrosine kinase (Lck), thus playing a role in its recruitment to the TCR signalling 
complex (Rudd et al., 1988; Veillette et al., 1988).  It is believed that ligand 
binding to the TCR induces conformational changes to the TCR/CD3 signalling 
complex  facilitating  the  phosphorylation  of  immunotyrosine  activation  motifs 
(ITAMS) on the CD3 molecules by Lck, or by a related and partially redundant 
kinase Fyn proto-oncogene (Fyn) (Nika et al., 2010) (reviewed in (Smith-Garvin 
et al., 2009)). 
The  phosphorylated  ITAMs  provide  docking  sites  for  SH2-domain  containing 
proteins, of which the Zeta-chain-associated protein kinase of 70kDa molecular 
(Zap70) is essential for TCR signalling (Arpaia et al., 1994; Chan et al., 1994a; 
Elder et al., 1994; Negishi et al., 1995).  Zap70 is a Syk family kinase containing 
two  N-terminal  SH2  domains  and  a  C-terminal  kinase  domain  (Figure 1.2)        
 45 
(Chan et al., 1992).  The SH2 domains bind to phosphorylated ITAMs on CD3  
and   -chains  (Wange  et  al.,  1993).    It  is  hypothesised  that  Zap70  must  be 
phosphorylated  on  Y315  and  Y319  to  facillitate  efficient  binding  to  ITAMs 
(Deindl et al., 2007), whilst the phosphorylation of Y292 is inhibitory for Zap70 
function (Kong et al., 1996).  Furthermore, optimal Zap70 function is achieved 
by the additional phosphorylation of Y492 and Y493, located on the activation 
loop of the Zap70 kinase domain.  It is believed that tyrosine phosphorylation of 
Zap70  is  mediated  by  Lck  or  by  transautophosphorylation  by  other  Zap70 
molecules (thus Y292 represents a negative feedback inhibitory mechanism).  
In addition, Y292, Y315 and Y319 are thought to play an important scaffolding 
role,  recruiting  further  SH2  domain  containing  proteins  to  the  TCR  signalling 
complex (Hsu et al., 2009; Magnan et al., 2001) (reviewed in (Au-Yeung et al., 
2009)).    Direct  targets  of  Zap70  kinase  activity  include  the  adaptor  proteins 
linker  of  activated  T-cells  (LAT)  (Zhang  et  al.,  1998),  and  SH2  domain 
containing leukocyte protein of 76kDa (Slp76) (Wardenburg et al., 1996).  These 
provide  docking  sites  for  a  number  of  signalling  molecules  inducing  further 
downstream  signals  (reviewed  in  (Samelson,  2002),  and  summarised  in 
Figure 1.3). 
A primary function of the TCR is to signal antigen recognition to the T-cells.  
TCR signalling induces an increase in the cytosolic concentration of calcium 
ions (referred to as calcium influx).  TCR signals result in the activation of PLC , 
which  acts  to  hydrolyse  the  membrane  associated  phospholipid 
phosphatidylinositol 4,5-bisphosphate (PIP2) to diacylglycerol (DAG) and inositol        
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triphosphate (IP3) (Yablonski et al., 1998; Yablonski et al., 2001).  IP3 induces 
opening of IP3 gated calcium channels on the ER, resulting in store operated 
calcium  entry  (SOCE)  (reviewed  in (Vig  &  Kinet,  2009).    The  transient  local 
increase  in  calcium  is  interpreted  by  calcium  sensing  domains  on  stromal 
interaction molecule (Stim) proteins.  Through an unknown mechanism, the ER 
associated Stim proteins then interact with plasma membrane associated Orai 
calcium  release-activated  calcium  modulator  (Orai)  proteins,  resulting  in 
multimerization and formation of a calcium channel at the plasma membrane 
(Luik et al., 2008) (reviewed in (Hogan et al., 2010)).  What follows is a large 
influx of calcium ions, which act as second messenger through interactions with 
calcium  binding  domains,  either  directly  or  via  calmodulin.    Of  particular 
importance in T-cells, this leads to the activation of the phosphatase calcineurin, 
which dephosphorylates and hence activates nuclear factor of activated T-cells 
(NFAT) proteins (reviewed in (Macian, 2005)). 
TCR  signalling  also  results  in  activation  of  mitogen  activated  protein  kinase 
(MAPK) signalling cascades, either through the sequential recruitment/activation 
of growth receptor bound 2 (Grb2)/son of sevenless (sos)/Ras proto-oncogene 
(Ras) (reviewed in (Samelson, 2002)), or through DAG-mediated activation of 
ras guanyl nucleotide-exchanging protein (RasGRP)/Ras pathways (Dower et 
al.,  2000).    In  T-cells,  the  important  MAPK  pathway  involved  the  sequential 
activation  of  Raf  proto-oncogene  serine/threonine-protein  kinase ( Raf), 
MAPK/Erk  kinase  (MEK)  and  Extracellular  signal  related  kinase  (Erk).    Erk 
leads to the subsequent induction of the activator protein 1 (AP-1) transcription        
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factor  (reviewed  in  (Mor  &  Philips,  2006)).    Furthermore,  TCR  signalling 
activates the NF B pathway through the DAG-mediated activation of Protein 
kinase  C  (PKC)  (reviewed  in  (Baeuerle  &  Henkel,  1994)).    NFAT,  AP-I  and 
NF B are the classical targets of TCR signalling leading to T-cell activation. 
However, the function of TCR signalling is not limited to T-cell activation, TCR 
signalling  has  been  implicated  in  development,  homeostasis,  anergy  and  in 
cytoskeletal  reorganisation  following  recruitment  of  non-catalytic  region  of 
tyrosine kinase adaptor protein-1 (Nck) and Vav oncogene (Vav) to LAT, and 
subsequent  Vav  activation  (Costello  et  al.,  1999;  Zeng  et  al.,  2003).    As  a 
further level of complexity, signals through the TCR induce negative feedback 
regulatory loops affecting TCR signal transducing complexes.  This results in 
sensory adaptation and permits the resolution of true signals from background 
noise  (reviewed  in  (Acuto  et  al.,  2008)).    The  context  and  nature  of  TCR 
signalling  therefore  results  in  divergent  effector  functions,  but  how  a  T cell 
interprets these signals is not well-characterized. 
1.4.2 The crossregulation of TCR and IL7R signalling 
It has also been suggested that complex feedback mechanisms may influence 
TCR and IL7r  signalling and expression.  IL7 signalling is regulated in T-cells 
by  modulating  the  levels  of  IL7r ,  whilst  the   c  is  constantly  expressed 
(reviewed in (Mazzucchelli & Durum, 2007)).  It has been shown that IL7 signals 
downregulate IL7r  on naïve T-cells (Park et al., 2004).  Downregulation of the 
IL7r  in IL7-signalled T-cells may be  altruistic , so that other T-cells receive less        
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competition  from  their  recently  signalled  counterparts  for  this  critical 
homeostatic  factor  (Munitic  et  al.,  2004).    Furthermore,  Park  et  al.  have 
proposed  a  model  termed  coreceptor  tuning,  based  on  the  finding  that  IL7 
signalling stabilises CD8 coreceptor expression on lymph node T-cells (LNTs) in 
vitro.  This model suggests that IL7 signals downregulate IL7r , but upregulate 
CD8 coreceptor expression.  High CD8 coreceptor expression was postulated to 
confer increased TCR signalling sensitivity.  The authors further hypothesise 
that TCR signals block IL7R signalling and thus upregulate IL7r , increasing IL7 
signalling  sensitivity.    Such  a  cyclical  model  implies  that  T-cells  temporally 
alternate between TCR and IL7 signalling during normal homeostasis (Park et 
al., 2007).  Although this model is intriguing, in vivo evidence relies largely on 
correlative data between IL7r  expression and the TCR signalling marker CD5 
in TCR transgenic mice, which are commonly found to be lymphopenic (Azzam 
et al., 2001; Ge et al., 2004).  The differences in endogenous IL7 levels in these 
mice may further complicate these conclusions.  In addition, CD4 coreceptor 
expression  was  unaffected  by  IL7  signals,  and  the  authors  provided  no 
explanation  as  to  how  CD4  homeostatic  signalling  is  regulated  (Park  et  al., 
2007).    Therefore  the  physiological  relevance  of  coreceptor  tuning  remains 
questionable.   
In contrast to the findings of Park et al., Cho et al. recently found that TCR 
signalling augments IL7R signals, by inducing colocalisation of the IL7r  and  c 
in lipid rafts (Cho et al., 2010).  Also, Takada et al. found that in the absence of 
TCR:spMHC  interactions,  IL7r   levels  were  decreased  on  naïve  T-cells        
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(Takada & Jameson, 2009).  This contrasts findings in Lck-inducible transgenic 
mice, where the experimentally induced deletion of Lck has no affect on IL7r  
expression levels (Seddon et al., 2003).  These seemingly paradoxical results 
are likely to result from differences in experimental systems used, and therefore 
the relationship between TCR and IL7 signalling is still unclear.  Indeed, the 
molecular identities of putative factors involved in the cross-regulation of IL7r  
and TCR signals have not yet been described. 
1.4.3 Mechanisms of T-cell homeostasis 
The signalling pathways activated by IL7R and TCR signalling are for the most 
part  divergent,  and  the  crossregulation  between  IL7R  and  TCR  signalling 
pathways  remains  controversial.    Nevertheless,  both  of  these  signalling 
pathways synergise to promote the homeostasis of T-cells.  TCR / -deficient 
mice  and  IL7r -deficient  mice  both  exhibit  severe  blocks  in  T-cell 
lymphopoiesis, showing an essential role for both TCR and IL7R signals in this 
process  (Peschon  et  al.,  1994;  Philpott  et  al.,  1992)  (see  below,  sections 
1.5-1.7).  Peripheral homeostasis of naïve T-cells also depends on signals from 
cytokines and the TCR.   
Mature T-cell numbers are maintained by protecting these cells from apoptosis 
(homeostatic  survival).    In  addition,  in  a  lymphopenic  environment  the  cell 
turnover  rate  is  modulated,  so  that  there  is  a  net  gain  of  cells  through 
proliferation  (homeostatic  proliferation)  (Goldrath  &  Bevan,  1999;  Kieper  & 
Jameson, 1999; Sprent & Tough, 1994).  Schluns et al. found a survival defect        
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in MHC-I-restricted TCR transgenic OT-I Rag1
-/- Il7r
-/- (IL7r -deficient) T-cells 
relative to OT-I Rag1
-/- controls, following transfer to an intact wild-type (WT) 
mouse.  In addition, transfer of OT-I Rag1
-/- cells to T-cell-deficient Rag1
-/- and 
Rag1
-/-
 Il7
-/- (IL7-deficient) hosts showed impaired homeostatic proliferation in 
the absence of IL7 (Schluns et al., 2000).  WT CD4 and CD8 T-cells were also 
lost over an one-month period following transfer to IL7-deficient hosts (Tan et 
al.,  2001).    Finally,  a  greater  loss  of  naïve  T-cells  was  observed  following 
treatment  of  thymectomized  mice  with  an  anti-IL7R  blocking-antibody, 
compared  to  untreated  controls  (Vivien  et  al.,  2001),  and  administration  of 
IL7R-blocking  antibody  also  impaired  homeostatic  proliferation  of  transferred 
T-cells in lymphopenic hosts (Seddon & Zamoyska, 2002a).  Furthermore, IL7 
signals play a role in CD4 and CD8 memory T-cell homeostasis (Kieper et al., 
2002; Seddon et al., 2003).  However, here IL15 plays a non-redundant role in 
the case of the CD8 memory cells (Kieper et al., 2002) (reviewed in (Surh & 
Sprent, 2008)). 
TCR signalling is also important for T-cell homeostasis, particularly in the case 
of naïve T-cells.  Transferred H-2
d-restricted TCR transgenic T-cells were found 
to be short lived (with a half-life of ~3.5 weeks) when transferred to H-2
b hosts, 
but persisted in H-2
d controls, suggesting that TCR-restricted MHC interactions 
permit homeostatic survival (Kirberg et al., 1997).  Subsequent studies involving 
the  conditional  peripheral  deletions  of  the  TCR -chain  (Polic  et  al.,  2001), 
MHC-II (Witherden et al., 2000), the CD4 coreceptor (Wang et al., 2001) or Lck 
(Seddon  et  al.,  2000;  Seddon  &  Zamoyska,  2002b)  have  confirmed  a        
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requirement for TCR signalling in the survival and/or homeostasis of both CD4 
and CD8 naïve T-cells.  Interestingly, it has been hypothesised that the same 
ligands mediating homeostatic survival in the periphery are the same as those 
driving thymic development of T-cells (Ernst et al., 1999).  In contrast, in the 
absence of spMHC-II or TCR signalling CD4 memory T-cells survive, but show 
impaired homeostatic proliferation (Grandjean et al., 2003; Seddon et al., 2003).  
CD8 memory cells also persist in the absence of MHC-I (Murali-Krishna et al., 
1999).  It is believed that memory cell homeostasis has a greater dependence 
on cytokine signals, predominantly mediated by IL7 and IL15 (reviewed in (Surh 
& Sprent, 2008)). 
Therefore a wide variety of homeostatic mechanisms exist to maintain T-cells at 
a constant level, despite various inputs and outputs to different T-cell pools.  
Regulating the different T-cells pools by their requirement for both overlapping 
and unique factors enables both broad and subset-dependent mechanisms to 
operate.    That  such  complex  regulatory  mechanisms  exist  highlights  the 
importance  of  not  just  maintaining  T-cell  numbers,  but  also  in  maintaining 
clones exhibiting diverse polyclonal TCR repertoires.  The elucidation of factors 
that govern this process are of clinical significance, with regards to improving 
immune function.  
A critical requirement for T-cell homeostasis is the generation of T-cells through 
thymic  development.    The  thymus  produces  a  constant  output  of  polyclonal 
T-cells,  which  can  confer  immunity  against  foreign  antigen  but  are  not 
self-reactive.    This  contrasts  with  homeostatic  proliferation,  which  generates        
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monoclonal T-cell daughter cells.  Thus it has been hypothesised that continued 
thymic  development  maintains  a  diverse  repertoire  of  peripheral  T-cells 
(reviewed  in  (Mackall  et  al.,  1997)).    Furthermore,  it  is  hypothesised  that 
peripheral lymphoid cells reach a replicative senescence following a particular 
number  of  divisions  due  to  shortening  of  the  telomere  in  the  absence  of 
telomerase  (referred  to  as  the  Hayflick  limit)  (Hayflick  &  Moorhead,  1961; 
Hayflick, 1965) (reviewed in (Effros, 1998)).  Thymic generation may prevent 
replicative  senescence  by  constantly  generating  new  T-cells  from  stem  cell 
precursors.  Finally, the T-cell compartment is permanently reduced in neonatal 
thymectomized  mice  (reviewed  in  (Stutman,  1986)),  whereas  the  peripheral 
T-cell pool is elevated following thymic engraftment (Berzins et al., 1998).  This 
suggests that the size of the naïve T-cell pool may be dictated by thymic export, 
although  these  studies  do  not  rule  out  the  contribution  of  thymically  derived 
cytokines.    In  addition,  both  TCR  and  IL7  signals  are  essential  for  thymic 
development, showing that overlapping factors regulate both the generation and 
homeostasis  of  naïve  T-cells.    Therefore,  identifying  the  mechanisms  and 
processes  underlying  T-cell  development  has  implications  for  understanding 
mature T-cell homeostasis. 
1.5 Thymic development 
The evolutionary appearance of the thymus correlates with the appearance of 
T-cells, in that it exists in all jawed vertebrates, but not lower species (reviewed 
in (Rodewald, 2008)).  Thymic development of T-cells permits the generation of        
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a  diverse  polyclonal  repertoire  of  T-cells.    Given  the  highly  effective  T-cell 
effector  response,  it  has  been  hypothesised  that  a  dedicated  organ  may  be 
necessary to reduce the potential for autoimmunity.  This contrasts with other 
haematopoietic cell types, including B-cells, which predominantly develop in the 
BM (Boehm & Bleul, 2007). 
The  requirements  of  thymopoiesis  include  T-cell  lineage  commitment  and 
generation  of  a  diverse  polyclonal  T-cell  repertoire  that  i)  weakly  recognises 
spMHC and ii) does not recognise spMHC with a strong enough avidity to lead 
to activation/autoimmunity.  The thymus is also the site mediating the terminal 
differentiation of   -lineage T-cells to either the CD4 or CD8 lineage, as well as 
the differentiation of    and NKT lineages.  Finally effector function must be 
conferred to newly developed T-cells, so they leave the thymus fully capable of 
eliciting an immune response.  These complex requirements are reflected in the 
intricate temporal sequence with which T-cell development progresses. 
The  temporal  progression  of    -T-cell  development  correlates  with  the 
changing surface phenotype of the maturing thymocyte populations.  Cells are 
differentiated  based  on  the  expression  of  the  CD4  and  CD8  coreceptors.  
Initially thymocytes are CD4
-CD8
- (referred to as double negative, DN).  At the 
DN stage, thymocytes commit to the T-cell lineage, and rearrange their antigen 
receptor chains through somatic recombination of Tcrb followed by Tcra genetic 
loci.    Thymocytes  next  enter  a  phenotypically  CD4
+CD8
+  coreceptor 
double-positive (DP) stage.  This is a developmental dead end for the majority 
of T-cells, as those cells receiving a negligible signal die by neglect.  However,        
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those cells that recognise spMHC and receive relatively weak homeostatic TCR 
signals  are  positively  selected  to  continue  maturation.    Following  positive 
selection,  T-cells  subsequently  commit  to  either  the  CD4
+CD8
-  or  CD4
-CD8
+ 
single  positive  (SP)  lineages.    Concomitantly  with  positive  selection  and 
CD4/CD8  SP  lineage  commitment,  T-cells  that  recognise  spMHC  with  a 
particularly  strong  avidity  (signalling  that  they  are  self-reactive)  are  clonally 
deleted.    Through  these  mechanisms,  only  T-cells  that  favourably  recognise 
spMHC  escape  thymic  development  and  are  permitted  to  emigrate  from  the 
thymus to join the naïve T-cell pool. 
1.6 Development of double negative thymocytes 
The  earliest  requirement  for  T-cell  development  is  the  migration  of  thymus 
seeding progenitor (TSP) cells from the BM.  However, the precise identity of 
these cells has remained elusive, and it has been suggested that multiple TSP 
populations may exist (reviewed in (Weerkamp et al., 2006)).  Following thymic 
migration  these  initially  DN  cells  can  be  further  subdivided  into  four  stages 
based on the expression of CD44 and CD25 (CD44
+CD25
-; DN1, CD44
+CD25
+; 
DN2, CD44
-CD25
+; DN3 and CD44
-CD25
- DN4) (Godfrey et al., 1993).  In the 
DN1  and  DN2  stages,  thymocytes  progressively  lose  myeloid  and  B-cell 
potential and hence commit to the T-cell lineage.  The upregulation of T-cell 
lineage-specific  mRNA  including  Rag1,  correlates  with  T-cell  lineage 
commitment  (reviewed  in  (Rothenberg  et  al.,  2008)).    The  extinction  of 
alternative fate potential is finalised in the DN2 stage.  Masuda et al. expressed        
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GFP  from  the  Lck  proximal  promotor  and  found  that  GFP
+  DN2  cells 
represented T-cell lineage committed cells, whereas GFP
- DN2 cells retained 
DC  differentiation  potential  (Masuda  et  al.,  2007).      Following  T-cell  lineage 
commitment, DN2 cells somatically recombine either their Tcrb (encoding the 
TCR  -chain) or Tcrg and Tcrd (encoding the   -TCR) genes.   
Those cells with in-frame    TCR rearrangements are subsequently signalled to 
commitment to the distinct   -T-cell lineage.    -T-cells are coreceptor negative, 
or  express  CD8    homodimers,  and  recognise  antigens  in  complex  with 
classical (MHC-I/MHC-II) and non-classical MHC molecules, including T10 and 
T22 in mice (reviewed in (Hayday, 2000)).  It has been suggested that   -T-cells 
recognise unique antigens and have a non-redundant role in both innate and 
adaptive  immunity.    For  example,    -T-cell-deficient  mice  exhibit  impaired 
mucosal  IgA  responses  following  oral  administration  of  tetanus  toxoid  and 
cholera toxin (Fujihashi et al., 1996), and show an increased susceptibility to 
Candida albicans infection (Jones-Carson et al., 1995). 
Nevertheless,   -T-cells  represent  a  minority  population  in  the  thymus.    The 
majority of DN2 thymocytes will rearrange TCR  and surface expression occurs 
along with the invariant pre-TCR  chain (referred to as the pre-TCR hereon) at 
the DN3 stage (Groettrup et al., 1993).  Commitment to the   -T-cell lineage 
over the   -lineage is finalized by pre-TCR signalling (Fehling et al., 1995).  Two 
recent papers suggest that    versus   -lineage commitment is likely to depend 
on the relative TCR signalling strengths conferred by the pre-TCR versus the        
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  -TCR.    Hayes  et  al.  found    -TCR  transgenic  mice  exhibited    -lineage 
committed  DP  cells  due  to  low  transgenic    -TCR  expression.    CD5  is  a 
negative  regulator  of  TCR  signalling  and  therefore  crossing  the  mice  onto  a 
CD5-deficient background increased signalling and was also found to reduce    
to   -lineage misdirection (Hayes et al., 2005).  In addition Haks et al. found 
that  attenuation  of  TCR  signalling  resulting  from  Lck-deficiency  redirected 
  -TCR  transgenic  mice  to  the    -lineage  (Haks  et  al.,  2005).    These  data 
suggest  that    -lineage  commitment  is  mediated  by  relatively  strong  TCR 
signalling, whereas   -commitment is mediated by relatively weaker pre-TCR 
signalling.  If such a model proves to be correct, it would show that T-cells make 
a developmental fate decision based on the interpretation TCR signal strength. 
In addition to cementing   -T-cell lineage fate, pre-TCR signalling induces the 
rearrangement  and  expression  of  the  TCR   chain  at  the  DN3  stage  of 
development (Koyasu et al., 1997).  What follows is a proliferative burst and a 
downregulation  of  CD25  as  cells  phenotypically  transit  to  the  DN4 
subpopulation  (Penit  et  al.,  1988;  Vasseur  et  al.,  2001).    CD4  and  CD8 
coreceptor  expression  is  subsequently  induced,  and  these  coreceptors  are 
expressed  with  asymmetric  kinetics,  so  cells  transit  through  a  coreceptor 
skewed  immature  single  positive  (ISP)  stage  on  the  way  to  becoming 
CD4
+CD8
+ coreceptor double-positive (DP) cells (Paterson & Williams, 1987). 
Therefore the major driving force behind DN to DP maturation in   -T-cells is 
the successful rearrangement of the TCR -locus and signalling mediated by the 
pre-TCR, known as the  -selection checkpoint.        
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In  addition  to  TCR  signalling,  IL7  signals  also  play  a  role  in  DN  T-cell 
development, where they augment pre-TCR signals to promote survival.  There 
is  severe  reduction  in  DN    -lineage  T-cells  in  IL7  or  IL7r -deficient  mice 
(Peschon  et  al.,  1994;  von  Freeden-Jeffry  et  al.,  1995),  however  transgenic 
expression  of  the  pro-survival  molecule  Bcl2  rescues    ,  but  not    -T-cell 
numbers (Akashi et al., 1997).  Therefore, IL7 signals are hypothesised to play 
a role in   -T-cell development beyond promoting survival.  These data also 
suggest that in addition to limiting the naïve T-cell pool numbers, IL7 also limits 
the production of T-cell precursors.  Fitting with this suggestion, early thymic 
precursors are increased in IL7 transgenic mice (Samaridis et al., 1991). 
1.7 Double positive thymocyte development 
The second TCR-signalling-dependent checkpoint in the development of T-cells 
occurs at the DP stage.  The DP population is a developmental dead-end for the 
majority of T-cells, which do not express in-frame TCR  rearrangements that 
can  successfully  pair  with  the  TCR -chain.    These  cells  cannot  receive  a 
spMHC-mediated signal, resulting in their death by neglect.  In contrast those 
cells  receiving  a  particularly  strong  TCR:spMHC  signal  are  clonally  deleted 
(referred to as negative selection), a mechanism to prevent autoreactive cells 
from gaining effector function (Kappler et al., 1987).  Only those cells receiving 
a  relatively  weak  spMHC  signal,  likened  to  a  homeostatic  TCR  signal  are 
positively selected to develop to maturity (reviewed in (Starr et al., 2003)).        
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1.7.1 Death by neglect 
In the absence of MHC molecules, T-cells are arrested at the DP stage (Grusby 
et al., 1993), showing that TCR:spMHC signals facillitate the positive selection 
of DP cells.  In addition, DNA labelled DP cells were found to have a 3.5 day 
lifespan (Huesmann et al., 1991).  Apoptosis of DP cells has been visualized in 
situ in the thymic cortex of MHC-deficient mice (Surh & Sprent, 1994), showing 
that DP cells will die in the absence of MHC.  Thus it follows that T-cells that 
cannot contact spMHC will die by neglect at the DP stage.  Further evidence for 
this comes from the TCR -deficient mice, that show a DP arrested phenotype, 
but  no  accumulation  of  DP  cells  (Mombaerts  et  al.,  1992a).    DP  cells  are 
particularly sensitive to apoptosis, as they do not express IL7r  (Sudo et al., 
1993),  express  high  levels  of  suppressor  of  cytokine  signalling  1  (SOCS1) 
(Chong et al., 2003) and are refractive to IL7/ c-cytokine survival signals (Van 
De Wiele et al., 2004).  Furthermore, non-positively selecting DP cells express 
low levels of the prosurvival molecule Bcl2 (von Freeden-Jeffry et al., 1997).  
Death by neglect ensures that T-cell clones incapable of self-recognition are 
rapidly deleted.  This is important because T-cells detect foreign antigen in the 
context of MHC. 
1.7.2 Negative selection 
A number of experimental models suggest that strong recognition of spMHC 
results in the clonal deletion of DP cells.  Strong signalling induced by anti-CD3 
treatment (Smith et al., 1989), or by exogenous administration of agonist TCR 
ligand in TCR transgenic mice induces the rapid and efficient deletion of DPs        
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(Sebzda et al., 1994).  Furthermore, it has been found that negatively selecting 
ligands  have  a  higher  affinity  for  the  TCR  compared  to  positively  selecting 
ligands (Alam et al., 1996).  Recent evidence suggests that clonal deletion to 
self-antigen  can  occur  in  the  thymic  cortex,  and  is  likely  to  be  efficiently 
mediated by a CD11c
+ DC cell subset (McCaughtry et al., 2008), although the 
unique  self-antigens  expressed  in  the  thymic  medulla  are  also  essential  for 
negative  selection  (see  below,  section 1.10.2).    It  is  thought  that  the  strong 
signals in the DP stage induce differential downstream signalling pathways than 
those  mediated  by  positive  selection  signals,  allowing  a  cell  to  distinguish 
between positive and negative selection (reviewed in (Starr et al., 2003)).  Thus 
only those cells with a weak avidity for spMHC undergo positive selection and 
progress beyond the DP stage of development. 
1.8 CD4/CD8 single positive lineage specification 
1.8.1 Positive selection 
Only cells with a weak affinity for spMHC undergo positive selection at the DP 
stage.    This  is  accompanied  by  phenotypic  changes  to  the  selecting  cell, 
including upregulation of the activation markers CD5 and CD69 (Azzam et al., 
1998; Lucas & Germain, 1996; Swat et al., 1993).  Positively selecting cells also 
undergo a developmental lineage choice, committing to either the CD4 or CD8 
lineage.  Lineage commitment is directed by the nature of the positive selection 
signal.  Those cells recognising spMHC-II subsequently commit to the CD4 SP 
lineage,  whereas  those  cells  recognising  spMHC-I  commit  to  the  CD8  SP        
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lineage.  Positive selection has been viewed solely as a developmental event.  It 
is unknown whether different clonal spMHC avidities have an impact on this 
process, or whether positive selection impacts the future homeostatic potential 
of a selecting T-cell clone.  Furthermore, the question of how T cells interpret 
MHC II versus MHC I mediated positive selection signals has been the subject 
of  much  contention.    A  number  of  different  models  have  been  proposed  to 
explain this process. 
1.8.1 Stochastic selection model 
The stochastic model of T-cell development proposes that CD4 or CD8 lineage 
commitment  occurs  at  random.    This  is  followed  by  a  coreceptor-mediated 
“rescue”  stage,  which  ensures  that  only  those  SP  cells  with  a  matching 
TCR/coreceptor:MHC interaction survive.  Support for this model was gained 
following  identification  of  CD4
hiCD8
lo  and  CD4
loCD8
hi  populations  in  both 
MHC-II-deficient  and  MHC-I-deficient  mice,  suggested  to  represent 
developmentally intermediate cells of a mismatched lineage (Chan et al., 1993).  
Evidence  for  the  stochastic  model  also  came  from  “coreceptor  rescue” 
experiments,  whereby  transgenic  expression  of  coreceptors  gave  rise  to  SP 
cells of a mismatched TCR:MHC specificity, albeit with a low efficiency (Davis et 
al., 1993; Itano et al., 1994). 
The  stochastic  model  therefore  predicts  that  CD4/CD8  lineage  commitment 
would be a highly error prone process, as 50% of positively selected cells would 
be expected to die following extinction of matched coreceptor expression.  The        
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finding that positive selection efficiency could approach 90% in TCR transgenic 
mice  therefore  opposes  the  stochastic  model  (Itano  &  Robey,  2000).  
Furthermore,  in  the  helper-deficient  (HD)  mice,  which  have  a  defect  in  CD4 
lineage commitment, MHC-II-restricted cells were redirected to the CD8 lineage 
and exported to the periphery (Keefe et al., 1999).  This paper suggested that 
cells  with  mismatched  coreceptors  were  not  short-lived  in  the  absence  of 
coreceptor:MHC  interaction.    Furthermore  targeting  of  CD4  coreceptor 
expression specifically to CD8 lineage cells did not result in increased CD8 SP 
development, further arguing against coreceptor-mediated rescue (Adoro et al., 
2008).    These  results  are  paradoxical  compared  to  initial  coreceptor-rescue 
experiments, and it has been argued that the non-physiological nature of the 
transgene  expression  in  the  initial  studies  may  result  in  TCR  signal 
misinterpretation leading to alternative lineage choice (reviewed in (Singer et al., 
2008)).  When taken together, evidence suggests that lineage commitment is 
more likely to be instructed by differences in MHC-II or MHC-I-mediated positive 
selection signals. 
1.8.2 Instructive models of lineage specification 
Instructive  models  of  lineage  commitment  suggest  that  differential  signalling 
mediated by MHC-II versus MHC-I instructs the CD4/CD8 lineage commitment 
decision.    Initially  it  was  proposed  that  differential  recognition  of  MHC-II  or 
MHC-I  resulted  activated  divergent  TCR  signalling  cascades  (Robey  et  al., 
1991; Seong et al., 1992).  The lack of evidence for differential signalling led to 
the refinement of this model, to suggest that quantitative differences in TCR        
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signalling strength underlie the CD4 versus CD8 lineage decision (Matechak et 
al., 1996). 
1.8.2.1 Quantitative instructive model 
The quantitative instructive model was first proposed to reconcile the finding 
that MHC-II restricted T-cells develop to the CD8 lineage in the absence of the 
CD4  coreceptor.    It  was  suggested  that  loss  of  CD4  lowered  the  TCR:MHC 
avidity, resulting in a weaker signal (Matechak et al., 1996).  Thus CD4 lineage 
development is associated with stronger positive selection signalling, whereas 
CD8  SP  development  is  associated  with  weaker  signalling.    Underlying  this 
model  is  the  finding  that  the  cytoplasmic  tail  of  CD4  has  a  stronger  binding 
affinity for Lck than does CD8 (Wiest et al., 1993).  Culture of thymocytes in 
neonatal  thymic  organ  cultures  (NTOCs)  along  with  weak  agonist  ligands 
resulted in CD4 development (Bommhardt et al., 1997), whereas culture with 
antagonist ligands resulted in CD8 development (Basson et al., 1998).  Both 
constitutively active and overexpressed Lck resulted in preferential development 
of  CD4  SP  cells  (Hernandez-Hoyos  et  al.,  2000;  Legname  et  al.,  2000), 
whereas  expression  of  a  dominant-negative  form  of  Lck  favoured  CD8  SP 
development  (Hernandez-Hoyos  et  al.,  2000).    Furthermore,  Lck-deficiency 
results  in  an  incomplete  block  in  both   -selection  and  positive  selection.  
Lck-deficient mice show an increased frequency of CD8 SPs relative to CD4 
SPs in both the thymus and periphery (Molina et al., 1992). 
There  is  however  conflicting  evidence  that  cannot  be  explained  by  a  simple 
quantitative instructive model.  For example mutation of ITAMs on CD3 -chains        
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was found to reduce TCR signalling capacity without skewing the CD4 versus 
CD8 lineage frequency (Holst et al., 2008; Love et al., 2000).  Also, generation 
of  mice  expressing  chimeric  CD8   molecules  with  CD4  cytoplasmic  tails 
resulted  in  a  greater  recruitment  of  Lck  to  the  coreceptor  tails,  but  no  CD4 
lineage redirection in MHC-I signalled thymocytes (Bosselut et al., 2001; Erman 
et  al.,  2006).    In  addition,  despite  differences  in  proximal  signalling  strength 
associated  with  CD4  versus  CD8  SP  development,  how  a  selecting  cell 
integrates and interprets these signals remains unclear.  Given the wide range 
of potential spMHC avidities, it is unclear how a T-cell could distinguish a weak 
avidity  MHC-II  signal  from  a  strong  avidity  MHC-I  signal.    A  diagram 
summarizing the quantitative instructive model is shown in Figure 1.4 A. 
1.8.2.2 Kinetic signalling model 
The kinetic signalling model was proposed as an alternative to the quantitative 
instructive model of CD4/CD8 lineage commitment.  Critical experiments leading 
to the formulation of this model came from Yasutomo et al., who showed that in 
an in vitro culture system, the duration of contact with self-antigen presenting 
DCs  correlated  with  subsequent  DP  cell  lineage  choice.    Whereas  longer 
contact  promoted  CD4  lineage  development,  shorter  contact  promoted  CD8 
lineage  development (Yasutomo  et  al.,  2000).    It  was  previously  shown  that 
phenotypically  intermediate  populations  of  positively  selecting  cells  could  be 
identified  based  on  modulation  of  coreceptor  expression.    These  cells  have 
begun the process of positive selection, but are not yet committed to either the 
CD4  or  CD8  lineage,  and  are  phenotypically  CD4
hiCD8
lo  (Lucas  &  Germain,        
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1996;  Lundberg  et  al.,  1995).    Brugnera  et  al.  integrated  these  findings, 
suggesting  that  cells  recognising  MHC-II,  which  depended  on  the  CD4 
coreceptor received continuous signals at the CD4
hiCD8
lo stage.  In contrast, 
the  termination  of  the  CD8  coreceptor  expression  in  CD4
hiCD8
lo  cells  was 
hypothesised to interrupt and shorten TCR signalling, resulting in the CD8 SP 
fate decision (Brugnera et al., 2000).  This model represented a step forward 
from   classical   lineage  commitment  models,  as  for  the  first  time  it  took  into 
account  the  kinetic  distinction  between  initiation  of  positive  selection  and 
subsequent  lineage  commitment  (reviewed  in (Singer  et  al.,  2008)).    In  vivo 
evidence for the kinetic signalling model came the CD4
E8III mouse, where the 
CD4  coreceptor  is  under  control  of  CD8  expression  elements.    These  mice 
showed  premature  termination  of  the  CD4  coreceptor  following  positive 
selection, and developed MHC-II restricted CD8 SP lineage cells (Sarafova et 
al., 2005). 
It  has  additionally  been  proposed  that  IL7  provides  the  differentiation  signal 
needed to instruct CD8 SP development from CD4
hiCD8
lo cells.  Evidence for 
this  first  came  from  a  two-step  culture  system  in  vitro.    Following 
Phorbol 12-myristate  13-acetate  and  ionomycin  treatment,  DP  cells  cultured 
with IL7 in the secondary culture apparently developed into CD8 SP cells with a 
greater efficiency then cells cultured with medium alone (Yu et al., 2003).  It has 
been additionally suggested that IL7 induces Runt-related transcription factor 
(Runx)3  gene  expression,  a  factor  critical  for  CD4  silencing  and  CD8  SP 
development (Park et al., 2010) (see below, section 1.9.1).          
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There  are  however  discrepancies  between  the  kinetic  signalling  model  and 
some  experimental  data.    When  Zap70  was  expressed  under  control  of 
adenosine deaminase (ADA) expression elements, expression was restricted to 
early DP cells and was terminated upon initiation of positive selection (Liu et al., 
2003).  It was found that premature termination of Zap70 expression alone did 
not induce CD8 SP lineage fate in the absence of transgenic Bcl2 expression, 
leading researchers to argue for a TCR-mediated “proofreading” step in CD8 
development (Liu et al., 2003; Liu & Bosselut, 2004).  In addition, there is no 
obvious  change  in  the  CD4/CD8  ratio  in  the  IL7  or  IL7r -deficient  mice 
compared to controls (Peschon et al., 1994; von Freeden-Jeffry et al., 1995), 
and CD8 SP development is still permitted in  c-deficient mice (Di Santo et al., 
1999), suggesting that any instructive role played by IL7 may be redundant.  
Furthermore,  it  has  been  argued  that  the  kinetic  signalling  model  and 
quantitative instructive models are not mutually exclusive (reviewed in (He et al., 
2010)).  Premature termination of TCR signalling and quantitative differences in 
TCR signal strength may represent redundant mechanisms, enabling a greater 
degree of accuracy during the CD4/CD8 lineage decision.  Finally, whilst this 
model classifies positive selection as a distinct event from lineage commitment, 
the lack of phenotypic markers other than CD4 and CD8 precludes the reliable 
identification and analysis of developmentally intermediate subsets of cells. A 
diagram summarizing the kinetic signalling model is shown in Figure 1.4 B.        
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1.9 Single positive lineage commitment 
In  addition  to   top-down   approaches  that  examined  the  proximal  signalling 
events regulating the CD4/CD8 lineage decision, there has been an increasing 
focus  on  the  downstream  factors  responsible  for  cementing  CD4  and  CD8 
lineage commitment.  These so-called  bottom-up  approaches have identified 
numerous factors critical for the development of one or other   -T-cell lineage.  
For  example  the  transcription  factors  GATA-binding  protein  3  (Gata3)  and 
T-helper-inducing  POZ/Krueppel-like  factor  (ThPOK)  are  essential  for  CD4 
lineage development, whereas Runx3 is required for CD8 development. 
1.9.1 CD8 lineage commitment 
Runx proteins were first implicated in the CD4/CD8 lineage decision by their 
essential  role  in  silencing  of  Cd4  gene  transcription  in  CD8  lineage  cells 
(Taniuchi et al., 2002).  Deletion of Runx3 reduced CD8 SP generation (Woolf et 
al.,  2003),  and  the  subsequent  generation  of  Runx3-deficient  mice  with  a 
CD4-Cre-mediated  DP  deletion  of  the  redundant  factor  Runx1  revealed  an 
essential  role  for  Runx  factors  in  CD8  lineage  development  (Egawa  et  al., 
2007).  Overexpression of Runx3 increased the proportion of mature CD8 SP 
thymocytes, although it did not entirely ablate CD4 lineage development (Kohu 
et  al.,  2005).    In  addition,  enforced  Runx3  expression  did  not  induced  CD8 
lineage differentiation in unsignalled DP thymocytes (Park et al., 2010).  This 
suggests the role of other non-redundant factors involved in the selection of 
CD8 lineage cells.  Interestingly, Runx proteins have been implicated in playing        
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an  antagonistic  role  in  the  regulation  of  the  CD4  lineage-commitment  factor 
ThPOK (reviewed in (Collins et al., 2009) and see below). 
In addition, a recent study Jones and Zhuang generated mice that conditionally 
deleted the E proteins E2A and HEB in DP thymocytes.  In these mice DP cells 
spontaneously developed into CD8 lineage cells that emigrated to LNs, even in 
the  absence  of  MHC  (Jones  &  Zhuang,  2007).    However,  the  relationship 
between  E  proteins,  TCR  signaling  and  other  transcriptional  networks 
implicated in the CD4/CD8 lineage decision remains to be clarified. 
Other than a non-redundant role for Runx proteins and potentially the negative 
regulation  of  E  proteins,  not  much  is  known  of  the  factors  and  mechanisms 
required for CD8 development.  When thymus high-mobility box protein (Tox) 
was overexpressed, it was found to block CD4 SP development, leading to the 
conclusion  that  this  factor  may  be  involved  in  determining  CD8  lineage  fate 
(Aliahmad  et  al.,  2004).    However,  CD4  SPs  were  paradoxically  absent  in 
Tox-deficient  mice,  whereas  CD8  SP  development  was  intact  (Aliahmad  & 
Kaye,  2008).    The  role  of  Tox  is  therefore  unclear,  but  it  certainly  does  not 
appear to play a non-redundant role in CD8 SP fate specification.  Similarly, it 
was  thought  that  notch  signalling  played  a  role  in  instructing  lineage 
commitment,  based  on  gain  of  function  studies.    However,  loss-of-function 
studies  revealed  no  redirection  of  MHC-II-restricted  thymocytes  to  the  CD8 
lineage,  suggesting  that  rather  than  lineage  commitment,  notch  may  be 
promoting CD8 lineage survival (reviewed in (Laky & Fowlkes, 2008)).  Indeed        
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the studies with notch reveal the difficulty in discriminating lineage commitment 
factors, from factors differently involved in CD4 and CD8 homeostasis. 
1.9.2 CD4 lineage commitment 
The  transcription  factor  Gata3  is  dispensable  for  positive  selection,  but 
necessary  for  CD4  SP  lineage  commitment.    Transgenic  overexpression  of 
Gata3  blocked  CD8  SP  lineage  development  in  fetal  thymic  organ  cultures 
(FTOC).  In contrast, inhibiting Gata3 expression through transfection of small 
inhibitory RNA (siRNA) or Gata3 function through overexpression of a Gata3 
antagonist  blocked  CD4  SP  lineage  commitment  (Hernandez-Hoyos  et  al., 
2003).  It was subsequently confirmed that Gata3 is essential for CD4 SP but 
dispensable  for  CD8  lineage  development,  in  mice  where  Gata3  was 
conditionally deleted at the DP stage using a CD4-cre/Loxp-mediated system 
(Pai et al., 2003).  Gata3 was shown to be downstream of TCR signalling in DP 
cells, perhaps induced or augmented by the cMyb transcription factor (Maurice 
et al., 2007).  Thus a link may exist between TCR signalling strength/length and 
induction of a factor essential for CD4 SP lineage development. 
Examination of a spontaneous HD mouse mutant that lacked CD4 but not CD8 
lineage T-cells revealed another essential transcription factor for CD4 lineage 
development  (Dave  et  al.,  1998a;  Keefe  et  al.,  1999).    Genetic  mapping 
revealed a loss-of-function point-mutation in a DNA binding domain of the factor 
ThPOK,  and  ectopic  ThPOK  expression  led  MHC-I-restricted  thymocytes  to 
adopt  a  CD8  lineage  fate.    Therefore  it  was  suggested  that  ThPOK  is  a        
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 master-regulator  of CD4 lineage commitment (He et al., 2005).  Although the 
mode  of  action  of  ThPOK  on  the  lineage  commitment  decision  is  not  well 
characterized, it has been suggested to oppose Runx-mediated repression of a 
CD4 silencer region, thus promoting maintenance of CD4 coreceptor expression 
(Wildt et al., 2007).  ThPOK expression depends on the function of cis-acting 
enhancer and repressor regions (reviewed in (He et al., 2010)).  Deletion of two 
conserved Runx binding sites in the Thpok repressor region was associated 
with Thpok-reporter gene de-repression in the CD8 lineage (Setoguchi et al., 
2008), although other researchers report no effect from deleting this region (He 
et al., 2008).  In contrast it has been reported that Gata3 is downstream of TCR 
signalling and upstream of ThPOK induction during CD4 lineage commitment 
(Maurice et al., 2007; Muroi et al., 2008; Wang et al., 2008).  Two conserved 
Gata3  binding  sites  exist  in  the  Thpok  promotor  sequence,  although  their 
function  remains  to  be  tested  in  knockout  studies.    Thus  Gata3  has  been 
suggested to act as a lineage-specifying factor, whereas ThPOK is suggested 
to  play  a  role  in  lineage  commitment (Wang  et  al.,  2008).    Future  work  will 
undoubtedly  reveal  additional  factors  regulated  by  ThPOK,  however  ThPOK 
appears  to  be  prominently  positioned  in  a  transcriptional  network  involving 
many of the key players in the CD4/CD8 lineage decision. 
The  experimental  evidence  to  date  has  therefore  identified  a  number  of  key 
transcription  factors  involved  in  the  CD4/CD8  lineage  commitment  decision.  
Future work must focus on addressing i) What are the upstream regulators of 
such  factors,  and  how  ultimately  they  are  regulated  by  TCR  signalling,  in        
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addition  to  ii) What  are  the  downstream  target  genes  for  these  lineage 
commitment  factors.    The  subdivision  of  the  CD4/CD8  lineage  commitment 
decision into distinct positive selection, lineage specification and finally lineage 
commitment  stages  has  broadened  the  understanding  of  the  transcriptional 
networks involved.  Examination of the various lineage commitment factors with 
a finer temporal resolution may enable further insights to their functions. 
1.10 Single positive maturation 
Following lineage specification and commitment, thymocytes are phenotypically 
CD4 or CD8 SP, but still require further maturation.  Whereas DN and DP T-cell 
development occurs in the thymic cortex, lineage committed thymocytes rapidly 
migrate  to  the  medulla  (Witt  et  al.,  2005),  where  they  are  exposed  to  an 
environment  that  uniquely  expresses  tissue-restricted  antigens  (TRAs) 
(reviewed  in  (Anderson  et  al.,  2007)).    The  most  immature  SP  thymocytes 
express  high  levels  of  Heat-stable  antigen  (HSA,  CD24),  and  are  subject  to 
clonal  deletion  following  strong  TCR  stimulation (Kishimoto  &  Sprent,  1997).  
Cells that strongly recognise self-antigens expressed in either the thymic cortex 
or medulla are rapidly deleted.  Alternatively, the remaining cells that do not 
exhibit  strong  reactivity  to  self-antigen  gain  the  potential  to  elicit  an  immune 
response, and subsequently emigrate to peripheral lymphoid tissues. 
1.10.1 Migration from the thymic cortex to medulla 
DN and DP thymocytes reside in the thymic cortex, whereas SP thymocytes 
relocate to the thymic medulla (reviewed in (van Ewijk, 1991; Yin et al., 2006)).         
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Evidence suggests that the relocation of positively selected SP thymocytes to 
the  thymic  medulla  involves  their  long-range  and  directed  migration  towards 
chemotactic factors produced in the medulla (Witt et al., 2005).  This occurs 
because  positive  selection  induces  changes  in  chemokine  sensitivity.    For 
example,  treatment  of  cells  with  phorbol 12-myristate  13-acetate  (PMA)  and 
ionomycin  at  concentrations  known  to  mimic  the  positive  selection  signal 
induces  the  upregulation  of  CCR7  (Adachi  et  al.,  2001),  which  is  also 
upregulated in vivo following positive selection (Misslitz et al., 2004).  CCR7 is 
the receptor for C-C motif chemokine ligand (CCL)19 and CCL21 (Yoshida et 
al., 1997), which are highly expressed by the thymic medulla (Misslitz et al., 
2004; Ueno et al., 2002).  The upregulation of CCR7 correlates with an increase 
in sensitivity to CCL19 and CCL21 (Campbell et al., 1999; Kim et al., 1998a).  
Furthermore, CCR7-deficient mice or mice with a spontaneously arising deletion 
of both CCL19/CCL21 genes, first identified as exhibiting a paucity of lymph 
node T-cells (referred to as plt/plt mice), exhibit an accumulation of SP cells in 
the thymic cortex (Misslitz et al., 2004; Nakano et al., 1998; Ueno et al., 2004).  
Hence CCR7:CCL19/CCL21 interactions are essential to mediate homing of SP 
thymocytes to the medulla. 
The question arises as to what the role of cortical to medullary migration is in 
thymocyte  development.    Crosstalk  between  SP  thymocytes  and  medullary 
thymic  epithelial  cells  (mTECs)  is  required  for  mTEC  terminal  differentiation 
(reviewed  in  (Anderson  &  Jenkinson,  2001))  and  in  keeping  with  this 
phenomenon; CCR7-deficient and plt/plt mice additionally exhibit dysregulated        
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thymic medullary architecture (Misslitz et al., 2004).  Furthermore, the medulla 
represents  a  unique  thymic  microenvironment  where  TRAs  are  ectopically 
expressed, facilitating the deletion of autoreactive thymocytes before they reach 
maturity  (see  below,  section  1.10.2).    Indeed  SP  cells  developing  in 
CCR7-deficient  mice  showed  increased  self-reactivity,  causing  potent 
dacryoadenitis and sialadenitis (Kurobe et al., 2006).  This finding suggests that 
the directed migration of positively selected thymocytes to the thymic medulla is 
a  requirement  for  central  tolerance.    Thus,  following  positive  selection,  the 
thymus can influence the T-cell repertoire before maturation is completed. 
1.10.2 Negative selection in the thymic medulla 
DP and newly generated SP cells are subject to deletion following stimulation 
with a strong TCR signal (Kishimoto & Sprent, 1997), suggesting that negative 
selection can occur in both the thymic cortex and the medulla.  Indeed, of the 
TCR  transgenic  mice  that  have  been  used  to  model  clonal  deletion, 
approximately half were found to delete in the cortex and the other half in the 
medulla  (reviewed  in  (Hogquist  et  al.,  2005)).    However,  the  frequency  of 
apoptotic cells found in the thymic cortex was identical in MHC-deficient and 
MHC-sufficient  polyclonal  mice,  suggesting  that  medullary  deletion  has  a 
greater  physiological  relevance  with  regards  to  negative  selection  (Surh  & 
Sprent,  1994).    That  cells  with  defects  in  medullary  migration  exhibit 
autoimmunity  provides  further  evidence  for  the  essential  role  of  the  thymic 
medullary environment in establishing central tolerance (Kurobe et al., 2006).        
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Autoimmune polyendocrinopathy-candidiases-ectodermal dystrophy (APECED) 
is a rare genetic disease in humans characterised by chronic mucocutaneous 
candidiases, hypoparathyroidism and adrenal insufficiency, resulting in a failure 
of  central  tolerance  (reviewed  in  (Mathis  &  Benoist,  2009)).    The  genetic 
mutations responsible for this condition were identified in a gene subsequently 
named autoimmune regulator (AIRE) (Aaltonen et al., 1997).  Knocking out Aire 
in  mice  similarly  resulted  in  autoimmunity  (Anderson  et  al.,  2002).    Aire  is 
hypothesised to function as a transcription factor, mediating thymic medullary 
expression  of  TRAs  (reviewed  in  (Mathis  &  Benoist,  2009).    Hence,  in  the 
thymic medulla, those T-cells strongly recognising TRAs will be clonally deleted 
before  reaching  maturity  (reviewed  in  (Hogquist  et  al.,  2005)).    In  contrast, 
AIRE-deficiency leads to a break in central tolerance and permits the maturation 
of autoreactive T-cell clones. 
1.10.3 Further differentiation of CD4 T-cells 
The thymic medulla is also likely to be the site of further differentiation of the 
CD4 lineage.  The majority of CD4 SP thymocytes will remain committed to the 
  -T-cell  lineage,  however  this  population  also  represents  the  likely  branch 
point for thymically derived Tregs cells and NKTs. 
Tregs  represent  a  distinct  lineage  of    -T-cells,  characterised  by  their 
expression  of  Foxp3,  in  addition  to  other  activation  markers  (reviewed  in 
(Sakaguchi, 2004).  It is thought that Treg development occurs from CD4 SP 
precursors that have a relatively strong avidity for spMHC, above the threshold        
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for positive selection, but just below the negative selection threshold.  Currently, 
a two-step model of Treg development is favoured, suggesting that strong TCR 
signalling upregulates CD25, facilitating enhanced IL2 sensitivity (Lio & Hsieh, 
2008).  This permits subsequent signalling from IL2, required to cement Treg 
lineage fate (reviewed in (Josefowicz & Rudensky, 2009).  
NKT  cells  also  represent  a  conserved  CD4  SP-derived  T-cell  sub-lineage.  
These  cells  express  an  invariant  TCR -chain  and  are  restricted  to  CD1d,  a 
molecule  related  to  MHC-I.    These  are  thought  to  represent  T-lineage  cells, 
however  they  additionally  express  the  NK-cell  marker  NK1.1  (reviewed  in 
(Kronenberg, 2005)).  Although the physiological relevance of NKT cells is not 
well  characterised,  their  development  along  with  Tregs  from  CD4  SP  cells 
further  highlights  the  role  of  the  thymus  in  shaping  the  peripheral  T-cell 
repertoire,  by  facilitating  signals  that  divert  SP  cells  to  particular  lineages 
(reviewed in (Godfrey & Berzins, 2007)). 
1.10.4 Thymic egress 
A final hurdle for developing T-cells is their emigration from the thymus.  It has 
been estimated that 5x10
7 T-cells emigrate from the thymus per month in young 
adult  mice  (Scollay  et  al.,  1980).    However,  these  cells  must  compete  for 
integration  into  peripheral  niches,  so  the  exact  contribution  of  recent  thymic 
emigrants (RTEs) to the naïve pool in a full host remains unknown.  Peripheral 
T-cell numbers are maintained in thymectomized adult mice (Tough & Sprent, 
1994),  although  in  the  absence  of  thymic  development  there  is  a  relative        
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increase  in  the  CD44
hi  memory-like  phenotype  cells,  and  a  corresponding 
decrease in naïve cells (Tanchot & Rocha, 1995).  In addition, the loss of thymic 
output  may  also  be  associated  with  a  decrease  in  naïve  T-cell  repertoire 
diversity, which may increase disease susceptibility (reviewed in (Mackall et al., 
1997)). 
Thymic emigration requires upregulation of sphingosine-1-phosphate receptor-1 
(S1P1) on T-cells and occurs in a sphingosine-1-phosphate (S1P) dependent 
manner (reviewed in (Weinreich & Hogquist, 2008)).  Although S1P1-deficient 
mice  die  of  vascular  defects  in  utero  (Pilorget  et  al.,  2007),  chimeric  mice 
reconstituted  with  S1P1-deficient  fetal  liver  cells  showed  relatively  normal 
thymocyte  development,  but  no  thymic  egress  (Matloubian  et  al.,  2004).  
Zachariah and Cyster have recently shown that neural-crest derived pericytes, 
which  ensheath  blood  vessels  at  the  cortico-medullary  junction  provide  an 
essential source of S1P to mediate egress (Zachariah & Cyster, 2010).  The 
mechanisms underlying the kinetics of S1P1 expression on newly generated SP 
thymocytes are unknown (reviewed in (Weinreich & Hogquist, 2008)), although 
this process is thought to occur over several days following positive selection 
(Le Campion et al., 2000; McCaughtry et al., 2007).  Nonetheless, the regulation 
of thymic egress has relevance to the question of how long a SP cell is retained 
in the thymic medulla and is thus amenable to negative selection.        
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1.11 Thesis aims 
That  T-cells  require  a  specialised  organ  to  facillitate  their  development 
highlights  the  complexity  of  this  selective  process.    The  thymic 
microenvironment  facilitates  the  random  rearrangement  of  TCRs,  which  are 
then  screened  to  ensure  sufficient  but  not  overt  levels  of  self-reactivity.  
Thymocytes are subsequently directed to either the CD4 or CD8 lineage, based 
on the MHC-restriction of their TCR.  
How a CD4 or CD8 SP fate decision is made by a DP thymocyte has been the 
subject  of  extensive  research.    It  is  recognised  that  positive  selection  and 
CD4/CD8 lineage commitment occurs over several days.  However, a lack of 
phenotypic  markers  that  can  reliably  identify  developmentally  intermediate 
populations  of  selecting  thymocytes  has  proven  to  be  a  major  obstacle  in 
studying this process.  There is a consensus that differences in TCR signalling 
likely conferred by the CD4 or CD8 coreceptor instruct a DP cell to commit to 
either  SP  lineage.    However,  the  precise  nature  of  these  disparate  signals 
remains  intensely  debated,  with  recent  models  suggesting  that  quantity  or 
duration  of  TCR  signalling  plays  a  role.    Furthermore,  such  models  do  not 
address whether there is a temporal component to the integration of lineage 
commitment signals.  For example, it is unknown whether CD4 and CD8 SP 
development occurs with identical kinetics following positive selection.   
The nature of the positive selection signal is also likely to vary within the same 
lineage, as unique T-cell clones are likely to have a different avidity for spMHC        
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and  may  be  subject  to  different  levels  of  clonal  competition.    It  is  unknown 
whether the quality of the positive selection impacts on the homeostatic survival 
potential of a selected T-cell, or whether all positively selected T-cell clones 
have an equal chance of peripheral survival.  Researching the mechanisms of 
thymic development is essential to understand how a diverse peripheral T-cell 
repertoire is maintained. 
Thus we aimed to investigate three broad aspects of thymic development: 
  i)  The  kinetics  of  the  CD4  versus  CD8  lineage  decision,  and  the 
phenotypic changes associated with this event. 
  ii)  The  interpretation  of  the  positive  selection  TCR  signal  by  selecting 
thymocytes. 
  iii) The impact of the positive selection signalling strength on the future 
homeostatic survival potential of mature T-cells.        
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Figure 1.1 IL7R signaling pathways 
A schematic representation of signalling pathways activated downstream of the 
IL7-receptor  (IL7R).    IL7  binding  induces  phosphorylation  of  Janus  kinase 
(JAK)1, JAK3 and subsequently IL7r -chain.  This resultant signalling cascades 
lead first to signal transducer and activator of transcription (STAT)5 recruitment 
to phosphorylated immunotyrosine activation motif (ITAM)s on the IL7r  chain.  
Recruited STAT5 is subsequently phosphorylated by JAK1/JAK3, facilitating its 
dimerization  and  subsequent  nuclear  translocation.    Secondly,  IL7  signalling 
induces  phosphatidylinositol-3-kinase  (PI3K)  recruitment  to  the  IL7r   chain.  
This recruitment brings PI3K in close proximity with the plasma membrane and 
permits the phosphorylation of phosphatidylinositol 4,5,-bisphosphate (PIP2) to 
phosphatidylinositol  3,4,5,-triphosphate  (PIP3).    Akt  and  its  activating  kinase 
3-phosphoinosite-dependent  protein  kinase-1  (PDK1)  both  possess  plekstrin 
homology (PH) domains, that facillitate lipid binding and thus co-localization with 
PIP3.    The  co-localization  of  PDK1  and  Akt  results  in  Akt  activation,  and 
induction  of  downstream  signalling  cascades  leading  to  a  pro-survival,  cell 
growth and cell proliferation response.  Transcription factors activated by IL7R 
signalling are shown in shaded red.        
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Figure 1.2 The structure of Zap70 
A schematic diagram showing Zap70 domains, and important tyrosine residues 
involved in signal transduction.  Zap70 consists of two N-terminal SH2 domains 
(shaded salmon) and a C-terminal kinase domain (shaded blue), separated by a 
flexible linker domain (interdomain B).        
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Figure 1.3 TCR signaling pathways 
A schematic representation of signalling pathways activated downstream of the 
TCR, following signalling mediated by sp/pMHC.  Crosslinking of the TCR and 
coreceptor induces the phosphorylation of ITAMs on CD3- ,  ,   and  -chains.  
Phosphorylated  ITAMS  facilitate  binding  and  activation  of  SH2-domain 
containing proteins of which Zap70 is essential.  The proximal TCR signalling 
events result in downstream phosphorylation of adaptor and scaffolding proteins 
including linker of activated T-cells (LAT) and SH2 domain containing leukocyte 
protein of 76kDa (Slp76), thus inducing formation of a large signalling molecule 
complex.  The associated effector molecule phospholipase C  -isoform (PLC ), 
hydrolyzes PIP2 to Inositol triphosphate (IP3) and diacylglycerol (DAG).  These 
lipid  products  act  as  second  messengers.    The  binding  of  IP3  to  IP3-gated 
calcium  channels  induces  store  operated  calcium  entry  and  subsequently 
calcium influx.  The cytosolic calcium binds calmodulin, which acts as a cofactor 
for  the  calcineurin  enzyme.    Calcineurin  dephosphorylates  nuclear  factor  of 
activated  T-cells  (NFAT),  permitting  nuclear  translocation  and  transcriptional 
activity.    In  contrast  DAG  activates  protein  kinases  including  Ras  guanyl 
nucleotide-exchanging  protein  (RasGRP)  and  PKC,  through  binding  to  C1 
domains.  This results in phosphorylation cascades, culminating in NF B and 
activator protein-1 (AP-1) activation.  Finally TCR signalling has been implicated 
in cytoskeletal reorganisation and cellular adhesion via Vav oncogene (Vav) and 
non-catalytic region of tyrosine kinase adaptor protein-1 (Nck) , which interact 
via  the  LAT  scaffold.    Transcription  factors  activated  by  TCR  signalling  are 
shown in shaded red.         
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Figure 1.4 Instructive models of CD4/CD8 lineage commitment 
A  diagram  showing  the  instructive  models  of  lineage  commitment.    (A) The 
quantitative instructive model states that differences in signal strength underlie 
the CD4 versus CD8 lineage choice.  Relatively stronger signalling mediated by 
CD4/TCR:spMHC  instructs  CD4  lineage  commitment,  whereas  weaker 
signalling  mediated  by  CD8/TCR:spMHC  instructs  CD8  lineage  commitment.  
(B) The  kinetic  signalling  model  states  that  differences  in  signalling  length 
underlie the CD4 versus CD8 lineage choice.  Initial positive selection signalling 
induces  transient  downregulation  of  the  CD8  coreceptor,  so  cells  are 
phenotypically  CD4
hiCD8
lo.    Those  cells  receiving  a  consistent  signal  in  the 
CD4
hiCD8
lo populations are instructed to commit to the CD4 lineage, whereas 
the  cells  in  which  signalling  is  disrupted  commit  to  the  CD8  lineage.    CD8 
lineage commitment may possibly depend on additional instructive IL7 signals.        
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Chapter 2 
Materials and Methods 
2.1 Mice 
2.1.1 Experimental mice used in this study 
Mice used in this study are shown in Table 2.1.  Mice were bred and housed at 
the  NIMR  animal  facility  under  specific  pathogen  free  (SPF)  conditions  in 
accordance with UK Home Office regulations.  Genotyping was performed by a 
combination  of  flow  cytometric  analysis  of  blood  and  PCR  analysis  of  DNA 
obtained from tails.  All experimental mice were used at 5-12 weeks of age.   
Table 2.1 List of mice used in this study. 
Mouse strain (designated in 
text) 
Background  Reference 
BALB/c  BALB/c   
C57B6/NIMR (B6 CD45.2)  C57B6/NIMR   
B6.SJL-Ptprc (B6 CD45.1)  C57B6/J   
B6.129-H2
dlAb1-Ea (MHC-II  / )  C57B6/J  (Madsen et al., 1999) 
D011.10 Rag1
-/-  BALB/c  (Murphy et al., 1990) 
F5 Rag1
-/- CD45.2 (F5 Rag1
-/-)  Mixed  (Mamalaki et al., 1993) 
F5 Rag1
-/- CD45.1  Mixed          
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F5
+/- Rag1
-/-  Mixed   
F5
+/- Rag1
-/- Zap70
-/- Zap70
Tre 
rtTA
huCD2 (F5 TetZap70) 
Mixed  (Saini et al., 2010) 
F5 Rag1
-/- b2m
-/-  Mixed  (Smyth et al., 1998) 
F5
+/- Rag1
-/- rtTA
HuCD2 Zap70
-/- 
(F5
+/- Rag1
-/-Zap70
-/-) 
Mixed  (Saini et al., 2010) 
rtTA
HuCD2 Lck
-/- (Lck
-/-)  Mixed  (Molina et al., 1992) 
OT-I Rag1
-/-  C57B6/J  (Hogquist et al., 1994) 
OT-II Rag1
-/-  C57B6/J  (Barnden et al., 1998) 
Rag1
-/-  C57B6/J 
(Mombaerts et al., 
1992b) 
Rag1
+/- b2m
-/- (b2m
-/-)  Mixed  (Koller et al., 1990) 
Rag1
-/- b2m
-/-  Mixed   
Rag2
-/-  C57B6/J  (Shinkai et al., 1992) 
SKG  BALB/c  (Sakaguchi et al., 2003) 
Zap70
Tre rtTA
huCD2 Zap70
-/- 
(TetZap70)  Mixed  (Saini et al., 2010) 
Zap70
-/-  C57B6/J  {Negishi, 1995 #39) 
 
All C57B6 or mixed mice are on an H-2
b background, and all BALB/c mice are 
on an H-2
d background. 
2.1.2 Tetracycline inducible Zap70 mice 
Mice were generated bearing a construct encoding Zap70 and a human CD2 
(huCD2) reporter gene, under control of a tetracycline response element (TRE) 
(Zap70
Tre) (Gossen & Bujard, 1992; Saini, 2007; Saini et al., 2010) (TreZap70).         
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These  mice  were  crossed  with  a  strain  expressing  a  reverse  tetracycline 
transactivator  protein  (rtTA)  under  control  of  HuCD2  regulatory  elements 
(rtTA
huCD2) (Legname et al., 2000; Zhumabekov et al., 1995).  Mice were then 
bred  to  an  endogenous  Zap70  deficient  background  to  generated  Zap70
Tre 
rtTA
huCD2 Zap70
-/- mice (TetZap70) (Figure 2.1). 
2.1.3 Doxycycline induction of TetZap70 mice 
TetZap70  mice  were  induced  to  express  Zap70  by  the  administration  of  the 
tetracycline derivative doxycycline (dox) in food, at a concentration of 3mg/g 
(3% w/w).        
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2.2 Media 
Phosphate buffered saline (PBS) (was either produced in house at the NIMR or 
purchased from GIBCO). 
Fluorescent activated cell sorting (FACS) buffer:  PBS supplemented with either 
5% (v/v) heat-inactivated fetal calf serum (FCS) (Biosera) or 0.5% (v/v) sodium 
azide (Sigma) and 0.5% (w/v) bovine serum albumin (BSA) (Sigma).  
Air buffered Iscove s modified Dulbecco s medium (IMDM): produced in house 
at the NIMR. 
Handling media: Air buffered IMDM containing 1% (w/v) BSA. 
IMDM (FCS):  Air buffered IMDM containing 5% (v/v) FCS. 
ACK  lysis  buffer:  150mM  NH4Cl,  10mM  KHCO3,  0.1mM 
Ethylenediaminetetraacetic acid (EDTA). 
Complete Dulbecco s modified Eagle s medium (cDMEM): Dulbecco s modified 
Eagle s  medium  (DMEM)  (GIBCO)  supplemented  with  10%  (v/v)  FCS,  4mM 
L-glutamine  (Sigma),  50µM   -mercaptoethanol  (2ME)  (Sigma),  100µg/mL 
Penicillin G sodium (Sigma) and 100µg/mL Streptomycin sulphate (Sigma). 
Chemotaxis  medium:  Roswell  Park  Memorial  Institute  1640  (RPMI)  (GIBCO) 
supplemented with 5% (v/v) FCS, 0.5% (w/v) fatty acid (FA)-free BSA (Sigma),        
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4mM  L-glutamine  (Sigma),  100µg/mL  Penicillin  G  sodium  (Sigma)  and 
100µg/mL Streptomycin sulphate (Sigma). 
Wash buffer (for confocal microscopy slides):  PBS containing 1% FCS (v/v) 
0.5% Tween20 (v/v) (Sigma).        
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2.3 Antibodies for flow cytometry 
2.3.1 Primary antibodies 
A list of primary antibodies used for flow cytometry in this study is shown in 
Table 2.2.  
Table 2.2 List of conjugated cell surface antibodies used in this study 
Specificity  Clone 
(manufacturer) 
Conjugate/s  Working 
concentration 
B220 (CD45R) 
RA3-6B2 
(eBioscience) 
PE  1µg/mL 
CD4 
L3T4 
(eBioscience) 
PerCP, APC, PB, 
EF450, PO 
1.25µg/mL 
CD4 
RM4-5 
(Invitrogen)  PETR  1.25µg/mL 
CD4  RM4-5 
(Invitrogen) 
PO  2.5µg/mL 
CD5 
53-7.3 
(eBioscience) 
FITC, PE-Cy7, 
APC, EF450 
1.25µg/mL 
CD8   53-6.7 
(eBioscience) 
PE, PE-Cy7, 
EF450  0.5µg/mL 
CD8   5H10 (Invitrogen)  PETR  1µg/mL 
CD8   5H10 (Invitrogen)  PerCP, PO  0.5µg/mL 
CD19  1D3 (eBioscience)  APC-Cy7  0.5µg/mL 
CD24 (HSA) 
M1/69 
(eBioscience) 
FITC  1.25µg/mL 
CD25  PC61.5 
(eBioscience)  PE-Cy7  1.25µg/mL 
CD45.1  A20 (eBioscience)  FITC, PE  2.5µg/mL 
CD45.2  104 (eBioscience)  PE, Biotin  2.5µg/mL 
CD44  IM7 (eBioscience)  APC-EF780  0.5µg/mL 
CD69  H1.2F3 
(eBioscience) 
PE  1µg/mL        
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CD127 (IL7r )  A7R34 
(eBioscience) 
PE  1µg/mL 
HuCD2  RPA-2.10 (BD)  PE  Diluted 1 in 50 
HuCD2 
RPA-2.10 
(eBioscience) 
PE-Cy5  Diluted 1 in 50 
TCR   H57-597 
(eBioscience)  PE, PeCy5, APC  1µg/mL 
FITC –  Fluoerescein  isothiocyanate,  PE –  Phycoerythrin,  PerCP –  Peridinin-
chlorophyll protein, PETR – PE-Texas Red, APC – Allophycocyanin, EF780 – 
eFluor780, EF450 – eFluor450, PB – Pacific Blue, PO – Pacific orange, HSA – 
Heat stable antigen, HuCD2 – Human CD2.        
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2.3.2 Intracellular antibodies 
A list of Intracellular antibodies used in this study is shown in Table 2.3. 
Table 2.3 List of intracellular antibodies used in this study 
Antibody  Clone 
(Manufacturer) 
Conjugate  Working 
Concentration 
Erk2  G263-7 (BD)  APC-A647  Diluted 1 in 5 
Fyn 
Sc-434 (Santa Cruz 
Biotechnology) 
PE  1µg/mL 
LAT 
Rabbit Polyclonal 
(Cell Signaling 
Technology) 
n/a  Diluted 1 in 200 
Lck  MOL 171 (BD)  n/a  1µg/mL 
pSTAT5 (Y694)  47 (BD)  APC-A647  Diluted 1 in 50 
Slp76  HS76 (eBioscience)  FITC  0.05µg/mL 
Zap70  1E7.2 (eBioscience)  PE  1µg/mL 
A647  –  APC  conjugated  for  Alexa-Fluor  647,  Erk2  –  Extracellular  regulated 
kinase2, Fyn – Fyn proto-oncogene, LAT – Linker of activated T-cells, Lck – 
Leukocyte-specific  protein  tyrosine  kinase,  pSTAT  –  Phosphorylated  signal 
transducer  and  activator  of  transcription,  Slp76  –  SH2  containing  leukocyte 
protein  of  76  kDa  molecular  weight,  Zap70  –  Zeta-chain-associated  protein 
kinase  of  70kDa  molecular  weight,  kDa  –  kilodaltons,  n/a  –  Not  applicable 
(unconjugated antibody).        
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2.3.3 Secondary antibodies, reagents and isotype controls 
A list of secondary antibodies, reagents and isotype controls used in this study 
are shown in Table 2.4 
Table 2.4 List of secondary antibodies, reagents and isotype controls 
used in this study 
Antibody/Reagent  Clone 
(Manufacturer) 
Conjugate  Working 
Concentration 
Human Fc  
(CCL19-Fc 
secondary) 
Goat polyclonal 
(eBioscience)  PE  0.25µg/mL 
Mouse IgG1 
isotype control  A85- 1 (BD)  PE  1µg/mL 
Mouse IgG1 
isotype control 
MOPC-21 (BD)  APC-A647  Diluted 1 in 5 
Rabbit IgG1 (LAT 
secondary) 
Goat Polyclonal 
(Jackson labs) 
FITC  5µg/mL 
Rat IgG2a isotype 
control 
n/s (eBioscience)  FITC  2.5µg/mL 
Streptavidin  n/a (eBioscience)  PE  0.5µg/mL 
Streptavidin  n/a (BD)  PETR  0.5µg/mL 
IgG – Immuglobulin G, Fc  – Fc receptor  -fragment        
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2.4 Preparation of single cell suspensions  
2.4.1 Thymus, spleen and lymph nodes 
Cervical, axillary, brachial, mesenteric and inguinal lymph nodes (LNs), spleen 
and thymus were dissected from mice.  Lymphocytes were teased into ice cold 
handling media via mechanical disintegration through 75µm nylon mesh.  Cells 
were  washed  1-2  times  with  an  equal  volume  of  FACS  buffer,  centrifuged 
(Multifuge 3 s-r, Heraeus) (1200 RPM, 4min) and re-suspended in fresh FACS 
buffer.    Total  lymphocyte  counts  were  taken  using  a  Casy-1  cell  counter 
(Schärfe System) according to the manufacturers instructions.  Cells were kept 
on ice throughout. 
2.4.2 Peripheral blood 
100µL  of  peripheral  blood  was  obtained  by  nicking  the  lateral  tail  vein  of 
experimental mice with a scalpel blade.  Blood was collected in microfuge tubes 
containing  ~100µL  heparin  (dissolved  in  PBS,  according  to  manufacturer s 
instructions, Sigma).  Red blood cell lysis was performed by the addition of 2mL 
ACK lysis buffer followed by vigorous vortexing, for approximately three minutes 
at  room  temperature,  before  samples  were  washed  in  2mL  ice  cold  FACS 
buffer. 
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2.5 Flow cytometry 
2.5.1 Surface immunostaining and FACS analysis 
Lymphocytes were incubated on ice and in the dark in 100µL primary antibody 
cocktail per 2-5x10
6 cells, made with antibodies conjugated to fluorescent labels 
or  biotin.    Antibodies  were  made  up  to  appropriate  working  concentrations 
(indicated in Table 2.2) in ice-cold FACS buffer and staining was performed for 
one hour.  To visualise biotinylated antibodies, cells were washed once and 
secondary staining was performed with streptavidin conjugated to PE or PETR 
(as detailed in Table 2.4).  Cells were then washed 1-2 times in FACS buffer 
and filtered through 35µm-pore cell strainers (BD Falcon).  Flow cytometry was 
performed on CyAN ADP (Beckman Coulter), BD LSRII, BD FACSCantoII or BD 
FACSAria  flow  cytometers  (all  BD)  and  data  analysis  was  performed  using 
Flowjo software (v8.8.6 or v9.01) (Tree Star).   
2.5.2 CCR7 detection 
Lymphocytes  were  incubated  on  ice  and  in  the  dark,  in  primary  antibody 
cocktails  additionally  containing  CCL19-Human  Fc  receptor   -fragment  (Fc ) 
(eBioscience) at a working concentration of 0.25µg/mL.  Cells were stained in 
100µl of antibody cocktail per 2x10
6 cells, for one hour.  Lymphocytes were then 
washed  one  time,  and  subsequently  incubated  in  100µL/2x10
6  cells  PBS 
containing 2% normal rat serum (Caltag), 2% Normal mouse serum (Invitrogen) 
and  PE-conjugated  anti-human  IgG  Fc   fragment  specific  mouse  polyclonal        
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antibody (Table 2.4) for one hour.  Cells were subsequently washed 1-2 times 
and analysed by flow cytometry.   
2.5.3 Intracellular flow cytometry 
2.5.3.1 NP40 permeablisation 
Cells were first stained for surface antigens as described in section 2.5.1.  For 
analysis of Fyn, Lck or Zap70 expression, cells were washed once in PBS and 
fixed with IC fixation buffer (eBioscience) at room temperature for 20 minutes.  
Cells  were  washed  and  re-suspended  in  0.1%  nonidet  P-40  (NP40)  (Igepal 
ca-630) (Sigma-Aldrich) in distilled water (dH2O) (v/v) for three minutes.   Cells 
were  subsequently  washed  in  1mL  PBS  and  re-suspended  in  intracellular 
antibody cocktail containing antibody at concentrations indicated in Table 2.3, 
made  up  in  PBS.    Staining  was  performed  overnight.    For  unconjugated 
antibodies  (Lck),  cells  were  washed  and  primary  staining  was  visualised 
following a secondary incubation with polyclonal anti-mouse IgG1 conjugated to 
PE  at  appropriate  concentrations  in  100µL  per  2x10
6  cells,  for  one  hour 
(Table 2.4).  Cells were washed twice and analysed by flow cytometry.  Where 
applicable,  cells  stained  with  isotype  control  antibodies  were  treated  in  an 
identical manner. 
2.5.3.2 Methanol Permeablisation 
For analysis of Erk2, LAT, pSTAT5 and Slp76 expression, lymphocytes were 
surface  stained,  washed  once  in  PBS  and  fixed  in  IC  fixation  buffer  for  20 
minutes at room temperature.  Cells were washed and re-suspended on ice with        
  98 
500µL  90%  methanol  in  dH2O  (v/v)  (originally  at  -20ºC)  for  28  minutes.  
Lymphocytes were the washed twice in at least 4mL FACS buffer, before being 
incubated with intracellular antibody at appropriate concentrations (Table 2.3), 
in 100µL FACS buffer for one hour.  Staining was performed on ice, with the 
exception  of  pSTAT5,  where  it  was  performed  at  room  temperature.    For 
unconjugated antibodies (LAT), cells were washed and primary staining was 
visualised following a secondary incubation with polyclonal goat anti-rabbit IgG1 
conjugated to FITC at appropriate concentrations in 100µL per 2x10
6 cells, for 
one  hour  (Table  2.4).    Cells  were  then  washed  twice  and  analysed  by  flow 
cytometry.  Where applicable, cells stained with isotype control antibodies were 
treated in an identical manner.  
2.6 Radiation bone marrow chimeras 
2.6.1 Bone marrow isolation 
Bone  marrow  (BM)  was  isolated  from  tibiae  and  femora  of  TetZap70  mice.  
Epiphyses  were  removed  and  BM  was  obtained  by  flushing  handling  media 
through the medullary canal with a 25-gauge needle.  The BM was next filtered 
through a 35µm cell strainer and washed twice in handling media before being 
re-suspended in handling media at a concentration of ~2.5x10
7 cells/mL. 
2.6.2 Irradiation and bone marrow reconstitution 
Rag1
-/- host mice were irradiated with 500 Rads (caesium source) and allowed 
to rest for 12-24 hours.  Transfer of BM cells was performed by intravenous        
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(I.V.) administration of ~200µL cell suspension (5x10
6 cells) into the lateral tail 
vein of irradiated host mice with a 0.5mL microfine insulin syringe (BD).  Mice 
were subsequently treated with water supplemented with 0.02% (v/v) Baytril® 
for one month (Sigma, UK).  Mice were left for at least eight weeks to allow 
reconstitution of the lymphoid compartment, which was confirmed by phenotypic 
analysis of peripheral blood.  Peripheral blood was prepared as described in 
section 2.3.2.  Cells were washed with a further 2mL FACS buffer and analysed 
for the expression of cell surface B220, CD19 and TCR by flow cytometry as 
described  in  section 2.5.1.    Reconstituted  chimeras  were  identified  by  the 
presence of B220
+CD19
+ B-cells and the absence of T-cells. 
2.7 Cell sorting 
Cells  were  stained  for  expression  of  cell  surface  markers  as  described  in 
section 2.5.1, with handing media used in place of FACS buffer.  Cells were 
then washed and re-suspended in handling media at a concentration of  1x10
8 
cells/mL.  FACS sorting was performed using Moflo (Dako) or BD FACSAria 
(BD) cell sorters, and sorted cells were collected in ice cold handling media.  
2.8 mRNA expression analysis 
2.8.1 Isolation of total cellular mRNA 
Cell populations were obtained by cell sorting (section 2.6), or total lymph node 
T-cells (LNTs) were used (as indicated in figure legends).  Cells were washed in 
PBS  and  were  lysed  in  750µL  Trizol®  reagent  (Invitrogen),  in  sterile  1.5mL        
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microfuge tubes (Eppendorf) at a concentration of  7.5x10
6 cells/mL.  Samples 
were mixed by repetitive pipetting and incubated at room temperature for ~10 
minutes.    200µL  of  phenol-chloroform  was  added  to  samples,  which  were 
shaken  vigorously  and  left  for  5-10  minutes  to  permit  phase  separation.  
Samples  were  centrifuged  at  12000RPM  for  15  minutes  at  4°C  in  a 
mini-centrifuge (Biofuge fresco, Heraeus).  The aqueous phase was transferred 
into  a  fresh  sterile  microfuge  tube  with  an  equal  volume  of  isopropanol.  
Samples were snap frozen on dry ice and stored overnight at -70°C.  Samples 
were thawed and centrifuged in a mini-centrifuge at 13000 RPM for 30 minutes, 
before  the  supernatent  was  carefully  removed  by  pipetting.    Pellets  were 
washed  once  in  200µL  70%  ethanol  in  dH2O  (v/v)  and  centrifuged  for  five 
minutes at 13000 RPM.  The RNA pellet was re-suspended in 20µL RNase free 
dH2O (Ambion) and RNA was quantified by a nanodrop 1000 (Thermoscientific).  
2.8.2 Reverse transcription of mRNA to cDNA 
First  strand  cDNA  synthesis  was  produced  using  olio(dT)12-18  primers 
(Invitrogen).    cDNA  was  produced  with  Superscript  II  reverse  transcriptase 
(Invitrogen).  Both were used according to the manufacturer s instructions. 
2.8.3 Quantitative real time polymerase chain reaction 
PCR mix was made with 12.5µL/reaction TaqMan universal PCR master mix 
(Applied Biosystems), 1.25µL/reaction qPCR assay mix (Applied Biosystems) 
containing  PCR  primers  (900nM  final  concentration),  6-carboxyfluorescien 
(FAM)  labelled  TaqMan  MGB  probe  (250nM  final  concentration)  and  1.25µL        
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RNase free dH2O.  PCR primers used in this study are shown in Table 2.5. 
PCR mix (15µL/reaction) was added along with 10µL cDNA sample (containing 
40ng of RNA prior to reverse transcription, diluted in dH2O) into one well on a 
MicroAmp  96-well  reaction  plate  (Applied  Biosystems).    All  reactions  were 
performed  in  triplicate  for  45  cycles  on  an  ABI  x7900  or  x7000  Sequence 
Analyser (Applied Biosystems), following the manufacturer s instructions.  Data 
was analysed by the standard curve method (Applied Biosystems) (reviewed in 
(Nolan et al., 2006)) and expression of the gene of interest was normalised to 
expression  of  the  housekeeping  gene  Hypoxanthine-guanine 
phosphoribosyltransferase1 (Hprt1) (Steen et al., 1990).  Normalised expression 
was calculated according to the equation: 
 
Ct is an arbitrary measure of fluorescence and is the mean average of three 
replicate wells. 
Table 2.5 qPCR primers used in this study 
Common Name  Gene  mRNA 
designation 
in text 
Applied 
Biosystems primer-
probe assay 
number 
CD5  Cd5  Cd5  Mm00432417_m1 
Cathepsin W  CtsW  CtsW  Mm00515599_m1        
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Forkhead box O1  Foxo1  Foxo1  Mm00490672_m1 
GA binding protein 
transcription factor, beta 
subunit 1 
Gabpb1  Gabpb1  Mm00487471_m1 
GATA binding protein 3  Gata3  Gata3  Mm01337569_m1 
Hypoxanthine-guanine 
phosphoribosyltransferase 
Hprt1  Hprt1  Mm01318743_m1 
Interleukin-7 receptor  -chain  IL7r  Il7r  Mm00434295_m1 
Runt-related transcription 
factor 1 
Runx1  Runx1  Mm01213405_m1 
Runt-related transcription 
factor 1 
Runx3  Runx3  Mm00490666_m1 
Zinc finger and BTB domain 
containing 7B 
Zbtb7b  Thpok  Mm00784709_s1 
Zeta-chain-associated 
protein kinase of 70kDa 
molecular weight 
Zap70  Zap70  Mm00495255_m1 
 
2.9 Intrathymic cell transfers 
Donor  cells  were  isolated  by  cell  sorting  as  described  in section  2.7,  or  F5 
Rag1
-/-  b2m
-/-  thymi  were  used  as  a  source  of  non-selecting  F5  donor  DP 
thymocytes.  Cells were re-suspended at a concentration of  1x10
8 cells/mL in 
handling media.  Intrathymic injection was performed with modifications from a 
previously  published  protocol  (Goldschneider  et  al.,  1986).    Mice  were 
anaesthetised through inhalation of isofluorane (Abbott).  A ~1-2cm incision was 
made  in  the  skin,  along  the  midline  overlying  the  lower  cervical  and  upper 
thoracic region.  Cell suspension (10µL, 5x10
4-1x10
6 cells) was injected into the 
anterior  superior  portion  of  each  thymic  lobe  using  a  1mL  microfine  insulin 
syringe  mounted  on  a  Tridak  stepper  (Tridak).    Injection  depth  varied  from        
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~5-10mm.    Following  injection,  the  incision  was  closed  with  9mm  surgical 
wound clips (BD).  Mice were left for indicated numbers of days, before entire 
thymi  were  analysed  by  flow  cytometry  for  expression  of  cell  surface  and 
intracellular antigens as described in section 2.5.  Flow cytometric analysis of 
whole thymi was performed using a CyAN ADP flow cytometer. 
2.10 Cell culturing 
2.10.1 One day culture of DP thymocytes 
Thymocyte  subpopulations  were  obtained  by  cell  sorting  (section 2.7)  and 
cultured at 37°C in a Sanyo CO2 incubator (Sanyo) at 5% carbon dioxide (CO2) 
overnight in cDMEM in 96 well plates, in 100µL medium at a concentration of 
 5x10
6 cells/mL.  Cells were then washed once before analysis of cell surface 
marker expression by flow cytometry as described in section 2.5. 
2.10.2 in vitro positive selection culture  
Non-selecting  (DP1,  see  chapter 3)  thymocytes  were  obtained  through  the 
negative selection of mature thymocytes from B6 thymus.  B6 thymocytes were 
surface  stained  at  a  concentration  of   1x10
8  cells/mL  with  biotinylated 
antibodies  to  CD3  CD25  and  CD69  (1µg/mL  CD3  (clone  145-2C11, 
eBioscience), 2.5µg/mL CD25 (clone PC61.5, eBioscience) and 2.5µg/mL CD69 
(clone 17A2 BD)).  Cells were washed and depleted using streptavidin coated 
Dynal® magnetic beads (Invitrogen) at a 1:1 ratio to cells, at a concentration of        
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2-4x10
7  cells/mL  according  to  manufacturer s  instructions.    Unlabelled  cells 
were collected, transferred to a fresh tube and counted. 
in vitro positive selection cultures were based on a previously published protocol 
(Ohoka et al., 1996) .  Lymphocytes (4-5x10
6) were cultured in 1mL cDMEM 
with Phorbol 12-myristate 13-acetate (PMA) (0.2ng/mL) (Sigma) and ionomycin 
(0.2µg/mL) (Sigma) for 14 hours at 37°C in 5% CO2
 (primary culture) unless 
otherwise indicated.  Cells were washed twice in fresh cDMEM and cultured in 
1mL  cDMEM  for  the  remaining  time  as  indicated  (secondary  culture  =  total 
culture time less 14 hours primary stimulation).  Where indicated, inhibitors were 
used  throughout  the  primary  and  secondary  cultures  at  the  following 
concentrations:  actinomycin D (ActD) (5µg/mL), cyclohexamide (Chx) (1µg/mL), 
Kn93  (20ng/mL),  U0126  (3.8µg/mL),  cyclosporin  A  (CsA)  at  indicated 
concentrations  (1-100ng/mL)  and  FK506  (10ng/mL)  (all  Sigma).    Cells  were 
harvested  at  the  timepoint  indicated  and  analysed  by  flow  cytometry 
(section 2.5). 
2.11 Chemotaxis assays 
Thymocytes  were  dissected  into  chemotaxis  medium,  counted  and 
re-suspended  in  chemotaxis  medium  at  a  concentration  of  1x10
8  cells/mL.  
Chemotaxis assays were performed in 24-well tissue culture transwell plates 
with  5µm  pore  polycarbonate  filters  (Corning).    Transwell  inserts  (upper 
chamber) were coated overnight at 37°C with 100µL 2µg/mL fibronectin in PBS 
(R&D systems).  Fibronectin was then replaced with 100µL 1% FA-free BSA in        
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PBS and incubated at 37ºC for one hour.  The 1% FA-free BSA solution was 
then replaced with 100µL of cell suspension (1x10
7 cells/well).  600µL CCL21 
chemokine (R&D systems) was added to the lower chamber at a concentration 
of  500ng/mL.    Cells  were  incubated  at  37°C  with  5%  CO2  for  four  hours  to 
permit chemotaxis.  As an input control, 1x10
7
 cells were added directly to the 
lower chamber of a control well with identical amounts of chemokine.  Following 
incubation, transwell inserts were discarded and FITC conjugated polystyrene 
beads (caliBRITE beads, BD) were added to samples and control wells.  Beads 
were diluted (~3 drops in 5mL) and 100µL beads were added per well.  Cells 
were washed in FACS buffer and underwent surface staining as described in 
section 2.5.1.  Cells were then analysed on a BD LSRII flow cytometer.  Beads 
could  be  distinguished  from  cells  based  on  their  higher  side  scatter  (SSc) 
relative  to  lymphocytes.    Frequency  of  migration  (% migration)  for  gated  cell 
populations was calculated according to the following equation: 
 
2.12 Confocal microscopy 
2.12.1 Embedding, sectioning and fixation of tissue 
Thymi were dissected, snap-frozen on blocks of dry ice and stored at -70°C until 
use.    Wet  filter  paper  was  frozen  onto  a  chuck  inside  a  cryostat  (Bright 
Instrument Co Ltd).  Optimal cutting temperature (OCT) compound (1mL) was        
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next used to adhere whole thymi onto the filter paper before being frozen with 
Cryospray (Bright Instrument Co Ltd.).  Continuous 20µm slices were made with 
a microtome (Bright Instrument Co Ltd) to remove epithelial layers and expose 
the internal thymic structure.  5µm sections were cut and adhered to a four spot 
Vectabond coated multispot slide (Vector Laboratories).  Slides were dried at 
room temperature for at least one hour and fixed in pre-cooled 90% acetone 
(v/v)  at  4°C  for  20  minutes.    Following  fixation  slides  were  air  dried  for  10 
minutes and stored at -20°C. 
2.12.2 Immunolabelling and visualisation of tissue sections   
Slides  prepared  as  above  (section 2.12.1)  were  washed  in  wash  buffer  in  a 
glass slide holder.  Slide spots were then dried with grade-three filter paper 
(Whatman) and placed in a humid chamber for incubation.  Antibody staining 
was  then  performed  for  one  hour  at  room  temperature.    Slide  spots  were 
incubated  with  50µL  antibody  cocktail  containing  antibodies  specific  for  CD4 
(clone  GK1.5,  eBioscience)  conjugated  to  Alexa-Fluor  647  with  an  antibody 
labelling  kit  (Molecular  probes))  and  CD8-Bio  (clone  H3517.2,  eBioscience).  
Following  a  15  minute  wash  in  wash  buffer,  visualisation  of  CD8-Bio  was 
performed  by  a  secondary  incubation  with  streptavidin  Alexa-Fluor  555 
(Invitrogen).  Slides were washed for 15 minutes in wash buffer and airtight 
coverslips were sealed on with clear nail varnish (La Femme).  Visualisation 
was performed using a Zeiss Confocal Microscope (Carl Zeiss AG).         
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2.13 Analysis of intracellular calcium flux by flow cytometry 
Isolated  lymphocytes  were  re-suspended  in  IMDM  (FCS),  counted  and 
incubated  at  a  concentration  of  4-6x10
6  cells/mL  with  the  calcium  indicator 
Indo1 (2µg/mL) (Grynkiewicz et al., 1985), conjugated to acetoxymethyl ester 
(Indo1 AM)  (Invitrogen).    Cells  were  incubated  for  40  minutes  at  37ºC  to 
facilitate hydrolysis of Indo1 AM to Indo1 by endogenous esterases.  Cells were 
washed and incubated at room temperature for 30 minutes in antibody cocktails, 
made up in IMDM (FCS) and additionally containing 10µg/mL anti-CD3 (clone 
145-2C11,  BD).    Cells  were  washed  and  re-suspended  in  ~300µL  handling 
media  at  room  temperature, for  use  as  a  stock  sample.    Stock  sample  was 
diluted 1 in 10 in room temperature handling media and analysed on a BD LSRII 
flow  cytometer,  equipped  with  a  355nm  UV  laser,  at  a  rate  of  ~20,000 
events/second.    Analysis  was  performed  for  30  seconds,  before  addition  of 
0.2µg/mL  crosslinking  antibody  (polyclonal  goat  anti-Armenian  hamster  IgG 
(H&L)) (Rockland) or 1µg/mL ionomycin.  Samples were vortexed briefly, before 
being  analysed  for  a  further  ~10  minutes.    Data  was  analysed  using  Flojo 
V8.8.6.    Cells  were  analysed  for  the  ratio  of  Violet  (405±20nm,  calcium 
bound):Blue (530±30nm, calcium unbound) light emission over time.  Calcium 
flux  was  shown  graphically  as  the  percentage  of  cells  over  an  arbitrary 
threshold  of  Violet/Blue  emission  (kept  consistent  throughout  the  same 
experiment) as a moving average over time.         
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2.14 Preparation of cell lysates and western blotting 
2.14.1 Western blotting reagents and solutions 
2.14.1.1 Solutions 
Lysis buffer:  50mM tris pH7.5, 150mM NaCl, 1mM NaOVa, 5mM EDTA, 10mM 
NaF, 10mM sodium pyrophosphate, 1% NP40 and one complete mini protease 
inhibitor cocktail (Roche).  
Sample buffer:  187.5mM tris-HCL, 6% (w/v) sodium dodecyl sulphate (SDS) 
(Sigma),  30%  (w/v)  glycerol,  150mM  dithiothreitol  (DTT)  and  0.03%  (v/v) 
bromophenol blue. 
PBS-Tween:  PBS and 0.001% (v/v) Tween20. 
Running buffer (Bio-Rad):  10x stock (tris/glycine/SDS buffer) diluted in dH2O.  
Transfer  buffer:    10mM  N-cyclohexyl-3-aminopropanesulfonic  acid ( CAPS) 
buffer pH11.  
Membrane  blocking  solution:    PBS  with  additional  3%  (w/v)  skimmed  milk 
powder (Marvel) and 0.05% Tween20 (v/v). 
2.14.1.2 SDS-PAGE acrylamide protein gels 
10%  resolving  gel:  1M  Tris  at  pH8.8,  H2O,  10mL  protogel  (National 
Diagnostics), 300mL 20% (w/v) SDS, 100µL 10% (w/v) ammonium persulphate 
(AMPS), 20µL Tetramethylethylenediamine (TEMED).        
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4% Stacking gel: 2.5mL 1M Tris at pH6.8, 13.3mL H2O, 3.3mL protogel, 200mL 
20% (w/v) SDS, 100mL 10% (w/v) AMPS, 20mL TEMED (10mL volume).  The 
stacking gel was cast over the resolving gel to aid sample resolution.  
2.14.2 Preparation of cell lysates 
Cell populations were obtained by cell sorting as described in section 2.6.  Cells 
were lysed at a concentration of 1x10
7 cells/mL in lysis buffer for 30 minutes at 
4°C.    Lysates  were  centrifuged  at  13000  RPM  for  30  minutes  at  4°C  in  a 
mini-centrifuge to pellet cellular debris.  Supernatant was decanted into a new 
microfuge  tube  and  incubated  with  an  equal  volume  of  sample  buffer  and 
agitated for one hour or overnight at 4°C.  Samples were stored at -70°C until 
use. 
2.14.3 Western blotting 
Samples were heated to 100°C for five minutes and spun for four minutes at 
13000 RPM in a mini-centrifuge.  Lysate equivalent to 2x10
5 cells was loaded 
onto  the  stacking  gel  in  a  volume  of  75µL  and  was  separated  on  a  10% 
SDS-PAGE gel in running buffer overnight (~14 hours) at 50V.  Control lanes 
were  loaded  with  Rainbow  coloured  protein  molecular  weight  marker 
(Amersham  Biosciences).    Proteins  were  wet  transferred  onto  methanol 
activated  polyvinylidene  difluoride  (PVDF)  membranes  (Millipore)  in  10mM 
transfer  buffer  at  ~400mA  for  2.5  hours.    Membranes  were  blocked  in 
membrane blocking solution for one hour at room temperature on a platform 
rocker  (Bibby  Scientific).    Membranes  were  washed  3x15  minutes  in        
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PBS-Tween and incubated with 50mL monoclonal Zap70 antibody (diluted 1 in 
1000  in  PBS-Tween,  clone  99F2,  Cell  Signaling  Technology)  or  50mL 
monoclonal GAPDH control (diluted 1 in 5000 in PBS-Tween, clone 14C10, Cell 
Signaling Technology) overnight on a platform rocker at 4°C.  Membranes were 
then  washed  (3x15  minutes)  in  PBS-Tween  at  room  temperature  and 
Horseradish  peroxidase  (HRP)  linked  secondary  antibody  (Anti-goat  IgG) 
(Promega) diluted 1 in 5000 in 1% (w/v) skimmed milk powder in PBS-Tween 
on  a  platform  rocker  for  one  hour.    Protein  bands  were  visualised  by 
chemiluminescence  with  enhanced  chemiluminescence  reagent  (ECL) 
(Amersham) developed on medical X-ray film (Kodak).   
2.14.4 Quantification of protein expression 
Zap70  protein  expression  was  normalised  to  GAPDH  using  densitometric 
analysis of scanned blots, with Image SXM software v1.62 (NIH).   
2.15 Comparative genomics 
Comparative  genomics  of  the  Zap70 5    and  upstream  region  and  graphical 
annotation  were  performed  using  ECR  browser,  available  online  at 
http://ecrbrowser.dcode.org  (accessed  September  2010).    Evolutionary 
conserved  transcription  factor  binding  sites  were  identified  using  rVISTA  2.0 
(Loots  &  Ovcharenko,  2004),  via  the  ECR  browser  website,  utilising  the 
TRANSFAC  professional  V10.2  library  for  vertebrates,  with  matrix  similarity 
optimized  for  function.    Mouse  versus  human  alignment  of  sequence  was 
performed using the ECR transcription factor binding site alignment function.         
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2.16 Adoptive transfer of F5 and OT-I lymph node cells 
2.16.1 Intravenous adoptive cell transfers 
Lymphocytes  were  obtained  from  LN  of  OT-I Rag1
-/-  or  F5 Rag1
-/-  mice  as 
described  in  section 2.4,  before  being  re-suspended  at  a  concentration  of 
2.5x10
7/mL.    Cell  suspension  (200µL,  5x10
6  cells)  was  administered 
intravenously into the lateral tail vein of indicated hosts, using a 0.5mL microfine 
insulin  syringe.    Mice  were  left  until  indicated  timepoints  following  injection, 
before  phenotypic  analysis  of  T-cells  was  performed  by  flow  cytometry  as 
described in section 2.5. 
2.16.2 pSTAT5 induction 
Lymphocytes were transferred, re-isolated and surface stained as described in 
section 2.16.1.    Where  <5x10
6  cells  were  isolated,  tubes  were  spiked  with 
congenically  disparate  B6  T-cells  to  ensure  equal  staining.    Samples  were 
washed in 1mL PBS, prewarmed to 37°C and stimulated with indicated amounts 
of interleukin (IL)-7 (Peprotech) for 30 minutes at 37°C.  Fixation was performed 
by addition of an equal volume of IC fixation buffer to samples after 30 minutes, 
before  incubation  at  room  temperature  for  30  minutes.    Samples  were 
subsequently permeablised with methanol and stained for intracellular pSTAT5 
(section 2.5.3).  Flow cytometry was performed on a BD FACSCantoII or BD 
LSRII flow cytometer and analysed using Flojo software (V8.8.6-9.0.1).        
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2.17 Calculations and statistical testing 
Calculations were performed using Microsoft Excel for Mac V12.2.4 (Microsoft).  
Statistical  tests  (two-tailed  small  sample  t-tests  unless  otherwise  indicated) 
were performed using Prism 5 for Mac OS X (Graphpad). 
2.18 Collaborations 
Flow cytometry for intact TetZap70 mice in Figure 3.2 D and B6 and TetZap70 
mice in Figure 5.1 F-H was performed by Moni Saini and Ben Seddon at NIMR, 
UK.  Jara Joedicke performed chemotaxis assays in Figure 3.10 C, at NIMR, 
UK.  Confocal microscopy and slide preparation in Figure 3.11 was performed 
in collaboration with Dr. Andrea White at the University of Birmingham, UK.          
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Figure 2.1 Tetracycline inducible control of Zap70 expression 
Illustrative diagram showing doxycycline (dox) inducible control of the Zap70 
and  HuCD2  transgenes.    TetZap70  mice  express  the  reverse  tetracycline 
transativator (rtTA) (blue) under control of the HuCD2 promotor (rtTA
HuCD2) and 
Zap70/HuCD2  reporter  under  control  of  a  tetracycline  response  element 
(Zap70
Tre).    In  the  presence  of  dox  (yellow),  the  rtTA  protein  binds  the 
tetracycline response element, where it acts as a transcription factor, driving the 
expression  of  Zap70  (red)  and  HuCD2  (green).    TetZap70  mice  are  on  an 
endogenous  Zap70-deficient  background,  ensuring  that  the  only  source  of 
Zap70 come from this tetracycline inducible system.        
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Chapter 3  
The Kinetic Regulation of Positive Selection 
and Lineage Commitment 
3.1 Introduction 
The thymic development of   -T-cells is a requirement for a functional immune 
system.  Patients with defects in T-cell development (Arpaia et al., 1994; Elder 
et al., 1994; Gelfand et al., 1995) or in ontogeny of the thymus (Kirkpatrick & 
DiGeorge, 1968) typically manifest a severe combined immunodeficient (SCID) 
phenotype.    Therefore  the  mechanisms  governing  T-cell  development  and 
differentiation  are  of  interest  with  regards  to  developing  future  treatments.  
Classically developmentally intermediate populations of thymocytes have been 
characterised by the phenotypic changes in a few surface proteins.  Different 
maturation  stages  can  be  identified  based  on  the  expression  of  the  T-cell 
receptor  (TCR)  coreceptors  CD4  and  CD8.    Thymocytes  are  initially  double 
negative (DN), lacking expression of the CD4 and CD8 coreceptors but can be 
further subdivided based on the expression of CD44 and CD25 (CD44
+CD25
-; 
DN1, CD44
+CD25
+; DN2, CD44
-CD25
+; DN3 and CD44
-CD25
- DN4) (Godfrey et 
al., 1993).  T-cells subsequently enter a CD4
+CD8
+ double positive (DP) stage, 
before they commit to either the CD4 or CD8 single positive (SP) lineage.  The 
ability  to  phenotypically  distinguish  between  developmentally  intermediate        
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populations  of  thymocytes  has  enabled  the  elucidation  of  important 
developmental checkpoints throughout T-cell ontogeny. 
Progression through the DN stages depends on successful rearrangement and 
expression of the TCR  chain, pairing with an invariant alpha chain (pre-T ) 
and subsequent pre-TCR signalling at the DN3 stage (known as  -selection) 
(Godfrey  et  al.,  1994;  Mombaerts  et  al.,  1992a).     -selection  is  followed  by 
rearrangement and expression of the TCR  chain (Koyasu et al., 1997), which 
is expressed along with both CD4 and CD8 coreceptors at the DP stage (Levelt 
et  al.,  1993).      -TCR  signalling  is  required  for  further  development  of  DP 
thymocytes and is mediated by contact with self peptide antigen displayed in 
the  context  of  major  histocompatibility  complex  (spMHC)  ligands  on  cortical 
thymic epithelial cells (cTECs) (Mombaerts et al., 1992a)(reviewed in (Starr et 
al., 2003)).  Only those T-cell clones that weakly recognise spMHC will mature 
beyond the DP stage, through a process known as positive selection.  As a 
further  level  of  complexity  those  T-cell  clones  recognising  spMHC-II  (which 
additionally depends on CD4 coreceptor recognition) will subsequently commit 
to the CD4 SP lineage, whereas T-cell clones recognising spMHC-I molecules 
(additionally depending on CD8 coreceptor recognition) will commit to the CD8 
SP  lineage.    The  mechanisms  underlying  how  a  TCR  signal  can  result  in 
divergent  developmental  outcomes  based  on  its  major  histocompatibility 
complex (MHC)-restriction have been the subject of much research (reviewed in 
(Germain, 2002)).        
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Positive selection TCR signalling depends on transduction through downstream 
kinases.  The most proximal signalling event is the recruitment of the kinase 
leukocyte-specific protein tyrosine kinase (Lck) to the TCR signalling complex, 
which depends on the cytoplasmic tails of either CD4 or CD8 (Rudd et al., 1988; 
Veillette  et  al.,  1988).    Following  initiation  of  TCR  signalling,  Lck  activates 
Zeta-chain-associated  protein  kinase  of  70Kda  molecular  weight  (Zap70) 
(Iwashima  et  al.,  1994)  and  Zap70  itself  targets  a  number  of  downstream 
adaptor  and  effector  proteins,  which  leads  to  positive  selection  (reviewed  in 
(Samelson,  2002)).    Indeed  Zap70
-/-  mice  show  developmental  arrest  at  the 
pre-positive  selection  DP  stage,  showing  an  essential  role  for  Zap70  in 
transducing the positive selection signal (Negishi et al., 1995).  In contrast, how 
a  positively  selecting  cell  distinguishes  an  MHC-I  versus  MHC-II  mediated 
selection signal is less well established.   
A currently favoured kinetic signalling model proposes that following an initial 
non-lineage-specifying signal, DP cells transiently downregulate expression of 
the CD8 coreceptor and enter a CD4
hiCD8
lo population.  It is suggested that 
CD4 dependent MHC-II signals can persist, whereas CD8 dependent MHC-I 
signalling  is  broken  off.    This  led  to  the  hypothesis  that  interpretation  of  a 
continued  or  intermittent  TCR  signal  underlies  the  CD4  versus  CD8  fate 
decision (Brugnera et al., 2000; Yasutomo et al., 2000).  Nevertheless, whether 
the  CD4
hiCD8
lo  population  is  indeed  an  obligate  step  for  CD8  lineage 
commitment is controversial (reviewed in (Hogquist, 2001)).  In addition, neither 
of these models addresses whether the CD4 versus CD8 lineage decision is        
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temporally regulated, as is commonly the case for developmental fate decisions 
(reviewed in (Freeman & Gurdon, 2002)). 
A number of recent studies have addressed the question of how lineage fate is 
specified  by  investigating  the  downstream  factors  responsible  for  lineage 
fixation.  For example, the nuclear factors GATA-binding protein 3 (Gata3) and 
T-helper-inducing  POZ/Kruppel-like  factor  (ThPOK)  have  been  shown  to  be 
essential for CD4 SP lineage commitment (He et al., 2005; Hernandez-Hoyos et 
al., 2003; Pai et al., 2003).  In contrast Runt-related transcription factor (Runx)3 
is required for CD4 silencing and CD8 SP lineage development (Egawa et al., 
2007;  Taniuchi  et  al.,  2002).    Importantly,  whilst  many  transcription  factors 
involved in lineage commitment are known, the question remains as to how their 
expression is related to the upstream positive selection signal.  Although it is 
known that positive selection occurs over a number of days (Lucas et al., 1993; 
Lucas et al., 1994; Lucas & Germain, 1996; Lundberg & Shortman, 1994), there 
are  a  lack  of  well-characterised  phenotypic  markers  that  can  distinguish 
populations  of  developmentally  intermediate  cells.    This  has  proved  to  be  a 
major obstacle with regards to answering the question of how TCR signalling 
directs lineage fate. 
Following lineage commitment SP T-cells migrate from the thymic cortex to the 
medulla.    In  the  medulla  they  are  exposed  to  peripheral  tissue  restricted 
antigens (TRAs), which if strongly recognised by a T-cell clone will induce clonal 
deletion (referred to as negative selection) (reviewed in (Anderson et al., 2007)).  
If T-cells can avoid negative selection, they emigrate from the thymus, populate        
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peripheral lymphoid tissues and are henceforth competent to elicit an immune 
response  (reviewed  in (Starr  et  al.,  2003)).    Recently  thymic  emigration  has 
been  tracked  in  mice  expression  GFP  under  control  of  the  Rag2  promotor.  
These experiments have suggested that medullary residency time is as short as 
4-5  days  (McCaughtry  et  al.,  2007).    These  results  are  in  contrast  to  older 
experiments suggesting a longer thymic residency time (Egerton et al., 1990).  
However,  the  kinetics  of  migration  from  the  cortex  to  the  medulla  following 
positive selection have not been studied.  For example it is unknown whether 
this migration differs for cells recognising MHC-I versus MHC-II. 
In this chapter we have sought to investigate the temporal regulation of positive 
selection and the phenotypic changes associated with CD4 versus CD8 lineage 
commitment.    Furthermore,  we  wanted  to  investigate  the  kinetics  of  SP 
thymocyte  maturation,  as  cells  migrate  to  the  thymic  medulla  and  undergo 
peripheral export.  Zap70
-/- mice are blocked at the DP stage of development 
(Negishi et al., 1995).  Therefore mice were generated in the lab, which allowed 
for  tetracycline  inducible  expression  of  Zap70  protein  on  an  endogenous 
Zap70-deficient background (see Materials and Methods section 2.1.2).  We 
hypothesised that administration of the tetracycline derivative doxycycline (dox) 
would  alleviate  the  block  at  the  DP  stage  of  development,  enabling  the 
continuation of thymic development.  This would allow us to characterise the 
kinetics of reconstitution of mature thymic compartments.        
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3.2 Results 
3.2.1 Phenotypic characterization of TetZap70 mice 
We wanted to explore the role of Zap70-dependent TCR signals beyond the DP 
block exhibited by Zap70
-/- mice (Negishi et al., 1995).  Mice were generated 
previously in the lab to allow for tetracycline inducible Zap70 expression on an 
endogenous  Zap70
-/-  background.    These  mice  possessed  a  transgene 
encoding Zap70 and downstream internal ribosomal entry site (IRES)-Human 
CD2  (HuCD2)  tailess  reporter,  under  the  control  of  a  tetracycline  response 
element (TRE) (Zap70
Tre strain hereon) (Gossen & Bujard, 1992; Saini, 2007; 
Saini et al., 2010).  These mice were crossed with a strain expressing a reverse 
tetracycline  transactivator  (rtTA)  protein  under  control  of  HuCD2  expression 
elements (rtTA
huCD2) (Legname et al., 2000; Zhumabekov et al., 1995).  Mice 
were additionally bred to an endogenous Zap70-deficient background (Negishi 
et al., 1995), ensuring that induced Zap70
Tre transgene was the only source of 
Zap70 expression (generating Zap70
Tre rtTA
huCD2 Zap70
-/- mice, TetZap70 mice 
hereon) (Saini et al., 2010).  Zap70 induction could be achieved through the oral 
administration  of  the  tetracycline  derivative  doxycycline  (dox),  in  the  food  of 
these  mice  (refer  to  Materials  and  Methods,  sections 2.1.2-2.1.3  and 
Figure 2.1) (Saini et al., 2010).  
We wanted to investigate the kinetics of thymic development beyond positive 
selection  by  inducing  Zap70  for  short  periods  of  time  and  phenotypically 
characterising the first wave of developing cells.  However, we first wanted to        
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know if the TetZap70 transgenic system enabled dox-inducible expression of 
Zap70 in vivo.  To investigate this, TetZap70 mice were fed dox for  7 days 
(TetZap70
on  hereon).    Examination  of  the  thymic  T-cell  phenotype  by  flow 
cytometry  revealed  expression  of  both  Zap70  and  the  HuCD2  reporter  by 
TetZap70
on  thymocytes  (Figure 3.1 A).    In  addition,  when  we  compared  the 
abundance of Zap70 in B6 and TetZap70
on thymocytes, we found that Zap70 
was expressed at similar levels (Figure 3.1 A, lower panel).  HuCD2 appeared 
to be a faithful reporter of Zap70 expression, as there was a positive correlation 
between  Zap70  and  HuCD2  expression  in  TetZap70
on  thymocytes 
(Figure 3.1 B).    Typically  dox  administration  resulted  in  Zap70/HuCD2 
expression  in  ~50-60%  of  the  thymocytes  (Figure 3.1 C).    Failure  to  induce 
Zap70/HuCD2 in some thymocytes may result from variegated expression of 
the Zap70
Tre transgene, which lacks a locus control region (LCR) (Saini, 2007) 
(reviewed in (Festenstein & Kioussis, 2000)).  Collectively these results indicate 
that  dox  administration  to  TetZap70  mice  results  in  variegated  induction  of 
Zap70 expression in vivo. 
Mature CD4 and CD8 SP thymocytes are absent in Zap70
-/- thymi due to a 
block in the positive selection of DP thymocytes (Negishi et al., 1995).  We 
wanted to investigate whether transgenic expression of Zap70 was sufficient to 
alleviate this developmental block and subsequently facilitate reconstitution of 
the mature SP thymic compartments.  We began by asking whether SP thymic 
populations were present in TetZap70
on mice.  CD4 and CD8 SP populations 
were indeed detectable in TetZap70
on thymi, in addition to B6 control mice.  In        
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contrast,  SP  populations  were  confirmed  to  be  absent  in  Zap70
-/-  thymi 
(Figure 3.1 D, top row).  We also wanted to examine the restoration of mature 
T-cell compartments independently of coreceptor expression.  Expression of the 
TCR  is  upregulated  with  maturity  following  positive  selection  (Havran  et  al., 
1987;  Penit,  1990;  Shortman  et  al.,  1991).    CD5  is  also  upregulated  on 
thymocytes that are undergoing or have completed positive selection (Azzam et 
al., 1998) and is believed to be a negative regulator of TCR signalling (Azzam et 
al.,  2001;  Tarakhovsky  et  al.,  1995).    We  further  investigated  whether 
tetracycline-inducible  Zap70  facilitates  mature  thymocyte  development  by 
comparing  TCR  and  CD5  expression  on  TetZap70
on  thymocytes  with  B6  or 
Zap70
-/-  controls.    Both  TetZap70
on  and  B6  thymi  showed  an  abundant 
TCR
hiCD5
hi  population,  whereas  Zap70
-/-  thymocytes  were  uniformly 
TCR
loCD5
lo (Figure 3.1 D, bottom row).  This suggested that transgenic Zap70 
expression  facilitates  mature  thymocyte  development  in  endogenous 
Zap70-deficient  thymocytes.    However,  we  did  find  the  TCR
hiCD5
hi  mature 
thymocyte  population  of  TetZap70
on  mice  to  be  significantly  reduced  in 
frequency  compared  to  equivalent  B6  controls  (p 0.001,  Student s  t-test  B6 
n=5, TetZap70
on n=8) (Figure 3.1 E).  The reduced frequency of mature cells 
may be partly due to transgene variegation, as the presence of Zap70-deficient 
cells  may  lead  to  an  overrepresentation  of  the  TCR
loCD5
lo  population.    We 
investigated this by gating on HuCD2
+ or HuCD2
- thymocytes from TetZap70
on 
mice  to  assess  their  comparative  phenotypes.    We  found  that  only  HuCD2
+ 
thymocytes showed phenotypic restoration of mature SP thymic compartments.  
In  contrast  HuCD2
-  cells  resembled  the  Zap70
-/-  phenotype,  arrested  at  a        
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TCR
loCD5
lo  DP  stage  (Figure 3.1 F).    Finally  we  asked  whether  transgenic 
Zap70  expression  could  restore  both  CD4  and  CD8  lineage  development 
equally.  When we examined the frequency of CD4 and CD8 SP cells within the 
TCR
hiCD5
hi  mature  thymocyte  population,  we  found  no  difference  in  the 
frequency of CD4 SPs in TetZap70
on compared to B6 mice.  However there was 
a  significant  reduction  in  the  CD8  SP  frequency  in  TetZap70
on  mice  as 
compared  to  B6  controls  (p 0.05,  Students  t-test  B6  n=6,  TetZap70
on  n=11) 
(Figure 3.1 G).  Taken together, these results indicate that Zap70
-/- thymocytes 
are  blocked  at  the  DP  stage  of  development  and  are  uniformly  TCR
loCD5
lo.  
However  tetracycline-inducible  Zap70  expression  can  alleviate  this  block  in 
thymic  development  and  facilitates  the  further  maturation  of  dox-induced 
TetZap70 thymocytes. 
3.2.2 Examination of the kinetics of positive selection 
The temporal regulation of positive selection and subsequent CD4/CD8 lineage 
commitment  is  not  well  characterised.    It  has  been  suggested  that  CD4  SP 
development  occurs  rapidly  following  positive  selection,  whereas  CD8  SPs 
develop  with  delayed  kinetics  (Ceredig  et  al.,  1983;  Lucas  et  al.,  1993; 
Lundberg  &  Shortman,  1994).    However  due  to  technical  limitations,  the 
experimental protocols previously employed to study this have been necessarily 
manipulative  or  indirect  (reviewed  in  (Germain,  2002)  and  see  section 
3.3 Discussion).  In contrast, the TetZap70 mice represented a system where 
we could synchronously restore DP arrested thymocyte development in vivo, 
with minimal experimental manipulation.  We therefore asked whether TetZap70        
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thymocytes showed a kinetic distinction in the development of CD4 and CD8 SP 
lineages  following  Zap70  induction.    To  do  this,  adult  TetZap70  mice  were 
maintained off dox, so they resemble a Zap70
-/- phenotype (Figure 3.2 A, left 
panel).  We induced Zap70 expression in these mice by administering dox for 
1-7 days and analysed the thymic phenotype at each timepoint.  This allowed 
us to follow the phenotypic changes as the first wave of cells matured beyond 
the  non-positively-selecting  (non-selecting  hereon)  DP  stage.    These 
experiments were first performed with bone marrow (BM) chimeras, in an effort 
to reduce the variability in Zap70 induction observed in intact TetZap70 mice 
(Figure  3.1).    BM  chimeric  TetZap70  mice  were  made,  by  reconstituting 
irradiated  Rag1
-/-  hosts  with  BM  from  TetZap70  mice.    Uninduced  chimeras 
resembled the Zap70
-/- phenotype inasmuch as they lacked both CD4 and CD8 
SP  populations  (Figure 3.2 A  left  panel,  Figure 3.1 D).    Chimeric  TetZap70 
mice induced for one day also lacked CD4 and CD8 SP populations, as no CD4 
SP cells were observed until at least two days after Zap70 induction.  However 
there was a much greater delay in the developmental kinetics of CD8 SPs, as 
this population was not observed until at least four days after Zap70 induction 
(Figure 3.2 A).    That  CD4  and  CD8  SPs  indeed  represented  post-selection 
thymic  T-cells  was  confirmed  by  first  gating  on  the  mature  TCR
hiCD5
hi 
population  (Figure 3.2 B).    The  temporal  distinction  between  CD4  and  CD8 
development was further evident when we examined the CD4:CD8 ratio during 
the timecourse.  We saw an initial increase in this ratio from approximately 15:1 
on day one to approximately 80:1 on day three.  The CD4:CD8 thymocyte ratio 
subsequently  decreased  between  days  3-7  as  the  first  wave  of  CD8  SPs        
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developed.  By the later day 6-7 timepoints the ratio had fallen to approximately 
15:1.  Interestingly the CD4:CD8 ratio of thymocytes from chimeric TetZap70 
mice induced for seven days was still higher than in the steady-state B6 thymus 
(Figure 3.2 C).  This was consistent with the significant reduction in CD8 SPs, 
but normal reconstitution of CD4 SPs in TetZap70
on thymocytes relative to B6 
mice (Figure 3.1 G). 
We  finally  confirmed  that  the  kinetics  of  CD4  and  CD8  SP  development  in 
TetZap70  BM  chimeric  mice  were  consistent  with  those  observed  in  intact 
TetZap70  mice,  by  comparing  their  respective  frequencies  of  CD4  and  CD8 
cells after dox-induction for 1-7 days.  We saw no difference in the kinetics of 
CD4 and CD8 SP development between chimeric or intact TetZap70 mice.  In 
both situations we saw a rapid increase in the frequency of CD4 SPs between 
0-3 days, followed by a delayed increase in the frequency of CD8 SPs between 
3-5 days (Figure 3.2 D).  The data suggested that BM chimeric mice behaved 
similarly  to  intact  TetZap70  mice  (Figure 3.2,  (Saini  et  al.,  2010))  and  we 
therefore  used  intact  TetZap70  mice  and  BM  chimeric  mice  interchangeably 
hereon  (all  subsequently  referred  to  as  TetZap70,  figure  legends  indicate 
whether data are from intact or BM chimeric mice). 
3.2.3 Examination of the maturation of single positive thymocytes 
We next wanted to examine the continued maturation of thymocytes beyond 
positive  selection,  within  the  SP  populations.    Heat  stable  antigen  (HSA)  is 
expressed on DP and immature SP thymocytes, before being downregulated on        
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SP thymocytes as they complete their maturation (Wilson et al., 1988).  We 
therefore examined the kinetics of HSA downregulation on newly generated SP 
cells from TetZap70 mice induced to express Zap70 for 1-7 days.  It was found 
that the CD4 SPs generated after 2-3 days of Zap70 induction were uniformly 
HSA
hi (Figure 3.3 A, middle row).  We saw downregulation of HSA expression 
on a subset of CD4 SPs at around day 4-5.  The development of the CD8 SPs 
by  day  four  after  Zap70  induction  correlated  with  an  almost  immediate 
downregulation  of  HSA  in  a  population  CD8  SP  cells  (Figure 3.3 A,  bottom 
row).  We therefore saw that HSA was downregulated at a similar time in both 
CD4 and CD8 SP populations, despite the asymmetric generation of the CD4 
and CD8 SP populations themselves (Figure 3.3 A). 
We next asked how long it took newly generated SP thymocytes to emigrate 
from the thymus and populate peripheral lymph nodes (LN) following induction 
of Zap70.  To do this, TetZap70 mice were induced to express Zap70 for 0-7 
days and the frequency of TCR
 expressing cells in the LN was determined.  We 
saw an extremely low background of TCR expressing cells between days 0-3, 
which may represent leaky Zap70
Tre transgene expression in a minority of cells, 
allowing them to overcome the block in positive selection.  However there was 
an increase in the frequency of TCR
+ cells between days 4-7 (Figure 3.3 B), 
which  correlated  with  HSA  downregulation  in  the  thymus  (Figure 3.3 A).  
Examining the frequency of CD4 or CD8 SP T-cells in the LN of TetZap70 mice 
induced for 1-7 days, revealed that CD4 and CD8 lineage T-cells both appear 
between days 4-7 (Figure 3.3 C).  However, due to the initially low frequency of        
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peripheral T-cells, it was not clear from this analysis whether there was any 
temporal distinction in the thymic egress of either SP lineage. 
3.2.4 Use of TCR and CD5 expression to define developmentally distinct 
subsets of DP thymocytes 
As our data suggested that CD4 SP and CD8 SP cells developed at different 
times  following  positive  selection,  we  wanted  to  identify  whether  phenotypic 
changes in positively selecting DP cells were associated with the appearance of 
CD4  or  CD8  lineage  cells  respectively.    TCR  expression  is  upregulated  on 
positively selecting thymocytes and previous studies have taken advantage of 
this marker to identify temporally distinct subsets of T-cells both in vitro and in 
vivo  (Anderson  et  al.,  1994;  Lucas  &  Germain,  1996).    CD5  is  a  negative 
regulator  of  TCR  signalling  and  is  developmentally  regulated (Azzam  et  al., 
1998;  Tarakhovsky  et  al.,  1995).    We  therefore  wished  to  investigate  the 
developmental regulation of TCR and CD5 early in thymic positive selection.  
We  first  compared  the  TCR  and  CD5  expression  on  DP  thymocytes  of 
TetZap70 mice that had been induced to express Zap70 for different numbers of 
days.  We found that all DP cells in uninduced mice were TCR
loCD5
lo.  One day 
after  induction  of  Zap70,  and  prior  to  CD4  SP  or  CD8  SP  development,  we 
identified  a  population  of  TCR
intermediate  (TCR
int  hereon)  CD5
hi  cells,  which 
preceded the development of the CD4 SP population at day two.  Further to this, 
we noted the presence of TCR
hiCD5
int cells by day three, which preceded the 
development  of  the  CD8  SP  population  (Figure 3.4 A).    We  subsequently 
referred to these three temporally distinct DP populations in the following way:         
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TCR
loCD5
lo as DP1 hereon, TCR
intCD5
hi as DP2 hereon and TCR
hiCD5
int as 
DP3  hereon  (Figure 3.4 B),  in  keeping  with  the  nomenclature  for  temporally 
distinct populations of DN thymocytes (DN1-4) (Godfrey et al., 1993). 
To investigate the lineage relationships between these novel DP subsets and 
the  mature  SP  cells,  TCR  and  CD5  expression  were  analysed  in  the  DP 
populations  of  TCR  transgenic  mice.    F5  and  OT-I  T-cells  express  MHC-I 
restricted TCRs, and therefore on a Rag1
-/- background will only generate CD8 
lineage  cells  (Figure 3.5)  (Hogquist  et  al.,  1994;  Mamalaki  et  al.,  1993).    A 
CD4
+CD8
lo population was observed in OT-I Rag1
-/- mice but not F5 Rag1
-/- 
mice, which may represent cells undergoing coreceptor reversal and are thus 
uncommitted  to  either  the  CD4  or  CD8  lineage  as  opposed  to  being  MHC-I 
restricted CD4 SP cells (Figure 3.5 A) (Brugnera et al., 2000).  We found that 
all  three  DP  populations  identified  in  Figure 3.4 B  were  present  in  both  the 
F5 Rag1
-/- and OT-I Rag1
-/- TCR transgenic mice.  We additionally analysed the 
thymic phenotype of the MHC-II restricted OT-II Rag1
-/- and DO11.10 Rag1
-/- 
TCR transgenic mice, which only generate CD4 SPs (Figure 3.5 A) (Barnden et 
al., 1998; Murphy et al., 1990).  Intriguingly, although we saw a DP2 population 
in both strains, the DP3 population was absent in both cases (Figure 3.5 B).  
As  a  further  control  we  examined  the  TCR  and  CD5  expression  on  SP 
populations in the transgenic mice relative to the DP2 or DP3 expression levels.  
In all cases, we found that the DP2 population had low surface expression of 
TCR  relative  to  mature  SPs.    In  contrast  the  DP3  populations  in  MHC-I        
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restricted mice had similar TCR expression compared to the mature CD8 SP 
population (Figure 3.5 C). 
Next  we  investigated  whether  DP1-3  populations  were  present  in  polyclonal 
mice selecting only one or other of the CD4 or CD8 lineages.  Mice that are 
homozygous null for MHC class-II genes H2-Ab1, H2-Aa, H2-Eb1, H2-Eb2 and 
H2-Ea  (B6.129-H2<dIab1-Ea>,  MHC-II   /   hereon)  cannot  positively  select 
CD4  SP  T-cells  (Madsen  et  al.,  1999),  whilst  mice  lacking   2-microglobulin 
( 2m) (b2m
-/- hereon) cannot positively select CD8 SP T-cells due to a failure of 
MHC-I  surface  expression  on  antigen  presenting  cells  (APCs)  (Koller  et  al., 
1990; Zijlstra et al., 1990).  Analysis of these strains revealed that all three DP 
populations were present in the MHC-II-deficient mice, whereas there was a 
severe  reduction  in  the  frequency  of  the  DP3  population  in  the  b2m
-/-  mice 
(Figure 3.6 B).  Comparison of TCR and CD5 expression on SP populations to 
the DP2 and DP3 cells confirmed that the mature SP populations had higher 
levels  of  TCR  expression  than  the  DP2  population,  whereas  the  CD8  SP 
population had similar levels of TCR and CD5 expression compared to the DP3 
population  (Figure  3.6  C).    Taken  together  this  data  suggests  that  MHC-II 
mediated  positive  selection  does  not  result  in  the  differentiation  of  the  DP3 
population.  In contrast, significant DP3 development was seen under conditions 
where positive selection was mediated by MHC-I.        
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3.2.5 DP subsets display a distinct mRNA expression profile 
These data led us to hypothesise that the DP1 population consisted of cells that 
have yet to undergo positive selection.  Furthermore they suggest that the DP2 
population  comprised  precursors  for  the  CD4  SP  population  and  indirect 
precursors  for  the  CD8 SP  lineage,  whereas  the  DP3  population  contained 
direct precursors for the CD8 SP lineage, as this population was seen prior to 
CD8 SP development. 
To  investigate  the  proposed  precursor-product  relationships  between  DP1-3 
subsets  and  mature  SP  thymocytes,  we  first  asked  whether  the  DP 
subpopulations showed differential expression of genes that are associated with 
either CD4 or CD8 lineage commitment.  DP1-3, CD4 SP and CD8 SP cells 
were sorted to high purity ( 95%) from thymi of B6 mice, and gene expression 
of lineage development factors analysed by RT-qPCR (Figure 3.7).  We first 
looked at expression of the transcription factor Gata3, which has been shown to 
be  necessary  for  CD4  SP  development  but  dispensable  for  CD8  SP 
development  (Hernandez-Hoyos  et  al.,  2003;  Pai  et  al.,  2003;  Wang  et  al., 
2008).  Levels of Gata3 in DP1 and DP3 cells were low.  In contrast Gata3 
expression  was  more  highly  expressed  within  the  DP2  population 
(Figure 3.7 A, top panel).  Gata3 was also highly expressed in the CD4 SP 
population  compared  to  the  CD8  SP  population  (Figure 3.7 A,  lower  panel).  
We next analysed the expression of Thpok, a transcription factor proposed to be 
a “master regulator” of CD4 SP lineage commitment (Egawa & Littman, 2008; 
He et al., 2005; Muroi et al., 2008).  Thpok was absent from all DP populations        
  131 
as well as CD8 SP thymocytes and was only found in the CD4 SP population 
(Figure 3.7 B).  This suggests that although DP2 cells may be predisposed to 
selection for the CD4 lineage due to increased expression of Gata3, they are 
not likely to be lineage committed at this stage, as they lack Thpok expression. 
Runx3 is a CD8-associated transcription factor, implicated as playing a role in 
Thpok silencing (Setoguchi et al., 2008), Cd4 repression (Taniuchi et al., 2002) 
and  necessary  for  CD8  SP  development  (Egawa  et  al.,  2007).    Examining 
Runx3 expression revealed low levels in DP1, DP2 and CD4 SP populations.  
However Runx3 was selectively upregulated in DP3 thymocytes and mRNA was 
expressed at similar high levels in CD8 SP cells (Figure 3.7 C).  Finally we 
looked at expression of Cathepsin W (encoded by the Ctsw gene), a marker 
used previously to identify terminally differentiated CD8 SP thymocytes (Liu & 
Bosselut,  2004).    Ctsw  was  expressed  at  low  levels  in  DP1-3  and  CD4  SP 
populations  and  high  expression  was  only  seen  in  the  CD8  SP  population 
(Figure  3.7  D).    Together  these  data  provide  evidence  for  the  differential 
regulation  of  lineage  commitment  factors  throughout  positive  selection.    We 
hypothesised that the DP2 population may be predisposed to selection for the 
CD4 SP lineage since there was high expression Gata3.  Similarly DP3 cells 
may be predisposed for CD8 SP lineage development as they express Runx3.        
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3.2.6  Precursor-progeny  relationships  between  DP  subsets  and  mature 
SP compartments 
We  wanted  to  directly  test  the  hypothesised  precursor-progeny  relationship 
between  the  DP  and  SP  subsets,  and  in  addition  provide  confirmation  of 
differences in the kinetics of CD4 and CD8 development.  To do so, DP1-3 
populations  were  sorted  to  high  purity  ( 90%)  from  congenically  marked 
CD45.2
+ B6 mice and injected directly into the thymus of CD45.1
+ B6 hosts.  
This allowed us to follow the development of a wave of B6 thymocytes, with no 
new input to the transferred population.  We first asked whether DP1 precursors 
differentiate into CD4 and CD8 SP thymocytes with similar kinetics as observed 
in TetZap70 mice.  Following intrathymic injection of DP1 cells, CD4 SP cells 
could be identified within two days, whereas CD8 SP cells were not present until 
four  days  (Figure 3.8 A).    This  timing  was  indeed  consistent  with  the 
developmental  kinetics  seen  upon  Zap70  induction  in  TetZap70  mice 
(Figure 3.2 A-C).    We  next  asked  whether  DP2  cells  could  differentiate  into 
either CD4 or CD8 SP cells following intrathymic transfer.  DP2 precursors were 
found to differentiate into both CD4 and CD8 SPs.  However, in this case the 
developmental  timing  was  advanced  by  one  day  compared  to  injected  DP1 
cells, so that now CD4 SPs were present one day after transfer, whereas CD8 
SPs were present three days after transfer (Figure 3.8 B).  Finally we wanted to 
address whether the DP3 population contained precursors for both CD4 and 
CD8 SP lineages.  In contrast to injected DP1 and DP2 populations, the DP3 
precursor  cells  only  differentiated  to  CD8  SPs  after  just  1-2  days  following 
intrathymic transfer (Figure 3.8 C).        
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To explore whether MHC-I restricted cells necessarily transit through the DP2 
population  en  route  to  the  CD8  SP  population,  we  examined  F5  thymic 
development  in  vivo.    In  the  absence  of  the   2m  component  of  MHC-I, 
thymocytes in F5 Rag1
-/- b2m
-/- mice are developmentally arrested at the DP 
stage (Koller et al., 1990; Saini et al., 2010) (Figure 3.8 D, left column).  We 
therefore  injected  total  F5 Rag1
-/- b2m
-/- CD45.2
+  thymocytes  into  thymi  of 
B6 CD45.1
+ hosts (that express the MHC-I selecting ligand), thereby alleviating 
the  block  in  positive  selection.    This  allowed  us  to  follow  the  developmental 
kinetics of a wave of F5 cells.  One day after intrathymic transfer we identified 
F5  cells  that  were  phenotypically  DP2.    In  addition  we  saw  an  apparent 
phenotypic progression through to DP3 on days 2-3 and subsequently to the 
CD8 SP population on days 4-7 following intrathymic transfer (Figure 3.8 D). 
This data suggests that regardless of MHC restriction, positively selecting cells 
initially transit to the DP2 population after approximately one day.  This DP2 
population may contain the direct precursors for the CD4 SP lineage (taking one 
further day) but also precursors of the CD8 lineage, which additionally transit via 
a DP3 intermediate.  This data also supports the hypothesis that the CD4 and 
CD8  lineages  do  indeed  develop  from  phenotypically  distinct  populations  of 
DPs. 
3.2.7 Lineage commitment requires intrathymic signalling 
To  investigate  whether  intrathymic  signals  are  required  for  the  continuing 
development of positively selecting thymocytes, we cultured DP2 or DP3 cells 
overnight in medium with no additional stimuli.  We found no evidence for the        
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phenotypic  conversion  of  these  DP2  or  DP3  cells  to  either  SP  or  other  DP 
phenotypes.    This  suggested  that  following  initiation  of  positive  selection, 
intrathymic signals are essential for the continued maturation of both DP2 and 
DP3 populations (Figure 3.8 E). 
3.2.8 Thpok mRNA is rapidly upregulated during CD4 SP development 
The  kinetic  signalling  model  of  T-cell  development  posits  that  positively 
selecting  thymocytes  transit  through  a  CD4
hiCD8
lo  population.    Such  a 
population is proposed to be uncommitted to either the CD4 or CD8 lineage 
(Brugnera  et  al.,  2000)  (reviewed  in  (Singer  et  al.,  2008)).    We  wanted  to 
distinguish whether SP cells that develop 2-3 days after positive selection in 
TetZap70 mice represented a CD4
hiCD8
lo uncommitted population or whether 
they  included  committed  CD4  lineage  cells.    ThPOK  has  recently  been 
described as being a “master regulator” of CD4 SP lineage commitment (see 
section 3.2.5).  We wanted to know the kinetics with which Thpok mRNA is 
upregulated in newly differentiated CD4 SP cells.  To do this, we sorted CD4 SP 
cells from TetZap70 mice that had been induced to express Zap70 for two or 
three days.  We compared Thpok mRNA expression in these cells to a variety of 
control  populations,  known  to  differentially  express  Thpok    (Figure 3.9 A) 
(Muroi et al., 2008).  Thpok mRNA was not expressed in Rag1
-/- thymocytes, in 
which T cell development is blocked at the DN3 stage (Godfrey et al., 1993; 
Mombaerts et al., 1992b), or in DP1 cells.  We also saw no expression in CD8 
SP cells.  Interestingly, we found that Thpok was specifically upregulated in the 
newly generated CD4 SP cells of the TetZap70 mice induced to express Zap70        
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for two or three days, although Thpok expression was at a higher level in B6 
control CD4 SPs.  In contrast Thpok expression in the CD4
hiCD8
lo population of 
MHC-II-deficient  mice,  was  at  a  much  lower  level  (Figure 3.9 B).    This 
suggested  that  newly  generated  CD4  SPs  in  Zap70-induced  TetZap70  mice 
rapidly  upregulate  Thpok  expression  and  by  implication  are  undergoing 
commitment to the CD4 lineage.  Surprisingly, identically gated CD4
hiCD8
lo cells 
from  B6  mice  had  relatively  higher  levels  of  Thpok  compared  to  the  same 
population in MHC-II-deficient mice, although it was still less than observed in 
TetZap70 CD4 SP thymocytes that had been induced to express Zap70 for two 
or three days (Figure 3.9 B, CD4
hiCD8
lo cell sorted populations are shown in 
Figure 3.9 A).  This implied that MHC-II and MHC-I-restricted CD4
hiCD8
lo cells 
exhibit distinguishing phenotypes. 
3.2.9  Sensitivity  to  medullary  chemoattractants  is  rapidly  increased 
during CD4 SP development 
It has been proposed that Thpok must reach a threshold of induction before 
lineage  commitment  takes  place (Muroi  et  al.,  2008).    Therefore  it  could  be 
argued  that  the  rapid  induction  of  Thpok  seen  in  newly  generated  CD4  SP 
thymocytes  from  TetZap70  mice  fell  below  this  threshold,  as  Thpok  mRNA 
expression in newly generated TetZap70 CD4 SP thymocytes was lower than a 
steady state B6 CD4 SP population (Figure 3.9 B).  We therefore wished to 
investigate  whether  the  most  immature  CD4  SP  thymocytes  were  lineage 
committed  independently  of  Thpok  expression.    Concurrent  with  positive 
selection and CD4/CD8 SP lineage commitment, thymocytes migrate from the        
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thymic cortex to the medulla (Witt et al., 2005).  The upregulation of c-c motif 
chemokine  receptor  (CCR)7  on  positively  selecting  thymocytes  confers 
sensitivity to the medullary chemokines c-c motif chemokine ligand (CCL)19 and 
CCL21 and is essential for this migration (Campbell et al., 1999; Misslitz et al., 
2004; Ueno et al., 2004).  We hypothesised that lineage committed CD4 SPs 
would express functional levels of CCR7.  To test this, we first analysed CCR7 
expression in steady state B6 thymocytes.  CCR7 was undetectable in DP1 and 
DP2 thymocytes (Figure 3.10 A).  In contrast, both immature HSA
+ CD4 SPs 
and  mature  HSA
-  CD4  SP  expressed  relatively  high  levels  of  CCR7 
(Figure 3.10 A).    We  next  investigated  the  kinetics  of  CCR7  upregulation  in 
TetZap70 mice, induced to express Zap70 for two or three days.  Similar to B6 
mice,  we  saw  no  expression  of  CCR7  in  either  DP1  or  DP2  populations  of 
TetZap70  mice  two  or  three  days  after  Zap70  induction  (Figure 3.10 B,  top 
row).  In contrast HSA
hi CD4 SPs generated after two or three days expressed 
high levels of CCR7.   
These  data  suggested  that  the  first  CD4  SPs  in  TetZap70  mice  rapidly 
upregulate  sensitivity  to  medullary  chemokines.    To  test  whether  the 
upregulated  CCR7  was  indeed  functional,  we  analysed  the  capacity  of 
TetZap70 mice to migrate towards CCL21 chemokine in a transwell chemotaxis 
assay.    We  found  that  neither  B6  nor  TetZap70  DP1  or  DP2  populations 
showed  high  levels  of  migration.    In  contrast  after  two  days  of  dox  feeding, 
approximately 40% of the TetZap70 CD4 SPs were able to migrate towards 
CCL21  and  after  three  days  this  increased  to  approximately  60%        
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(Figure 3.10 C).  This data suggests that the rapid upregulation of CCR7 on 
CD4 SPs of TetZap70 mice induced to express Zap70 for two or three days was 
indeed functional and indicative of the final stages of SP maturation. 
3.2.10 CD4 SP and CD8 SP thymocytes migrate from the thymic cortex to 
the medulla with different kinetics 
We next sought to determine whether the rapidly upregulated CCR7 expression 
seen in CD4 SPs from TetZap70 mice was indeed functional in vivo.  We asked 
how long it took for TetZap70 CD4 and CD8 SP cells to migrate from the thymic 
cortex to medulla following restoration of positive selection by Zap70 induction.  
TetZap70 mice were induced to express Zap70 for different numbers of days 
and thymic sections were subsequently analysed by confocal microscopy.  In 
dox-free mice (d0), medullary areas were devoid of T-cells and reduced in size, 
in keeping with the phenotype of Zap70
-/- mice (Figure 3.11, d0) (Negishi et al., 
1995).    In  contrast,  two  days  after  Zap70  induction,  we  saw  CD4  SPs  had 
migrated  to  thymic  medulla  that  was  concomitant  to  an  enlargement  of  the 
medulla (Figure 3.11, d2).  There was an apparently increased density of CD4 
SPs in the thymic medulla thee days after Zap70 was induced in the TetZap70 
mice, whereas CD8 SPs were absent at this timepoint (Figure 3.11, d3).  CD8 
SPs were subsequently found in the thymic medulla of TetZap70 mice that had 
been induced to express Zap70 for four or more days, fitting with the detection 
of  CD8  SPs  by  flow  cytometry  at  these  later  timepoints  (Figure 3.2 A-C, 
Figure 3.11).  Collectively this data suggests that CD4 and CD8 SP thymocytes        
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migrate to the thymic medulla with different kinetics following Zap70 induction in 
TetZap70 mice. 
3.3 Discussion 
In  this  chapter  we  have  investigated  the  temporal  kinetics  and  phenotypic 
progression of SP thymocyte development following positive selection.  To do 
so  we  used  a  tetracycline-inducible  Zap70  mouse  as  a  tool,  enabling  us  to 
experimentally  induce  Zap70  expression  in  otherwise  Zap70-deficient 
thymocytes.  In the absence of Zap70 thymocytes are arrested in the DP stage 
of  development,  however  experimental  induction  of  Zap70  allowed  us  to 
alleviate this block.  This permitted us to induce Zap70 for 1-7 days in TetZap70 
mice and follow the development of the first wave of positively selecting cells.  
We found that lineage committed CD4 SP and CD8 SP populations developed 
with temporal distinction.  The CD4 SP cells rapidly developed as they induced 
Thpok  and  migrated  from  the  thymic  cortex  to  medulla  after  only  two  days 
following positive selection.  In contrast lineage committed CD8 SPs were only 
present four days after positive selection as they were only found in the medulla 
at this later time.  Furthermore we identified temporally distinct DP populations 
(termed  DP1-3)  that  possess  different  developmental  potential.    The  DP1 
population  consisted  of  non-selecting  cells.    In  contrast  the  DP2  population 
contained  the  precursors  for  CD4  and  CD8  lineages,  whereas  the  DP3 
population only contained precursors for the CD8 SP lineage.  In addition all of 
these DP populations required intrathymic signals to complete their maturation,        
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suggesting  that  none  of  the  DP  cells  were  lineage  committed.    Importantly, 
analysis of DP1-3 populations permitted study of temporally distinct subsets of 
positively  selecting  thymocytes,  a  distinct  advantage  over  using  coreceptor 
expression levels alone.  We also investigated the kinetics of thymic emigration 
of mature cells.  Our data suggested that T-cells reside in the thymic medulla for 
a matter of days before emmigrating to the periphery 4-5 days after positive 
selection. 
The TetZap70 mice allowed us to restore thymic development beyond the DP 
stage with minimal experimental manipulation, in order to examine the kinetics 
of subsequent thymic development.  Such a system has advantages in that it 
does  not  require  ex  vivo  manipulation  of  thymocytes.    In  addition,  Zap70 
induction occurred extremely rapidly following dox administration (Saini et al., 
2010) and Zap70 itself was expressed at physiological levels (Figure 3.1 A).  
This  contrasts  with  the  tetracycline  inducible  Lck  transgenic  mice,  which 
express 10-fold higher Lck in thymocytes relative to wild-type (WT) (Legname et 
al., 2000).  Furthermore, most defects in TCR signalling machinery result in a 
block  at  the   -selection  developmental  checkpoint  (reviewed  in  (Germain, 
2002)).  In contrast Zap70 exhibits an almost complete redundancy with the 
related  kinase  Syk  in  the  DN3  stage,  allowing  for  TCR  signal  transduction 
during  -selection (Chan et al., 1994b; Kadlecek et al., 1998; Palacios & Weiss, 
2007).  Therefore Zap70-deficient thymocytes are unusual, as they exhibit a 
later  block  in  development  at  the  DP  stage,  where  they  are  poised  prior  to 
positive selection.  Induction of Zap70 expression in DP arrested thymocytes of        
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TetZap70  mice  represents  an  excellent  model  to  investigate  the  kinetics  of 
T-cell development beyond the DP stage. 
We subsequently used the TetZap70 mice to probe the temporal kinetics with 
which SP thymocyte lineages develop.  Following restoration of Zap70, CD4 SP 
cells developed early, by day two, whereas we saw no CD8 SP development 
until  at  least  four  days  following  positive  selection  (Figure 3.2 A-C).    This  is 
consistent  with  data  suggesting  that  fetal  CD4  SP  and  CD8  SP  thymocyte 
populations  develop  with  temporally  distinct  kinetics  during  thymic  ontogeny 
(Ceredig et al., 1983).  We have additionally shown this to be the case in the 
adult thymus.  Our data agrees somewhat with that of researchers who labelled 
thymocytes with a 5-Bromodeoxyuridine (BrdU) and followed their subsequent 
phenotypic transition (Baron & Penit, 1990; Lucas et al., 1993; Lucas et al., 
1994), who also found that CD4 SPs develop earlier than CD8 SPs, although 
there are discrepancies in the precise timings of these events between these 
studies and our own.  Whereas we saw development of CD4 and CD8 SPs two 
and four days after positive selection respectively, two studies by Lucas et al 
report more delayed kinetics suggesting that CD4 SPs develop between 3-6 
days, whereas CD8 SPs developed between 5-8 days following BrdU labelling 
(Lucas et al., 1993; Lucas et al., 1994).  An explanation could be that BrdU 
labels primarily cycling DN3-DN4 thymocytes (Baron & Penit, 1990; Penit et al., 
1995),  so  this  delay  in  CD4  and  CD8  SP  developmental  kinetics  may 
incorporate the additional thymic maturation before cells reach the DP stage.  
The  precise  timings  of  CD4  and  CD8  SP  development  in  Zap70-induced        
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TetZap70 thymocytes more closely resembles an in vitro reaggregate thymic 
organ culture (RTOC) system where CD4 SPs were found by day 2-3 and CD8 
SPs by day 3-4 (Anderson et al., 1994).  Indeed our findings suggest that such 
an in vitro system is physiologically relevant with regards to the developmental 
kinetics of positive selection.   
A  possible  criticism  of  the  TetZap70  system  is  that  the  kinetics  of  positive 
selection in TetZap70 mice may be an artefact of transgenic Zap70 expression, 
which  does  not  precisely  match  the  endogenous  expression  of  WT  mice.  
However,  we  were  able  to  verify  these  timings  of  lineage  commitment  by 
examining the development of B6 DP1 thymocytes following their intrathymic 
transfer  to  congenically  marked  B6  hosts.    The  kinetics  of  development 
precisely  mirrored  that  of  TetZap70  mice:  CD4  SPs  developed  two  days 
following injection of a non-selecting (DP1) population, whereas CD8 SPs were 
only  seen  four  days  after  transfer  (Figure 3.2 A-C,  Figure 3.8 A).    Not  only 
does this suggest that the kinetics of positive selection in TetZap70 mice are 
representative  of  a  WT  situation,  but  this  mutually  supports  the  use  of 
intrathymic transfers to study the kinetics of CD4 and CD8 positive selection.  
Indeed  Lundberg  et  al.  report  almost  identical  developmental  timings  with 
regards to CD4 and CD8 development following transfer of CD3
lo DP cells to 
WT  hosts  (Lundberg  &  Shortman,  1994).    Nevertheless,  a  limitation  of  the 
intrathymic transfer technique is that poor cell recovery precludes more detailed 
analysis  of  cells.    The  TetZap70  system  allowed  us  to  analyse  smaller        
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populations  of  cells,  such  as  the  DP2  and  DP3  populations  in  considerable 
detail (compare TCR and CD5 expression profiles in Figure 3.4 and Figure 3.8) 
In our study we examined not only the coreceptor phenotype during CD4 and 
CD8  development,  but  also  whether  these  SP  cells  were  indeed  lineage 
committed.    We  found  that  temporally  distinct  development  of  phenotypically 
CD4  and  CD8  SP  cells  was  also  accompanied  by  temporal  distinction  with 
regards to lineage commitment.  CD4 SPs found in TetZap70 mice that had 
been induced to express Zap70 for two or three days expressed high levels 
mRNA for the “master regulator” of CD4 lineage commitment Thpok (He et al., 
2005) (Figure 3.9 B), which has been shown previously to correlate well with 
ThPOK protein expression (Sun et al., 2005).  This suggested that some of the 
CD4 SPs generated after two days were indeed lineage committed.  However, 
recent  studies  suggest  that  ThPOK  must  reach  a  threshold  to  induce  CD4 
lineage specification (Muroi et al., 2008).  To refute the argument that the newly 
generated  CD4  SPs  may  express  ThPOK  at  a  level  below  the  lineage 
commitment threshold, it was important to confirm the lineage commitment of 
CD4 SP cells in another way.  We did so by examining the migration of the SP 
cells from the thymic cortex to medulla, which occurs following positive selection 
(reviewed in (van Ewijk, 1991)).  CD4 SP cells were shown to rapidly upregulate 
CCR7 (Figure 3.10 A-B), increase sensitivity to medullary derived chemokines 
(Figure 3.10 C) and were found to reside within the thymic medulla within two 
days of Zap70 restoration (Figure 3.11).  This led us to conclude that whereas 
some of the CD4 SP cells are indeed CD4 lineage committed by day two, the        
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CD8 SPs were unlikely to be lineage committed until four days after positive 
selection (Figure 3.2 A-C, Figure 3.8 A).   
It could be argued that the DP3 population represents committed CD8 lineage 
cells, as they only contained precursors for the CD8 SP lineage (Figure 3.8 C) 
and  expressed  similar  levels  of  the  CD8  lineage  associated  factor  Runx3 
(Figure 3.7 C).    Indeed  Runx3  was  expressed  with  a  similar  abundance  in 
DP3s relative to CD8 SPs, fitting with its direct implication in CD4 silencing in 
CD8 SP-committing cells (Taniuchi et al., 2002).  However, the DP3 cells did 
not spontaneously downregulate the CD4 coreceptor to phenotypically resemble 
CD8 SPs following overnight culture in medium alone (Figure 3.7 E).  That they 
do  so  one  day  after  intrathymic  transfer  to  B6  host  mice  suggests  that 
intrathymic  signals  are  required  to  complete  DP3  maturation  (Figure 3.7 C).  
Furthermore the DP3 population does not express high mRNA levels of the CD8 
lineage terminal differentiation marker Ctsw (Figure 3.8 E, Figure 3.7 D) (Liu & 
Bosselut, 2004).  In support of the hypothesis that DP3 cells are not lineage 
committed, it has recently been shown that Runx3 overexpression in cultured 
DP thymocytes is not sufficient to confer CD8 lineage commitment (Park et al., 
2010).  Furthermore, the requirement for additional intrathymic signals in CD8 
precursor cells is fitting with the concept of a “proof-reading” mechanism during 
CD8  lineage  commitment  (Liu  et  al.,  2003).    Whether  the  hypothesised 
intrathymic  signal  required  for  DP3  cells  to  commit  to  the  CD8  lineage  is 
mediated  by  the  TCR  signalling,  cytokine  signalling,  or  some  other  factor 
remains to be determined.  Nevertheless we suggest these previous studies are        
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compatible with our conclusion that the CD8 SPs are not lineage committed until 
four days after initiating positive selection.  However, the CD8 lineage choice 
may be predetermined at the DP3 stage, as this population contains precursors 
for the CD8 SP and not the CD4 SP lineage (Figure 3.8 C). 
The  conclusion  that  CD4  and  CD8  lineage  commitment  occurs  with  kinetic 
distinction  is  in  direct  opposition  to  previous  models  of  positive  selection.  
Symmetric lineage commitment models suggest that CD4 and CD8 commitment 
occurs with identical kinetics, but that residual levels of CD4 coreceptor remain 
on the cell surface, making such cells appear to be DP (Barthlott et al., 1997; 
Lucas  &  Germain,  1996).    However,  advances  in  understanding  the  genetic 
control of CD4 versus CD8 development have enabled us to investigate the 
lineage  potential  of  selecting  thymocytes  in  greater  detail.    We  additionally 
hypothesise that the early differentiation of CD4 SPs relative to CD8 SPs may 
enable the CD4 lineage to be permissive for further thymic differentiation, for 
example of Treg cells (Lio & Hsieh, 2008) (reviewed in (Josefowicz & Rudensky, 
2009)). 
A major obstacle in studying positive selection is the lack of markers allowing 
researchers  to  phenotypically  and  kinetically  distinguish  developmental 
intermediate populations of cells.  Many previous studies have employed tight 
gating  on  populations  based  on  differences  in  CD4  or  CD8  coreceptor 
expression (reviewed in (Germain, 2002) and (Kappes & He, 2005)).  It has 
been  argued  that  modulations  of  coreceptor  expression  have  functional 
implications on positive selection.  For example, the initial downregulation of the        
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CD8  coreceptor  (making  cells  phenotypically  CD4
hiCD8
lo)  allows  cells  to 
discriminate an MHC-I versus MHC-II mediated positive selection signals that 
are otherwise thought to be identical (Brugnera et al., 2000; Singer et al., 2008).  
Contrary to this view, however, we found that Thpok was expressed at much 
reduced  levels  in  the  CD4
hiCD8
lo  population  of  MHC-II-deficient  mice  as 
compared to B6 controls (Figure 3.9 B).  This suggests that the WT CD4
hiCD8
lo 
population may be heterogeneous with regards to gene expression and stage of 
selection.    Furthermore  when  we  examined  CD4  and  CD8  coreceptor 
expression  on  F5 Rag1
-/-  and  OT-I Rag1
-/--  TCR  transgenic  thymocytes,  we 
found that the CD4
hiCD8
lo population was infact absent in F5 Rag1
-/- thymi but 
intact in OT-I Rag1
-/- thymi, suggesting it is not an obligate stage during CD8 SP 
development  (Figure 3.5).  The CD4
hiCD8
lo population has been suggested to 
correlate with increasing avidity for spMHC and thus positive selection signal 
strength  (Ohashi  et  al.,  1993;  Singer  et  al.,  2008)  (reviewed  in  (Hogquist, 
2001)).    This  is  in  agreement  with  our  data,  as  OT-I Rag1
-/- T -cells  have  a 
higher  avidity  for  spMHC  than  F5 Rag1
-/-  mice  (Ge  et  al.,  2004)  (and  see 
Chapter 5).  We therefore conclude that our findings support a growing body of 
evidence to suggest that the intermediate stages of positive selection cannot be 
robustly distinguished based on coreceptor expression alone. 
The  suggestion  that  the  CD4
hiCD8
lo  population  consists  of  cells  that  are 
phenotypically  diverse  further  highlights  the  need  for  additional  phenotypic 
markers  that  differentiate  the  intermediate  stages  of  positive  selection.    We 
described  a  method  in  this  chapter  that  involved  analysing  TCR  and  CD5        
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expression on broadly gated DP cells.  We have termed three newly identified 
DP subsets DP1-3 (Figure 3.3-3.6, Figure 3.8).  Our studies lead us to suggest 
a new model for the phenotypic progression occurring during CD4 and CD8 
lineage commitment.  We suggest that all cells undergoing positive selection are 
initially recruited to the DP2 population.  The DP2 population contains the direct 
precursors  of  CD4  SP  and  indirect  precursors  of  CD8  SP  lineages.    We 
hypothesise that MHC-I restricted thymocytes selecting to the CD8 SP lineage 
must  transit  from  the  DP2  to  CD8  SP  population  via  the  DP3  population 
(Figure 3.12).  Critically, analysis of DP1-3 populations permits the identification 
of thymocyte populations in temporally distinct intermediate stages of positive 
selection, in a manner not possible using other phenotypic markers such as 
CD4  and  CD8.    We  therefore  hypothesise  that  analysis  of  the  DP1-3 
populations  will  give  new  insight  into  the  regulation  of  the  CD4/CD8  lineage 
decision. 
For  example,  analysis  of  gene  expression  within  the  DP1-3  populations  has 
allowed us to gain new insight into the kinetic regulation of transcription factors 
involved in the CD4/CD8 lineage decision.  Gata3 is specifically upregulated in 
the DP2 population, suggesting these cells may be predisposed to selection for 
the CD4 SP lineage (Figure 3.7 A).  Gata3 has been shown to be indispensible 
for  CD4  SP  development.    In  addition,  it  has  been  suggested  that  Gata3  is 
directly  regulated  by  TCR  signalling  in  positively  selecting  DPs  (Hernandez-
Hoyos et al., 2003; Maurice et al., 2007).  Furthermore Gata3 is proposed to be 
directly upstream of Thpok (Wang et al., 2008).  Our data entirely support these        
  147 
findings, as the DP2 population was found to contain the direct precursors for 
the  CD4  SP  population  (Figure 3.8 B)  and  had  upregulated  expression  of 
Gata3 compared to non-selecting cells (Figure 3.7 A), whereas Thpok mRNA 
was not expressed until the CD4 SP stage (Figure 3.7 B).  Future studies will 
investigate whether Gata3 is differentially regulated in the DP2 population of 
MHC-I-  or  MHC-II-deficient  mice.    In  addition  microarray  analysis  of  the  DP 
populations in MHC-I- and MHC-II-deficient mice may enable the identification 
of novel factors involved in positive selection that are induced specifically by 
MHC-I or MHC-II-mediated selection signals. 
We  have  also  addressed  the  thymic  maturation  events  that  occur  following 
positive  selection  and  SP  development.    We  found  that  after  restoration  of 
Zap70 in TetZap70 mice, CD4 SPs were found to reside in the thymic medulla 
after two days, whereas CD8 SPs were not found in the medulla until four days 
after  Zap70  was  induced.    Concomitantly  with  this,  we  saw  an  apparent 
enlargement of the thymic medulla (Figure 3.11, compare d0 with d2).  This 
data  is  in  agreement  with  implications  for  a  role  of  SP  T-cells  in  medullary 
maturation  (Shores  et  al.,  1991;  Surh  et  al.,  1992).    Indeed  the  TetZap70 
system may provide a useful tool to investigate medullary thymic epithelial cell 
(mTEC) development in an adult thymus.  It has been described that mTEC 
maturation  depends  on  interactions  of  CD4  SP  cells,  which  may  additionally 
include lymphoid tissue inducer (LTi) cells (reviewed in (Anderson et al., 2007)).  
Restoration of thymic development in TetZap70 mice may enable future studies 
to dissect the relative role of   -lineage T-cells to this maturation process.  In        
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addition, analysis of thymic restoration in MHC-II or MHC-I-deficient TetZap70 
mice may give insights as to whether the CD4 and CD8 SPs can contribute 
equivalently to mTEC maturation and proliferation. 
Our studies additionally gave insight to the question of how long a T-cell must 
reside  in  the  thymic  medulla  following  CD4/CD8  lineage  commitment.    Data 
presented in this chapter show the potential for a rapid emigration of thymocytes 
from the thymic medulla, which we first identify on day four (Figure 3.3 B).  This 
agrees  with  some  researchers  (McCaughtry  et  al.,  2007;  Tough  &  Sprent, 
1994),  although  contrasts  with  a  study  employing  semi-continuous 
[
3H]-thymidine labelling of total thymocytes, that only identified an accumulation 
of  peripheral  T-cells  after  ~20  days  (Egerton  et  al.,  1990).    It  has  been 
hypothesised that thymic emigration is a stochastic process, potentially allowing 
for T-cells to have a wide distribution of medullary residency times and referred 
to as the “lucky-dip hypothesis” (Kelly & Scollay, 1990) (reviewed in (Scollay & 
Godfrey, 1995)).  Such a model cannot be ruled out by our analysis of thymic 
egress in Zap70 induced TetZap70 mice. 
We  find  evidence  to  suggest  that  CD4  SPs  may  be  subject  to  medullary 
negative selection for a longer period than CD8 SPs.  We see CD4 SP cells 
resident in the thymic medulla by one day after Zap70 induction, whereas CD8 
SP  cells  do  not  appear  in  the  thymic  medulla  until  day  four  (Figure 3.11).  
Furthermore we found that TCR
+ cells egress from the thymus at around 4-5 
days following positive selection in TetZap70 mice (Figure 3.3 C).  Although our 
experiments could not pinpoint whether there was an asymmetric egress of CD4        
  149 
or CD8 lineage cells, evidence from recent studies suggests that this is not the 
case.  Two groups have tracked recent thymic emigrants (RTEs) by analysing 
the decay in GFP abundance in mice where GFP expression was controlled by 
the Rag2 promotor.  GFP transcription is turned off at the DP stage, but due to 
its long half-life, GFP protein expression persists as it is slowly turned over at a 
constant rate.  Therefore, the constant reduction in GFP expression allows it to 
be used as a molecular clock (Boursalian et al., 2004).  Using this method, it 
was found that CD4 and CD8 cells exported to the periphery had identical levels 
of GFP, taken to suggest that cells migrate at the same developmental stage 
from  the  medulla  (McCaughtry  et  al.,  2007).    When  taken  with  our  data 
suggesting that CD4 SPs migrate to the thymic medulla earlier than CD8 SPs 
(Figure  3.11),  this  suggests  that  CD8  SPs  may  have  a  shorter  medullary 
residency time, relative to CD4s.  Such a result implies that CD8 SPs may be 
less  susceptible  to  negative  selection  in  the  medulla  relative  to  CD4  SPs.  
Whether  this  has  implications  on  autoimmunity  remains  to  be  investigated.  
Typically CD8 T-cell activation requires CD4 help (reviewed in (Wong & Pamer, 
2003)), so a more stringent negative selection of autoreactive CD4 SP cells may 
indirectly  prevent  CD8-mediated  autoimmunity.    Perhaps  slowing  the  thymic 
egress  of  CD8  SPs  to  enable  more  efficient  negative  selection  may  have 
therapeutic benefits in cases where CD4 tolerance is broken. 
In conclusion the results presented in this chapter have described three novel 
DP subpopulations with different differentiation potential.  The DP2 population 
could give rise to both CD4 SPs and CD8 SPs, whereas the DP3 population        
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could give rise to CD8 SPs alone.  This leads us to suggest a model by which 
CD4 and CD8 lineage development occurs with temporal distinction, due to the 
underlying  temporal  differences  in  the  direct  precursor  populations 
(Figure 3.12).    As  MHC-I  signalled  cells  transit  through  the  DP2  population 
without  receiving  a  CD4  lineage  commitment  signal,  we  hypothesised  that 
differential signalling in the DP2 population may direct the CD4 versus CD8 fate 
decision.    We  therefore  investigated  the  signalling  requirements  for  positive 
selection and lineage commitment in Chapter 4.        
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Figure 3.1 Tetracycline inducible Zap70 expression promotes 
reconstitution of mature thymic development 
TetZap70  mice  were  fed  dox  for   7  days  (TetZap70
on,  red  line)  and  their 
thymocytes were analysed by flow cytometry, along with B6 (black line) and 
Zap70
-/- (grey fill) controls.  (A) Histograms show HuCD2 and Zap70 expression 
on live thymocytes.  (B) Density plot shows co-staining of Zap70 and HuCD2 on 
live TetZap70
on thymocytes.  (C) Box and whisker plots show the frequency of 
HuCD2
+ thymocytes (n=8) or Zap70
+ thymocytes (n=4) in live gated TetZap70
on 
thymocytes.  (D) Density plots show expression of CD4 against CD8 and CD5 
against  TCR  on  live  thymocytes  from  B6,  Zap70
-/-  and  TetZap70
on  mice.  
(E) Box plots show TCR
hiCD5
hi cells as a frequency of total live thymocytes for 
B6 (n=5),  TetZap70 (n=9)  and  Zap70
-/- (n=5)  mice.    *** p 0.001  (Student s 
t-test).  (F) Histogram shows HuCD2 expression on live TetZap70
on thymocytes 
in addition to HuCD2
+ and HuCD2
- gates.  Density plots show CD4 against CD8 
expression  and  CD5  against  TCR  expression  for  HuCD2
+  or  HuCD2
- 
populations as indicated.  (G) Box plots show frequencies of CD4 SP and CD8 
SP populations expressed as a percentage of the TCR
hiCD5
hi mature thymocyte 
population,  from B6  (n=6)  and  TetZap70
on  (n=11)  mice.    * p 0.05  (Student s 
t-test).  Data are representative of three or more independent experiments.        
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Figure 3.2 Mature CD4
 SP and CD8 SP thymocytes develop with distinct 
kinetics following positive selection in TetZap70 mice. 
BM chimeras were made by reconstituting irradiated Rag1
-/- mice with TetZap70 
BM.  TetZap70 BM chimeras or intact TetZap70 mice were fed dox for 0-8 days.  
B6 mice were also analysed as controls.  Expression of CD4, CD8, TCR, CD5 
and  HuCD2  was  analysed  by  flow  cytometry.    (A) Density  plots  show  CD4 
against  CD8  on  live  thymocytes  (d0  TetZap70  chimeras  or  B6  controls)  or 
HuCD2
+  TetZap70  chimeric  thymocytes  (d1-7).    (B) Density  plots  show  CD4 
against  CD8  on  TCR
hiCD5
hi  gated  live  thymocytes.    Data  in  (A-B)  are 
representative of  3 independent experiments.  (C) The line graph shows the 
mean CD4:CD8 SP ratio in TCR
hiCD5
hi gated thymocytes from intact TetZap70 
mice  or  B6  controls.    Each  point  represents   2  replicate  mice,  error  bars 
represent sd.  (D) Line graph shows the frequency of TCR
+ CD4 SP (circles) 
and TCR
+ CD8 SP thymocytes (squares) as a percentage of total cells (d0), or 
HuCD2
+  induced  cells  (d1-8).    Separate  data  sets  are  shown  for  chimeric 
TetZap70  (red  lines)  and  intact  TetZap70  mice  (blue  lines).    Each  timepoint 
represents  2 replicate mice.  Data collection and analysis for intact TetZap70 
mice in part (D) was performed by Moni Saini and Ben Seddon.        
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Figure 3.3 Maturation and thymic egress of TetZap70 T-cells 
BM chimeras were made by reconstituting irradiated Rag1
-/- mice with TetZap70 
BM.  TetZap70 chimeras or intact TetZap70 mice were left off dox or fed dox for 
1-7 days (indicated as d1-7).  Expression of CD4, CD8, TCR, CD5 and HSA 
was analysed by flow cytometry.  (A) Density plots show analysis for TetZap70 
chimeric mice induced for 1-7 days and B6 controls.  Density plots on the top 
row  show  CD4  against  CD8  expression  on  TCR
hiCD5
hi  gated  thymocytes.  
Density  plots  on  the  middle  row  show  HSA  against  TCR,  for  CD4  SP 
thymocytes (CD4 SP gating is shown on top row plots).  Density plots on the 
bottom row show HSA against TCR, for CD8 SP thymocytes (CD8 SP gating is 
shown  on  the  top  row  plots).    Data  is  representative  of  three  independent 
experiments.    (B) Line  graph  shows  TCR
+  cells  as  a  frequency  of  live 
lymphocytes, in the LNs of intact TetZap70 mice.  (C) Line graph shows TCR
+ 
CD4 SPs (red line) or TCR
+ CD8 SPs (blue line) as a frequency of lymphocytes, 
in the LNs of intact TetZap70 mice.        
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Figure 3.4 Temporally distinct DP populations are identified by differential 
TCR and CD5 expression 
(A) BM  chimeras  were  made  by  reconstituting  irradiated  Rag1
-/-  mice  with 
TetZap70 BM.  TetZap70 chimeras were left off dox or were fed dox for 1-7 
days (indicated as d1-7).  Expression of CD4, CD8, TCR, CD5 and HuCD2 was 
analysed by flow cytometry.  Density plots on the top row show CD4 against 
CD8  on  live  thymocytes  (d0  TetZap70  chimeras  or  B6  controls)  or  HuCD2
+ 
TetZap70  thymocytes  (d1-7).    The  top  row  plots  are  duplicated  from 
Figure 3.2 A to show DP gating.  Density plots on the bottom row show CD5 
against TCR for DP thymocytes.  (B) Enlarged density plot shows CD5 against 
TCR for DP gated B6 thymocytes.  DP1 (TCR
loCD5
lo), DP2 (TCR
intCD5
hi) and 
DP3 (TCR
hiCD5
int) populations are indicated on the plot.  Results in (A-B) are 
representative of  3 independent experiments.        
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Figure 3.5 Analysis of the thymic phenotype of TCR transgenic mice 
MHC-I  restricted  F5 Rag1
-/-  and  OT-I Rag1
-/-  mice,  MHC-II  restricted 
OT-II Rag1
-/- and DO11.10 Rag1
-/- mice and B6 or BALB/c control mice, were 
analysed by flow cytometry, for the expression of CD4, CD8, TCR and CD5.  
(A) Density plots show CD4 against CD8 expression for live thymocytes from 
indicated strains of mice.  CD4 SP, CD8 SP and DP gates in transgenic mice 
are  based  on  a  WT  control.    (B) Density  plots  show  CD5  against  TCR 
expression on DP gated thymocytes.  (C) Density plots show CD5 against TCR 
expression for CD4 SP and/or CD8 SP populations.  Density plots also show 
DP2 and DP3 gates from (B).  Data in (A-C) is representative of  3 replicate 
mice.        
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Figure 3.6 Analysis of the thymic phenotype of b2m
-/- and MHC-II  /  mice 
B6 control, b2m
-/- and B6.129-H2
dIab1-Ea (MHC-II  / ) mice were analysed by 
flow cytometry, for the expression of CD4, CD8, TCR and CD5.  (A) Density 
plots  show  CD4  against  CD8  expression  for  live  thymocytes  from  indicated 
strains of mice.  CD4 SP, CD8 SP and DP gates in b2m
-/- and MHC-II  /  mice 
are  based  on  a  WT  control.    (B)  Density  plots  show  CD5  against  TCR 
expression  on  DP  thymocytes.    (C)  Density  plots  show  CD5  against  TCR 
expression for CD4 SP and/or CD8 SP populations.  Density plots additionally 
show  DP2  and  DP3  gates  from  (B).    Data  in  (A-C)  is  representative  of   3 
replicate mice.        
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Figure 3.7 DP1-3 populations display a distinct mRNA expression profile  
DP1, DP2, DP3, CD4 SP and CD8 SP thymocytes were sorted to high purity 
( 95%) from B6 mice.  Cellular mRNA was purified and analysed by RT-qPCR.  
Bar charts show the mean expression of (A) Gata3, (B) Thpok, (C) Runx3 and 
(D) Ctsw relative to Hypoxanthine-guanine phosphoribosyltransferase-1 (Hprt1).  
Analysis was performed in triplicate wells and error bars represent the sd.  Data 
is representative of  3 independent experiments.        
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Figure 3.8 Lineage relationships between DP and SP populations 
(A-C) DP1, DP2 and DP3 thymocytes from B6 CD45.2
+ mice were isolated by 
cell sorting to  90% purity, and 1-2x10
6 cells were intrathymically transferred to 
B6 CD45.1
+ recipients.  At different days following transfer, CD45.1
+ host cells 
and CD45.2
+ donor cells were analysed by flow cytometry for the expression of 
CD4,  CD8,  CD5  and  TCR.    Density  plots  show  CD4  against  CD8  and  CD5 
against TCR on (A) DP1, (B) DP2 and (C) DP3 thymocytes recovered after 
indicated numbers of days. CD4 against CD8 is shown for total live cells and 
CD5  against  TCR  is  shown  for  populations  gated  as  indicated.    (D) Total 
thymocytes  were  isolated  from  F5  Rag1
-/-  b2m
-/-  CD45.2
+  mice  and  1-2x10
6 
cells were transferred intrathymically into B6 CD45.1
+ recipients.  At different 
days  following  transfer,  CD45.1
+  host  cells  and  CD45.2
+  donor  cells  were 
analysed by flow cytometry for the expression of CD4, CD8, CD5 and TCR.  
Density plots of CD5 against TCR (upper row) and CD4 against CD8 (lower 
row) on transferred F5 Rag1
-/- b2m
-/- CD45.2
+ F5 cells recovered after indicated 
numbers of days.  F5 Rag1
-/- b2m
-/- and F5 Rag1
-/- mice are shown as controls.  
Gates shown are based on host populations.  (E) DP2 and DP3 thymocytes 
from B6 mice were isolated by cell sorting to  90% purity, and cultured for one 
day at a concentration of 1-10x10
6 cells/mL in complete Dulbecco s modified 
Eagle s medium (cDMEM) at 37°C.  Live cells were analysed by flow cytometry 
for  the  expression  of  CD4,  CD8,  TCR  and  CD5.    Density  plots  show  CD4 
against CD8 on live cells and CD5 against TCR on DP gated cells as indicated.  
Gates shown are based on uncultured B6 populations.  Data is representative of 
 3 replicates per timepoint.        
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Figure 3.9 Thpok mRNA expression in thymic subpopulations 
TetZap70 mice were fed dox for two or three days.  CD4 SP populations were 
obtained from induced TetZap70 mice, CD4
hiCD8
lo populations were obtained 
from  B6.129-H2
dIab1-Ea  (MHC-II   / )  mice,  and  DP1,  CD4  SP  and  CD8  SP 
populations  were  obtained  from  B6  mice,  all  by  cell  sorting  to   90%  purity.  
Total Rag1
-/- thymocytes were also isolated.  Cellular mRNA was purified and 
analysed by RT-qPCR.  (A) Density plots show CD4 against CD8 expression on 
pre- and post-sorted thymocytes for indicated populations.  (B) Bar chart shows 
the mean expression of Thpok relative to Hprt1.  Analysis was performed in 
triplicate wells and error bars represent the sd.  Data is representative of  3 
independent  experiments.    Data  for  DP1,  CD4  SP  and  CD8  SP  B6  control 
populations are duplicated from Figure 3.7 B to enable comparison.        
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Figure 3.10 CD4 SP cells rapidly increase their sensitivity to medullary 
chemokines following positive selection 
B6 mice and TetZap70 mice fed dox for two or three days were analysed for the 
expression of CCR7 by flow cytometry.  (A) Histogram shows CCR7 expression 
on B6 DP1 (grey fill), DP2 (black line), TCR
+CD5
+CD4
+HSA
hi (CD4 SP HSA
hi, 
red line) and TCR
+CD5
+CD4
+HSA
lo (CD4 SP HSA
lo, blue line).  (B) Histograms 
show CCR7 expression on B6 DP1 cells (grey fill) and DP2 or CD4 SP HSA
hi 
populations from B6 mice (black line), or TetZap70 mice induced as indicated 
(red  line).    Data  in  (A-B)  is  representative  of   3  independent  experiments.  
(C) DP2 (light grey) and CD4 HSA
hi (dark grey) thymocytes from TetZap70 mice 
fed  dox  for  two  days  (n=1)  or  three  days  (n=3)  and  B6  controls  (n=3)  were 
analysed for their migration towards CCL21 in a chemotaxis assay.  The bar 
chart shows the frequency of migrant thymocytes as a proportion of input.  Bars 
indicate the mean frequency of migration (incorporating two wells per mouse), 
with error bars corresponding to the sd.  The data in (C) were obtained by Jara 
Joedicke.        
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Figure 3.11 Asymmetric migration of CD4 and CD8 SP cells to the thymic 
medulla following positive selection 
TetZap70 mice were fed dox for  8 days.  Thymic sections were prepared from 
induced  TetZap70  mice  or  B6  controls.    Sections  were  analysed  for  the 
expression  of  CD4  and  CD8  by  confocal  microscopy  at  10X  and  40X 
magnification, as indicated.  Resultant images show CD4 SP cells (red), CD8 
SP cells (green) and DP cells (yellow).  On 40X images the thymic cortex (c) 
and medulla (m) are indicated based on the presence or absence of DP cells 
respectively.    Data  is  representative  of   2  replicate  mice  per  timepoint.  
Preparation  of  thymic  sections  and  confocal  microscopy  was  performed  by 
Andrea White (University of Birmingham, UK).         
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Figure 3.12 A model for the phenotypic progression of positively 
selecting thymocytes 
A  model  for  the  phenotypic  progression  of  positively  selecting  thymocytes.  
Cells initially reside in the TCR
loCD5
lo DP1 population (non-selecting, black).  
Upon  initiation  of  positive  selection  through  MHC  recognition,  cells 
phenotypically  transit  to  the  TCR
intCD5
hi  DP2  population.    This  population 
contains  MHC-I  (blue)  and  MHC-II  (orange)  restricted  thymocytes.    MHC-II 
restricted  DP2  thymocytes  are  the  direct  precursors  of  the  CD4  SP  lineage.  
MHC-I  restricted  DP2  thymocytes  are  the  direct  precursors  of  the  DP3 
population.    The  DP3  population  consists only  of  MHC-I  restricted  cells  that 
represent the direct precursors of the CD8 SP lineage.  However, the efficient 
phenotypic  progression  from  DP3  to  CD8  SP  requires  additional  intrathymic 
signals.        
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Chapter 4 
The Interpretation of the Positive Selection 
Signal 
4.1 Introduction 
How positive selection instructs MHC-II restricted T-cells to commit to the CD4 
lineage, and MHC-I restricted T-cells to commit to the CD8 lineage remains an 
ongoing  question  (Alarcon  &  van  Santen,  2010).    TCR  signal  transduction 
classically leads to mitogen activated protein kinase (MAPK)/Activator protein 1 
(AP-1),  nuclear  factor  kappa-light-chain-enhancer  of  activated  B-cells  (NF B) 
and  Calcium  influx/Nuclear  factor  of  activated  T-Cells  (NFAT)  activation 
(reviewed in (Samelson, 2002)).  Evidence from knockout and transgenic mice 
suggests  that  such  signalling  pathways  are  required  for  positive  selection 
(reviewed in (Cantrell, 2002)).  However, how TCR signalling directly promotes 
the expression of lineage specifying factors remains to be elucidated (reviewed 
in (He et al., 2010)).  Currently, there are two favoured models addressing how 
signals  through  the  TCR  can  result  in  divergent  developmental  outcomes.  
These models focus on divergent signalling mechanisms mediated proximally to 
the TCR by either the CD4 or CD8 coreceptors.        
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MHC-II-restricted T-cells receive a relatively stronger positive selection signal 
then do MHC-I restricted T-cells because CD4 has a higher affinity for Lck than 
does CD8 (Wiest et al., 1993).  The quantitative instructive model proposes that 
stronger  signals  instruct  CD4  lineage  commitment,  whereas  weak  signals 
instruct CD8 lineage commitment (reviewed in (Hogquist, 2001)).  It was found 
that MHC-II restricted transgenic thymocytes that are CD4-deficient, will develop 
to  the  CD8  lineage,  presumably  because  they  receive  a  weaker  signal 
(Matechak et al., 1996).  Further evidence for a quantitative instructive model 
comes from studies utilising neonatal thymic organ culture (NTOC).  Culturing 
cells with agonist stimuli led to CD4 SP lineage generation (Bommhardt et al., 
1997), whereas culturing thymocytes with weaker antagonistic stimuli generated 
CD8 SP cells (Basson et al., 1998).  Additionally, constitutive TCR signalling 
mediated  by  Lck  directed  MHC-I-restricted  thymocytes  to  the  CD4  lineage, 
whereas a dominant-negative form of Lck directed MHC-II-restricted thymocytes 
to the CD8 lineage (Hernandez-Hoyos et al., 2000).  Overexpression of Lck in 
the  tetracycline-inducible  Lck  mice  was  also  found  to  favour  CD4  lineage 
generation (Legname et al., 2000).  However, not all experimental data supports 
a strictly quantitative model of lineage commitment.  For example, mutation of 
immunotyrosine  activation  motifs  (ITAMs)  in  TCR-associated  CD3 -chains 
reduced  TCR  signalling  sensitivity,  but  did  skew  the  CD4:CD8  lineage  ratio 
(Holst  et  al.,  2008;  Love  et  al.,  2000).    Furthermore  the  generation  of  mice 
expressing  chimeric  CD8   molecules  with  CD4  cytoplasmic  tails  that  recruit 
higher  levels  of  Lck,  revealed  no  evidence  of  lineage  redirection  of  MHC-I 
signalled  thymocytes  (Bosselut  et  al.,  2001;  Erman  et  al.,  2006).    Thus,        
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although quantitative difference in TCR signalling strength may play a role in the 
CD4/CD8 lineage decision, the quantitative instructive model cannot explain all 
of the experimental data. 
As  an  alternative  model,  it  has  been  proposed  that  signalling  duration  may 
instruct  the  CD4/CD8  lineage  decision,  with  longer  signals  promoting  CD4 
development and shorter signals promoting CD8 development (Yasutomo et al., 
2000).    Singer  and  colleagues  have  suggested  that  all  thymocytes  enter  a 
CD4
hiCD8
lo  population  following  an  initial  positive  selection  signal.    Thus 
CD4:spMHC-II  signals  can  be  maintained,  instructing  CD4  commitment, 
whereas  CD8:spMHC-I  signals  are  broken  off,  leading  to  CD8  development 
(Brugnera  et  al.,  2000)  (reviewed  in  (Singer  et  al.,  2008)).    Further  studies 
concluded that CD8 lineage specification additionally depended on interleukin 
(IL)7  signals  received  at  the  CD4
hiCD8
lo  stage  (Park  et  al.,  2010;  Yu  et  al., 
2006).    In  vivo  evidence  for  the  kinetic  signalling  model  came  from  the 
characterisation  of  the  CD4
E8III  mouse,  which  expresses  the  CD4  coreceptor 
under control of CD8 expression elements.  CD4 coreceptor expression was 
transcriptionally  downregulated  following  positive  selection,  resulting  in 
redirection of MHC-II restricted cells to the CD8 lineage (Sarafova et al., 2009).  
However,  it  could  be  argued  that  these  mice  exhibit  a  reduction  in  signal 
strength, as a function of time.  If CD4 was prematurely terminated, the overall 
signalling  strength  interpreted  by  a  cell  may  be  reduced.    Furthermore,  the 
presence of the CD4
hiCD8
lo population in MHC-I-restricted transgenic mouse 
models has been shown to correlate with TCR signalling strength, suggesting        
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coreceptor downregulation may function as a salvage pathway for high avidity 
MHC-I  restricted  cells  (Chan  et  al.,  1998;  Correia-Neves  et  al.,  2001).    A 
question  that  arises  is  whether  the  kinetic  signalling  model  and  quantitative 
instructive  model  are  mutually  exclusive,  or  whether  aspects  of  both  models 
may be true (reviewed in (Hogquist, 2001). 
Changes  in  TCR  and  associated  signal-transducing  molecules  occur  during 
positive selection.  TCR expression increases (Havran et al., 1987; Penit, 1990; 
Shortman et al., 1991), and Zap70 expression is higher in SP relative to DP 
populations (Chan et al., 1994b; Palacios & Weiss, 2007).  Furthermore, CD5 is 
a negative regulator of TCR signalling and is also modulated in developmentally 
intermediate  populations  of  positively  selecting  DPs  (Chapter 3,  Figure  3.4) 
(Tarakhovsky et al., 1995).  The temporal separation of developmental cues is a 
common  mechanism  by  which  cellular  developmental  fate  decisions  are 
triggered (reviewed in (Freeman & Gurdon, 2002)).  In Chapter 3 we showed 
evidence that the CD4/CD8 lineage decision in positively selecting thymocytes 
was  temporally  separated.    Therefore  an  important  question  is  whether  the 
temporal  modulation  of  signalling  proteins  will  differentially  impact  on  the 
signalling requirements for CD4 and CD8 lineage specification. 
In this chapter, we have investigated how a selecting T cell temporally interprets 
the CD4 versus CD8 lineage commitment signals.  Much is known about the 
essential role of Lck for CD4 lineage development, but we wished to address 
whether  the  downstream  kinase  Zap70  affects  the  lineage  commitment 
decision.  There is evidence that Zap70 expression is upregulated in mature        
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thymocytes relative to the DP population.  We have therefore investigated the 
kinetics and mechanisms behind this increase.  In Chapter 3, it was established 
that the DP2 population contained the direct precursors for the CD4 SP lineage, 
whereas the DP3 population contained the direct precursors for the CD8 SP 
lineage.  We were interested to address how TCR signalling thresholds may be 
differentially  regulated  between  the  DP2  and  DP3  populations,  and  how  this 
may impact on the interpretation of strong/consistent MHC-II-mediated versus 
the weak/intermittent MHC-I mediated positive selection signals.        
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4.2 Results 
4.2.1 Zap70 is rate limiting for TCR signal transduction in DP thymocytes 
We  first  wanted  to  investigate  whether  Zap70  expression  impacted  on  the 
positive  selection  signalling  sensitivity,  by  asking  whether  Zap70  expression 
could  be  a  rate-limiting  factor  in  TCR  signal  transduction.    Following 
CD3-crosslinking,  intracellular  calcium  influx  occurs  in  proportion  to  the  TCR 
signalling  sensitivity  (June  &  Rabinovitch,  1990).    Therefore  we  used  the 
TetZap70  system  to  investigate  whether  Zap70  abundance  contributes  to 
differences in TCR signalling sensitivity.  HuCD2 expression in the TetZap70 
mice faithfully reports Zap70 expression in live cells (Chapter 3, Figure 3.1 B).  
Hence, we tested whether different levels of HuCD2 expression on TetZap70 
thymocytes  correlated  with  a  differential  calcium  influx  following 
CD3-crosslinking.  TetZap70 mice were induced to express Zap70 for two days 
and  HuCD2  expression  was  first  examined  by  flow  cytometry.    TetZap70 
thymocytes exhibited a broad range of HuCD2 expression allowing us to gate 
on populations exhibiting differential expression (Figure 4.1 A, left histogram, 
gates 1-4).  We further found that HuCD2 expression positively correlated with 
the level of calcium influx (Figure 4.1 A, right panel).  In addition, this calcium 
influx  was  dependent  on  signals  transduced  through  Zap70,  as  Zap70
-/- 
thymocytes were not capable of fluxing calcium following a CD3-crosslinking 
stimulus (Figure 4.1 A, gate 5).  These data suggested that Zap70 expression 
is a rate-limiting factor during TCR signal transduction in DP thymocytes.        
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4.2.2 Transgenic Zap70 expression influences the developmental fate of 
TetZap70 thymocytes 
Differences  in  the  positive  selection  signal  strength  may  instruct  the  CD4  or 
CD8 lineage commitment decision (Hernandez-Hoyos et al., 2000; Matechak et 
al., 1996) (reviewed in (Hogquist, 2001).  Zap70 expression was found to be 
rate-limiting in TCR signal transduction (Figure 4.1 A).  We hypothesised that 
Zap70 may play a role in tuning TCR signalling sensitivity in positively selecting 
cells and thus may influence how TCR signal strength is interpreted.  To test 
this, we first asked whether transgenic Zap70 expression level influenced the 
developmental fate of TetZap70 thymocytes.  DP and SP thymic populations 
from TetZap70
on mice were examined by flow cytometry for the expression of 
Zap70.  We found that relative to non-selecting DP1 cells, the DP2 population 
expressed a high level of Zap70.  In contrast the DP3 population expressed 
relatively  low  levels  of  Zap70,  compared  to  both  DP1  and  DP2  populations 
(Figure 4.1 B, top panel).  Furthermore, Zap70 expression was higher in the 
mature  CD4  SP  population  relative  to  the  mature  CD8  SPs  (Figure 4.1 B, 
bottom  panel).    This  was  fitting  with  quantitative  instructive  model  of  T-cell 
development,  which  suggests  that  stronger  TCR  signals  promote  CD4  SP 
lineage  fate,  whereas  weaker  TCR  signals  promote  CD8  SP  lineage  fate 
(reviewed in (Hogquist, 2001)).  In B6 thymocytes Zap70 is under control of 
endogenous  regulatory  elements  as  opposed  to  the  TetZap70  transgenic 
system.  We therefore investigated whether the distribution of Zap70 abundance 
in  TetZap70  DP  and  SP  populations  was  also  reflected  in  B6  thymocytes.  
Zap70  expression  was  analysed  in  different  DP  and  SP  populations  in  B6        
  182 
thymocytes  by  flow  cytometry.    Relative  to  the  DP1  population,  we  saw  an 
increase  in  Zap70  expression  in  DP2  cells.    Surprisingly,  we  saw  further 
increased expression of Zap70 in the DP3 population (Figure 4.1 C, top panel).  
In  addition,  the  mature  SP  populations  had  the  highest  levels  of  Zap70 
expression, which were slightly but consistently higher in the CD8 SP lineage 
relative to the CD4 lineage (Figure 4.1 C, bottom panel).  We next confirmed 
that  the  increase  in  Zap70  expression  measured  by  the  1E7.2  anti-Zap70 
monoclonal  antibody  was  indeed  due  to  specific  differences  in  Zap70,  as 
opposed  to  changes  in  non-specific  binding  of  the  antibody  in  different 
developmental  subsets.    Zap70  expression  in  DP1-3,  CD4  SP  and  CD8  SP 
subsets  from  B6  mice  was  measured  by  western  blotting,  using  a  different 
monoclonal antibody (99F2) (see Materials and Methods, sections 2.3.1 and 
2.13.3).  Mirroring the results we see in B6 thymocytes with the 1E7.2 antibody 
by flow cytometry, we found Zap70 expression was low in the DP1 population of 
B6  mice  (expression  of  0.36  relative  to  GAPDH)  (Figure 4.1 D,  DP1).    In 
contrast  we  saw  a  progressive  upregulation  of  Zap70  in  the  DP2  and  DP3 
populations  (expression  of  0.68  and  0.74  respectively,  relative  to  GAPDH) 
(Figure 4.1 D, DP2 and DP3).  The CD4 and CD8 SP populations were again 
found to have the highest levels of Zap70 expression relative to GAPDH (0.87 
and 1.11 respectively, relative to GAPDH) (Figure 4.1 D, CD4SP and CD8SP).  
Taken  together  these  data  suggest  that  Zap70  expression  in  transgenic 
thymocytes could influence their developmental progression.  In contrast, Zap70 
expression  was  progressively  upregulated  during  the  development  of  B6 
thymocytes.         
  183 
4.2.3.  Progressive  upregulation  in  TCR  signalling  sensitivity  in  B6 
thymocytes 
We showed in Figure 4.1 C-D that Zap70 is upregulated during B6 thymocyte 
positive selection.  In addition, TCR and CD5 expression necessarily differ in 
these  populations  (see Chapter 3).    It  was  hypothesised  that  these  proteins 
would influence the intrinsic TCR signalling sensitivity of a positively selecting 
thymocyte.  We next wanted to directly assess whether there were changes in 
TCR signalling sensitivity in positively selecting DP thymocytes.  To do this, we 
examined calcium influx following CD3-crosslinking, first in B6 DP and CD8 SP 
populations.    We  saw  relatively  low  levels  of  calcium  flux  in  DP1  and  DP2 
populations,  suggesting  they  are  relatively  insensitive  to  TCR  signalling 
(Figure 4.2 A).    In  contrast  there  was  a  great  increase  in  TCR  signalling 
sensitivity in the DP3 population and these cells were almost as sensitive to 
TCR stimulation as B6 CD8 SPs (Figure 4.2 A).  This suggested there was a 
upregulation of TCR signalling sensitivity as B6 thymocytes progressively transit 
through the DP1-3 populations.  TetZap70 thymocytes do not upregulate Zap70 
expression in DP3 cells (Figure 4.1 B), however they express levels of TCR 
and CD5 identical to B6 mice (see Chapter 3).  This led us to ask whether 
differences  in  the  Zap70  expression  affected  TCR  signalling  sensitivity  in 
TetZap70 DP3 thymocytes.  To investigate this, TetZap70 mice were induced to 
express Zap70 for four or more days to allow for reconstitution of DP1-DP3 
populations.  Calcium flux was then induced in thymocytes by CD3-crosslinking 
and  examined  by  flow  cytometry.    Similar  to  B6  thymocytes,  TetZap70 
thymocytes showed relatively low levels of calcium flux in the DP1 and DP2        
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populations,  suggesting  the  were  relatively  insensitive  to  TCR  signalling 
(Figure 4.2 B).    In  contrast  to  B6  DP3  thymocytes,  the  TetZap70  DP3 
thymocytes did not show a great increase in TCR signalling sensitivity, as they 
showed  greatly  reduced  calcium  influx  compared  to  B6  CD8  SP  controls.  
Nevertheless  the  level  of  calcium  influx  exhibited  by  the  TetZap70  DP3 
population was slightly increased compared with the TetZap70 DP2 population 
(Figure 4.2 B). 
We next asked whether TetZap70 and B6 thymocytes had the same potential to 
influx  calcium,  independently  of  TCR  signalling.    We  stimulated  cells  with 
ionomycin,  a  calcium  ionophore  that  induces  calcium  influx  independently  of 
TCR  signalling (Liu  &  Hermann,  1978).    Upon  treatment  with  ionomycin,  we 
found no differences in the ability of thymocytes from TetZap70 and B6 mice to 
flux  calcium.    This  supports  the  conclusion  that  differences  in  calcium  influx 
following CD3-crosslinking between B6 and TetZap70
 DP3 populations are due 
to differences in TCR signalling sensitivity.  We additionally noted an increase in 
the  ionomycin  induced  calcium  influx  as  cells  mature  through  the  DP 
populations, which was identical for both TetZap70 and B6 thymocytes.  After 
approximately 250 seconds, 50% of DP1 cells to show calcium influx following 
ionomycin  treatment,  whereas  it  only  took  approximately  100  seconds  for 
calcium  influx  in  50%  of  DP3  cells  (Figure 4.2 C).    Finally,  to  test  whether 
differences in the capacity of TetZap70 and B6 DP thymocytes to influx calcium 
could be due to differential loading of the Indo1 calcium indicator.  When we 
measured Indo1 expression by flow cytometry in unstimulated cells, we found        
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Indo1 to be identically loaded in DP1-3 populations from both B6 and TetZap70 
mice (Figure 4.2 D).  Taken together this data suggests that a defect in TCR 
signal transduction underlies the defective ability of TetZap70 DP3 thymocytes 
to influx calcium following CD3-crosslinking. 
4.2.4 No evidence for signalling molecules other than Zap70 contributing 
to the reduced DP3 signalling sensitivity in TetZap70 thymocytes 
Our data suggested that TetZap70 DP3 thymocytes exhibited defective TCR 
signalling  relative  to  B6  controls.    Furthermore,  we  hypothesised  that  this 
reduction in TCR signalling was attributable to differences in the abundance of 
Zap70.    Conceivably  other  signaling  molecules  involved  in  TCR  signal 
transduction  may  be  differently  regulated  in  TetZap70  compared  to  B6 
thymocytes and thus impact on differences in TCR signalling between these 
mice.    To  investigate  this  we  compared  the  expression  levels  of  molecules 
involved in TCR signal transduction between DP1-3 populations, in TetZap70 
mice that had been induced to express Zap70 for four or more days and in B6 
control mice.  We first looked at the expression of the TCR proximal kinases Lck 
that is upstream of Zap70 (Iwashima et al., 1994) and the related and partially 
redundant Fyn proto-oncogene (Fyn) (Appleby et al., 1992).  Both Lck and Fyn 
were identically expressed in DP1-3 thymocyte populations of TetZap70 mice 
compared  to  B6  controls  (Figure 4.3).    We  also  analysed  the  expression  of 
linker of activated T-cells (LAT) and Src homology 2 (SH2) domain containing 
leukocyte protein of 76kDa (Slp76), adaptor proteins that are direct downstream 
targets of Zap70 (Wardenburg et al., 1996; Zhang et al., 1998).  Both LAT and        
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Slp76 were also expressed identically in DP1-3 populations of TetZap70 mice 
compared  to  B6  controls  (Figure 4.3).    Finally  we  looked  at  a  distal  MAPK 
family member extracellular regulated kinase (Erk)2, which is activated by TCR 
signalling and is downstream of LAT and Slp76 (reviewed in (Samelson, 2002)).  
We found no differences in Erk2 expression in the DP populations of TetZap70 
mice compared to B6 controls (Figure 4.3).  In summary, we found no evidence 
that signalling proteins other than Zap70 contributed to a TCR signalling defect 
in  TetZap70  thymocytes.    However  we  cannot  rule  out  that  other  signalling 
proteins, whose expression we have not examined, contribute to this difference. 
4.2.5  Increased  TCR  signalling  sensitivity  is  essential  for  CD8  SP 
development 
TetZap70 DP3 cells have a lower level of Zap70 expression relative to B6 DP3s 
(Figure 4.1), and this correlates with a defect in TCR signalling in the TetZap70 
DP3  population  (Figure 4.2).    The  DP3  population  contained  the  direct 
precursors for the CD8 SP lineage, which additionally depended on intrathymic 
signalling (Chapter 3, Figure 3.8 C, E).  Therefore, we investigated whether the 
defect in TCR signalling sensitivity in TetZap70 DP3 thymocytes had an impact 
on  the  continuing  maturation  of  these  cells  to  the  CD8  SP  lineage.    The 
TetZap70  mice  were  crossed  with  F5 Rag1
-/-  mice  that  express  an  MHC-I 
restricted TCR transgene on a Rag1
-/- background, giving F5
+/- Rag1
-/- Zap70
-/- 
Zap70
Tre rtTA
HuCD2 (refer to Materials and Methods, section 2.1, F5 TetZap70 
hereon).    This  allowed  us  to  assess  the  affect  of  transgenic  Zap70  on  a 
monoclonal population of positively selecting MHC-I restricted thymocytes.  To        
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first  address  whether  transgenic  Zap70  expression  permitted  thymocyte 
maturation beyond positive selection in the F5 system, we analysed the thymic 
phenotype  of  F5
+/- Rag1
-/-,  F5
+/- Rag1
-/- Zap70
-/-  and  F5 TetZap70  mice  that 
were  fed  dox  for   7  days  (F5  TetZap70
on  hereon),  by  flow  cytometry.    The 
post-selection DP2 and DP3 populations in addition to CD8 SPs were found in 
F5
+/- Rag1
-/-  mice  (Figure 4.4 A,  left  column).    In  contrast,  the 
F5 Rag1
-/- Zap70
-/- thymocytes were arrested at the DP1 stage; showing much 
reduced  frequencies  of  DP2,  DP3  and  CD8  SP  thymocytes  (Figure 4.4 A, 
middle  column).    When  we  examined  the  HuCD2
+  thymocytes  from 
F5 TetZap70
on  thymi,  we  found  that  transgenic  Zap70  expression  facilitated 
continued  thymic  maturation,  as  DP2,  DP3  and  CD8  SP  thymic  populations 
were  present.    However,  transgenic  Zap70  expression  abated  CD8  SP 
development, as this population was reduced in frequency relative to intact F5
+/-
 Rag1
-/- mice (Figure 4.4 A, right column).  To pinpoint the developmental block 
in CD8 SP development, we compared the ratio between precursor and progeny 
thymic populations in a cohort of F5
+/- Rag1
-/- and F5 TetZap70
on mice.  There 
was no significant difference in the DP3:DP2 ratio between F5
+/- Rag1
-/- and 
F5 TetZap70
on  mice  (Figure 4.4 B,  left).    In  contrast,  we  saw  a  significant 
reduction in the ratio of CD8 SP:DP3 cells in the F5 TetZap70
on mice compared 
to F5
+/- Rag1
-/- controls (p 0.01, Student s t-test: F5
+/- Rag1
-/- n=2, F5 TetZap70 
n=3) (Figure 4.4 B, right).  This data suggested that the failure to upregulate 
Zap70 in the DP3 population results in a significant block in positive selection 
between the DP3 and CD8 SP populations.        
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4.2.6 Reduced function but normal regulation of Zap70 affects the CD4 
and CD8 SP lineages equally 
TetZap70 thymocytes fail to upregulate Zap70 in the DP3 and SP populations.  
This affected the CD8 lineage development but had a much lesser effect on 
CD4  SP  generation  (Figure 4.4 B)  (Saini  et  al.,  2010).    We  therefore 
hypothesised  that  an  overall  reduction  in  Zap70-dependent  signalling  may 
specifically affect the development of the CD8 SP population.  To investigate 
this, we examined the thymic phenotype of SKG mice, which have a W163C 
mutation  in  the  carboxy-terminal  SH2  domain  of  Zap70,  resulting  in  a 
hypomorphic  allele  (Sakaguchi  et  al.,  2003).    We  first  investigated  whether 
positive selection was affected in a cohort of mice.  There was no difference 
between BALB/c and SKG mice in terms of thymic cellularity (Figure 4.5 A), 
however  there  was  a  significant  reduction  in  the  TCR
hiCD5
hi  population 
(Figure 4.5 B)  (p 0.001,  Student s  t-test  BALB/c  n=10,  SKG  n=10).    This 
suggested  that  there  was  a  defect  in  positive  selection  of  SKG  thymocytes, 
fitting with previous reports (Sakaguchi et al., 2003).  Examination of the thymic 
phenotype of SKG mice showed reduced frequencies of both CD4 and CD8 SP 
populations  relative  to  BALB/c  controls  (Figure 4.5 C,  top  row).    In  addition, 
there was a relative reduction in the frequency of DP2 and DP3 populations, 
with an overrepresentation of DP1 cells in the SKG mice (Figure 4.5 C, bottom 
row).    We  next  asked  whether  the  SKG  mutation  affected  peripheral  T-cell 
homeostasis.  There was a significant reduction in T-cell numbers in the LN of 
SKG mice relative to BALB/c controls (p 0.001, Student s t-test BALB/c n=10, 
SKG  n=10)  (Figure 4.5 D).    In  addition,  both  CD4  and  CD8  lineages  were        
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affected,  as  both  lineages  showed  reduced  percentages  as  a  frequency  of 
lymphocytes in SKG mice, relative to BALB/c controls (Figure 4.5 E).  Our data 
suggested that the SKG mutation had an effect on both CD4 and CD8 lineage 
development and homeostasis.  This led us to ask whether either the CD4 or 
CD8  lineages  were  more  severely  affected  by  the  reduction  in  Zap70 
expression.  We compared the CD4:CD8 ratio in thymi and LNs of a cohort of 
BALB/c control and SKG mice.  There was found to be no significant difference 
in the CD4:CD8 ratio in either the thymi or LNs of SKG mice (Figure 4.5 F) 
(CD4/CD8:  Thymus:  BALB/c=5.99±0.93  n=10,  SKG=6.40±0.64  n=10, 
LN:   BALB/c=2.51±3.00 n=5, SKG=2.17±2.71 n=5).  This implied that a simple 
reduction  in  Zap70  function  could  not  account  for  a  specific  defect  in  CD8 
lineage development in TetZap70 mice. 
In TetZap70 mice, the transgenic expression of Zap70 resulted not just in a 
reduction of Zap70 in more mature thymic populations, but also in dysregulated 
Zap70 expression during T-cell ontogeny (Figure 4.1 B).  We therefore asked 
whether  the  SKG  mice  also  showed  differences  in  the  pattern  of  Zap70 
expression.  Zap70 expression was examined in the DP1-3, CD4 and CD8 SP 
populations of SKG mice and BALB/c controls.  Relative to the DP1 population, 
we  saw  an  increase  in  Zap70  expression  in  DP2  cells  from  both  BALB/c 
controls and SKG mice.  Also there was a further increase in the expression of 
Zap70  in  the  DP3  population  (Figure 4.5 G,  top  panel).    The  mature  SP 
populations  of  BALB/c  and  SKG  mice  had  the  highest  levels  of  Zap70 
expression  (Figure 4.1 G,  bottom  panel).    This  was  despite  the  consistently        
  190 
lower expression of Zap70 in SKG mice compared to equivalent populations in 
BALB/c mice (Figure 4.1 G).  Taken together, this data suggests that SKG mice 
have an overall defect in positive selection, which affects both the CD4 and CD8 
lineages equally.  In addition, SKG mice show normal developmental patterns of 
Zap70 regulation, although overall abundance and function is reduced. 
4.2.7  Zap70  and  CD5  are  transcriptionally  regulated  during  positive 
selection 
TetZap70 mice exhibit a specific defect in CD8 lineage development relative to 
the  CD4  lineage  (Figure 4.2 B-C,  Figure 4.4)  (Saini  et  al.,  2010),  which 
correlated with lower Zap70 expression in DP2, DP3, CD4 SP and CD8 SP 
populations  relative  to  a  B6  control.    However,  SKG  thymocytes  also  have 
defects  in  TCR  signalling,  which  affects  both  CD4  and  CD8  lineage 
development equally (Figure 4.5) (Sakaguchi et al., 2003).  We hypothesised 
that the CD4/CD8 lineage decision may be more dependent on the regulation of 
Zap70,  rather  than  the  overall  abundance.    We  therefore  investigated  the 
mechanism controlling Zap70 regulation in WT cells during positive selection.  
To do this, we sorted DP1-3, CD4 SP and CD8 SP thymocytes from thymi of B6 
mice  and  examined  the  Zap70  gene  expression  in  these  populations  by 
RT-qPCR.    We  additionally  examined  expression  of  Zap70  in  total  Rag1
-/- 
thymocytes  that  are  blocked  at  the  DN3  stage  of  development  as  a  control 
(Godfrey et al., 1994; Mombaerts et al., 1992b).  DP1 cells expressed more 
Zap70 mRNA than total Rag1
-/- thymocytes, consistent with previous studies 
(Chan et al., 1994b; Palacios & Weiss, 2007).  However, when we looked in the        
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DP2  and  DP3  populations,  we  found  there  to  be  an  approximately  2-fold 
increase in the amount of Zap70 mRNA.  Zap70 mRNA levels in CD4 and CD8 
SP populations were found to be similar level to that of DP1 cells, suggesting 
that  Zap70  mRNA  is  reduced  upon  completion  of  positive-selection 
(Figure 4.6 A).  This contrasts with Zap70 protein expression, which highest in 
SP  populations  of  WT  mice  (Figure 4.1 C).    Thus  our  data  suggests  that 
post-transcriptional mechanisms may maintain high Zap70 protein expression in 
SP cells.  These mechanisms may include increased translation efficiency, or 
decreased Zap70 protein turnover. 
We also investigated CD5 mRNA expression, as it has been suggested that 
CD5  is  transcriptionally  regulated  during  thymic  development  (Yang  et  al., 
2004).    Similarly  to  Zap70,  CD5  was  found  to  be  expressed  at  background 
levels in Rag1
-/- thymocytes and expressed at low levels in TetZap70 DP1 cells.  
In addition CD5 mRNA showed an approximately 6-7 fold increase in DP2 cells 
compared to DP1.  However, in contrast to Zap70 mRNA expression patterns, 
DP3 cells exhibited a relatively low level of CD5 mRNA expression, similar to 
that of the DP1 population.  CD5 mRNA expression was approximately 2-3 fold 
increased over DP1 in the CD4 SP population, whereas it was expressed at a 
similar level to the DP1 cells in the CD8 SP population (Figure 4.6 B).  Taken 
together, these data suggest that both Zap70 and CD5 are under transcriptional 
regulation  during  positive  selection,  although  both  show  slightly  different 
expression  patterns,  particularly  in  the  DP3  population.    CD5  expression 
decreases in the DP3 population despite the finding that DP3 cells are more        
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sensitive to TCR signals than DP2 cells (Figure 4.6 B, Figure 4.2 A).  Thus our 
data also implies that CD5 is regulated independently of TCR signalling in DP3 
cells. 
4.2.8 Conserved transcription factor binding sites exist upstream of the 
Zap70 gene  
Analysis  of  Zap70  mRNA  levels  suggested  that  Zap70  was  transcriptionally 
regulated  during  positive  selection.    Genetic  elements  controlling  gene 
expression  are  often  conserved  across  species  (Levy  et  al.,  2001).    We 
therefore  asked  whether  any  evolutionary  conserved  regions  (ECRs)  were 
associated with the Zap70 gene.  To do this we compared the Zap70 sequence 
and approximately 5-10 kilobases (kb) upstream and downstream of the gene.  
We did this using a comparative genomics approach, comparing human and 
mouse  Zap70  sequences  using  the  ECR  browser  tool  (available  online  at 
http://ecrbrowser.dcode.org/,  accessed  September  2010).    Such  analysis 
revealed a number of noncoding ECRs associated with Zap70.  One notable 
region  was  approximately  250  base  pairs  (bp)  in  length  and  was  located 
proximally  upstream  of  the  transcriptional  start  site  (Figure 4.7 A).    We 
hypothesised that this represented conservation within the Zap70 promotor.  We 
further examined this by asking whether there were any evolutionary conserved 
transcription factor binding sites in the putative promotor sequence.  When we 
compared the mouse and human sequence to look for evolutionary conserved 
transcription factor binding sites, we found amongst others an E-twenty six (Ets) 
site, an E-box, an NFAT binding site and a cAMP response element-binding        
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(CREB) binding site within the ECR proximal to the Zap70 gene transcriptional 
start  site  (Figure 4.7 B,  left).    Furthermore,  direct  alignment  of  mouse  and 
human genomes showed that the conserved transcription factor binding sites 
within  this  region  were  almost  entirely  conserved,  or  have  incorporated  only 
transition mutations (Figure 4.7 B, right).  Taken together, this analysis shows 
that a noncoding ECR containing conserved transcription factor binding sites, 
exists upstream of the Zap70 gene. 
4.2.9  in  vitro  models  of  positive  selection  suggest  that  TCR  signal 
regulates Zap70 expression 
TCR signalling has been directly implicated in the regulation of factors binding 
to Ets, E-box, NFAT and CREB binding sites (reviewed in (Macian, 2005; Murre, 
2005; Shaywitz & Greenberg, 1999)).  Conserved binding sites for these factors 
are present immediately upstream of Zap70 in a non-coding ECR (Figure 4.7).  
Furthermore,  it  has  been  reported  that  Zap70  expression  is  upregulated  on 
mature  T-cells  following  antigenic  stimulation  (Chandok  et  al.,  2007).    We 
therefore wanted to investigate whether TCR signals could directly modulate 
Zap70 expression in DP thymocytes.  To test this, we treated DP1 cells in vitro 
using a combination of phorbol-12-myristate 13-acetate (PMA) and ionomycin, 
at  concentrations  known  to  mimic  positive  selection  signalling (Ohoka  et  al., 
1996).  We first purified DP1 cells, by depleting B6 thymocytes of CD3
+, CD69
+ 
and CD25
+ cells.  This enabled us to enrich DP1 cells to approximately 90% 
purity  (Figure 4.8 A).    We  cultured  the  enriched  DP1  cells  with  PMA  and 
ionomycin for 14 hours, before washing out the reagents and allowing the cells        
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to rest for the remainder of the culture time.  Cells were stimulated with PMA or 
ionomycin alone, or in the absence of reagents as controls.  After 22 hours, the 
combined PMA and ionomycin stimulation induced downregulation of both CD4 
and  CD8  coreceptors,  which  was  not  seen  in  the  absence  of  one  or  both 
reagents (Figure 4.8 B, top row).  By 46 hours, the PMA and ionomycin treated 
DP1 cells were phenotypically CD4 SP.  In contrast, control cells stimulated with 
PMA or ionomycin alone, or with neither reagent, remained phenotypically DP 
(Figure 4.8 B,  bottom  row).    CD69  is  upregulated  on  positively  selecting 
thymocytes, downstream of TCR signalling (Swat et al., 1993).  We next asked 
whether  the  PMA  and  ionomycin  treatment  in  our  protocol  induced  CD69 
upregulation. CD69 was highly expressed on the PMA and ionomycin treated 
cells  by  22  hours,  but  not  on  controls  treated  with  either  or  none  of  these 
reagents.  Furthermore CD69 was reduced in PMA and ionomycin treated cells 
by 46 hours (Figure 4.8 C, left column).  This data suggested that PMA and 
ionomycin treatment mimicked the positive selection TCR signal.   
We next asked if mimicking the positive-selection TCR signal would also induce 
Zap70 upregulation.  We found a large increase in Zap70 expression in PMA 
and  ionomycin  treated  DP1  thymocytes  by  22  hours,  which  was  maintained 
after  46  hours.    In  contrast,  untreated  cells  or  treatment  with  either  reagent 
alone did not upregulate Zap70 (Figure 4.8 C, right column).  This suggests 
that the TCR signal may directly regulate Zap70 expression in DP thymocytes.  
We wanted to determine whether the upregulation of Zap70 induced by PMA 
and ionomycin treatment depended on protein transcription and/or translation.         
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To investigate this, actinomycin D (ActD) (an inhibitor of transcription (Reich, 
1964)) or cyclohexamide (Chx) (an inhibitor of translation (Obrig et al., 1971)) 
were added to PMA and ionomycin stimulated DP1 thymocytes.  Addition of 
either  ActD  or  Chx  reduced  but  did  not  prevent  CD4  and  CD8  coreceptor 
downregulation  after  22  hours  (Figure 4.8 D,  density  plots).    We  found  that 
treatment with either inhibitor blocked Zap70 upregulation and furthermore that 
Zap70 abundance was reduced relative to non-treated controls (Figure 4.8 D, 
histogram).    These  data  suggested  that  TCR  signalling  controls  Zap70 
expression, through a mechanism that is dependent on both transcription and 
translation. 
TCR  signalling  activates  divergent  downstream  pathways  including  MAPKs 
(implicated  in  Ets  and  E-protein  regulation),  NFAT  and  CREB  (reviewed  in 
(Murre, 2005; Samelson, 2002; Shaywitz & Greenberg, 1999)).  To investigate if 
these downstream pathways contribute to Zap70 upregulation, we first treated 
cells with the MAPK inhibitor U0126 (an inhibitor of MAPK/Erk kinase (MEK) 
(Favata  et  al.,  1998))  and  the  CREB  inhibitor  Kn93  (an  inhibitor  of 
Calcium/calmodulin-dependent  protein  kinase  (CamK)-II  (Sumi  et  al.,  1991), 
which lies upstream of CREB activation (Sheng et al., 1991)), along with PMA 
and ionomycin.  Addition of either U0126 or Kn93 to the culture medium had no 
effect on Zap70 upregulation (Figure 4.8 E), suggesting that MAPK and CREB 
signalling pathways may not be important for Zap70 upregulation.   
We asked whether NFAT signalling was important by treating cells with varying 
concentrations  of  cyclosporin  A  (CsA)  (an  inhibitor  of  calcineurin,  which  is        
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essential for NFAT activation (McCaffrey et al., 1993)), along with PMA and 
ionomycin.  Increasing concentrations of CsA correlated with decreased CD4 
and CD8 coreceptor downregulation at 22 hours following PMA and ionomycin 
treatment  (Figure 3.8 F).    In  addition,  increasing  CsA  concentrations  also 
reduced Zap70 upregulation in PMA and ionomycin treated cells (Figure 3.8 G).  
To exclude a potential confounding role for off-target effects of CsA, we cultured 
cells with another NFAT inhibitor FK506 (McCaffrey et al., 1993).  In agreement 
with  results  following  CsA  treatment,  FK506  treated  cells  also  failed  to 
upregulate  Zap70  in  PMA  and  ionomycin  cultures  (Figure 3.8 F).    Taken 
together, these data represent in vitro evidence suggesting that TCR signalling 
regulates Zap70 gene transcription in a calcineurin/NFAT-dependent, but MEK 
and CamK-II-independent manner.
 
4.2.10 The positive selection signal modulates Zap70 expression during 
positive selection in vivo 
We  next  wanted  to  test  whether  Zap70  expression  could  be  modulated 
downstream  of  TCR  signalling  in  vivo.    F5 Rag1
-/- b2m
-/-  mice  show  DP1 
arrested  thymic  development,  as  they  lack  the   2m  selecting  ligand  for  the 
MHC-I restricted F5 TCR (Chapter 1, section 3.2.4).  We therefore investigated 
the effects of TCR stimulation on DP1 arrested F5 Rag1
-/- b2m
-/- thymocytes, 
following intraperitoneal (I.P.) administration of anti-CD3 antibody, along with a 
low dose of anti-CD28 on F5 Rag1
-/- b2m
-/- thymocytes.  We saw no changes in 
expression  of  the  CD4  or  CD8  coreceptors  on  thymocytes  24  hours  after 
injection (Figure 4.9 A, top row).  However, we did note the development of a        
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DP2 population in F5 Rag1
-/- b2m
-/- mice injected with anti-CD3/CD28, that was 
not present in controls (Figure 4.9 A, bottom row).  The DP2 population showed 
increased abundance of CD69 relative to anti-CD3/CD28 injected DP1 cells, or 
non-injected  controls  (Figure 4.9 B).    This  suggested  that  anti-CD3/CD28 
treatment  induced  TCR  signalling  in  thymocytes.    We  next  asked  whether 
Zap70  expression  was  increased  in  the  DP2  cells  in  F5 Rag1
-/-  b2m
-/-  mice, 
following I.P. injection of anti-CD3/CD28.  We observed a consistent increase in 
Zap70 expression in this DP2 population, as compared with DP1 populations in 
anti-CD3/CD28  treated  mice  or  non-injected  controls  (Figure 4.9 C).    Taken 
together,  these  data  suggest  that  TCR  signalling  in  vivo  upregulates  Zap70 
abundance in DP thymocytes. 
Finally,  we  wanted  to  test  whether  quantitative  differences  in  the  positive 
selection signal affected the regulation of Zap70.  To do this F5 Rag1
-/- b2m
-/- 
CD45.2
+ thymocytes were injected directly into thymi of F5 Rag1
-/- CD45.1
+ or 
B6 CD45.1
+ hosts.  This alleviated the block in positive selection, as both hosts 
expressed  the  MHC-I  selecting  ligand.    F5 Rag1
-/- b2m
-/- CD45.2
+  cells 
transferred to F5 Rag1
-/- donors must compete with a monoclonal population of 
T-cells for positive selection ligands.  In contrast, we hypothesised that transfer 
to  B6  hosts  results  in  a  reduction  in  intraclonal  competition,  and  thus  may 
improve  the  positive  selection  signal,  as  shown  by  others  (Canelles  et  al., 
2003).    To  investigate  the  effects  of  reducing  the  clonal  competition  on  the 
positive selection signal, CD69 expression was examined on transferred cells 
after two days.  We found that F5 Rag1
-/- b2m
-/- cells transferred to B6 hosts        
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displayed  higher  CD69  abundance  relative  to  F5 Rag1
-/- b2m
-/-  thymocytes 
transferred to F5 Rag1
-/- hosts (Figure 3.9 D), confirming that reducing clonal 
competition increases the positive selection signal strength or efficiency.  We 
next  investigated  whether  the  kinetics  of  Zap70  upregulation  differed  in 
F5 Rag1
-/- b2m
-/- thymocytes following intrathymic transfer to B6 or F5 Rag1
-/- 
hosts.  Cells transferred to B6 hosts upregulated Zap70 with more rapid kinetics 
and  to  a  greater  extent  than  those  transferred  to  F5 Rag1
-/-  hosts 
(Figure 3.9 E).    However,  despite  the  increased  kinetics  and  abundance  of 
Zap70 upregulation in F5 Rag1
-/- b2m
-/- thymocytes transferred to B6 hosts, B6 
host  CD8  SPs  still  expressed  relatively  higher  levels  of  Zap70.    This  is  in 
keeping  with  the  intrinsically  low  avidity  of  the  F5  TCR  for  spMHC 
(Figure 3.9 E,  host  CD8SP)  (Ge  et  al.,  2004).    When  taken  together,  the 
evidence presented in this chapter suggests that Zap70 expression is tuned in 
response to the TCR signalling strength during positive selection.        
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4.3 Discussion 
We have identified a novel developmental role for Zap70 in modulating the TCR 
signalling  threshold  during  positive  selection.    Zap70  was  found  to  be  a 
rate-limiting factor for TCR signal transduction in DP thymocytes.  In addition, 
the abundance of Zap70 correlated with the developmental fate decision taken 
by TetZap70 thymocytes.  In contrast, when we examined WT mice, we found 
that  Zap70  was  progressively  upregulated  along  with  maturity  throughout 
positive  selection.    TetZap70  thymocytes  exhibited  a  block  in  CD8  SP 
development,  whereas  the  CD4  SP  lineage  was  less  affected  (Chapter 1, 
Figure 3.1 G) (Saini et al., 2010).  We therefore hypothesised that the CD8 SP 
lineage  developmental  defect  resulted  from  either  a  reduction  in  function  of 
Zap70 expression, or dysregulated developmental upregulation.  We found that 
a  simple  reduction  in  Zap70  function  affected  both  CD4  and  CD8  lineages 
equally, and thus argue that developmental dysregulation of Zap70 underlies 
the CD8 SP developmental defect.  Finally we have provided evidence that the 
positive  selection  TCR  signal  directly  influenced  Zap70  expression  levels.  
Therefore, we suggest a model whereby the external signal mediated by MHC 
molecules  influences  the  internal  sensitivity  of  the  TCR.    CD4  and  CD8 
dependent  signals  are  likely  to  mediate  strong/consistent  versus 
weak/intermittent signals respectively.  In addition we have shown in Chapter 3 
that CD4 and CD8 lineage development occurs with temporal distinction.  A 
feedforward  loop  mechanism,  whereby  TCR  signals  promote  increased 
signalling  sensitivity  of  the  TCR,  may  enable  greater  resolution  of        
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strong/consistent MHC-II-mediated signals at early times and weak/intermittent 
MHC-I-mediated  signals  at  later  times.    Thus  by  temporally  separating  the 
CD4/CD8  lineage  commitment  decision,  signals  through  the  TCR  may  be 
conducive to triggering divergent developmental fates. 
We first found that Zap70-mediated signal transduction is rate-limiting for TCR 
signalling during positive selection.  When we analysed calcium influx following 
CD3-crosslinking in DP gated TetZap70 cells, we found that increased calcium 
influx  correlated  with  increased  HuCD2  (and  thus  Zap70)  expression  in 
thymocytes  (Figure 4.1 A).    Furthermore,  WT  Zap70  was  developmentally 
increased throughout positive selection (Figure 4.1 C).  In addition, TetZap70 
DP3  thymocytes  were  phenotypically  indistinguishable  to  those  of  WT  in  all 
aspects  examined,  except  with  regards  to  Zap70  abundance  (Chapter 3, 
Figure 3.1 D  and  Figure 4.2 C,  Figure 4.3).    This  difference  in  Zap70  in 
TetZap70  and  WT  DP3  populations  correlated  with  reduced  sensitivity  to 
anti-CD3  crosslinking  of  TetZap70  thymocytes  (Figure 4.2 A-B).    Other 
researchers have shown that WT SP thymocytes show increased calcium influx 
following CD3-crosslinking, relative to DPs (Davey et al., 1998; Finkel et al., 
1987; Havran et al., 1987; Hedin et al., 1995).  Our results suggest that Zap70 
expression  functionally  contributes  to  this  developmental  increase  in  TCR 
signalling sensitivity. 
Zap70  expression  levels  were  found  to  influence  the  developmental  fate 
decision of transgenic thymocytes.  Whereas high levels of Zap70 expression 
were found in DP2 and CD4 SP thymic populations in TetZap70
on mice, we        
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found a relatively lower abundance of Zap70 in DP3 and CD8 SP compartments 
(Figure 4.1 B).    Such  a  finding  is  entirely  reconcilable  with  the  quantitative 
instructive model of T-cell development, which states that strong avidity signals 
promote  CD4  SP  development,  whereas  weak  signals  promote  CD8  SP 
development (Hernandez-Hoyos et al., 2000; Matechak et al., 1996) (reviewed 
in  (Hogquist,  2001)).    In  TetZap70  mice,  higher  levels  of  Zap70  in  DP 
thymocytes  may  permit  stronger  signal  transduction  leading  to  CD4 
development.  The remaining cells with less transgenic Zap70 may be unable to 
transduce sufficiently strong signals to instruct CD4 lineage development and 
may be predisposed to CD8 SP lineage development.  This is consistent with 
the low level of Zap70 observed in TetZap70 DP3 cells (Figure 4.1 B).  
Thymic Zap70 expression in WT mice sharply contrasted with that seen in the 
TetZap70 mice.  We found a progressive upregulation of Zap70 throughout the 
DP populations in WT mice and showed that Zap70 is expressed at the highest 
levels in thymic SP populations (Figure 4.1 B, D).  The loss of developmental 
regulation of Zap70 in TetZap70 mice may therefore reveal underlying signalling 
requirements,  which  trigger  CD4  SP  versus  DP3  progression  from  the  DP2 
precursor population.  Such a conclusion assumes that lower Zap70 expression 
in TetZap70 DP3 thymocytes reflects a selective event, as opposed to resulting 
from  a  downregulation  of  Zap70.    We  favour  the  hypothesis  that  low  Zap70 
expression in DP3 cells represents a selective event, as there is no reported 
evidence  for  a  CD8  lineage-specific  downregulation  in  other  tetracycline 
inducible systems (Labrecque et al., 2001; Legname et al., 2000).  However,        
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this could be more conclusively determined by following cell fate of Zap70
hi and 
Zap70
lo cells, following intrathymic transfer to dox fed hosts. 
We showed evidence that intact TetZap70 mice have a specific defect in CD8 
lineage development, as TetZap70 CD8s were reduced in frequency in contrast 
to CD4 SPs that were unaffected (Chapter 1, Figure 1 G).  It has been reported 
elsewhere  that  such  a  CD8  lineage-specific  block  is  exacerbated  when 
TetZap70  cells  develop  in  competition  with  WT  cells  in  mixed  BM  chimeras 
(Saini  et  al.,  2010).    A  specific  defect  in  DP3  to  CD8  SP  developmental 
progression was identified in F5 TetZap70 mice, when they were compared to 
F5
+/- Rag1
-/-  controls  (Figure 4.4).    This  correlated  with  a  reduction  in  TCR 
signalling  sensitivity  following  anti-CD3-crosslinking  in  TetZap70  DP3  cells 
(Figure 4.2 A-B).    Nevertheless,  lower  Zap70  expression  promoted  the 
phenotypic  progression  of  TetZap70  thymocytes  to  the  DP3  compartment 
(Figure 4.1 B).  Taken together, these data suggest that although low levels of 
Zap70-mediated  signal  transduction  promote  DP3  generation,  relatively 
stronger  TCR  signals  may  be  required  for  DP3  to  CD8  SP  developmental 
progression.  Therefore we find evidence that the intrathymic signals required 
for DP3 to CD8 SP lineage progression are likely to be mediated at least in part 
through the TCR.  Such a conclusion is fitting with a “proof-reading” mechanism 
for CD8 lineage development (Liu et al., 2003), and contrasts the theory that 
CD8 lineage development is instructed solely by IL7 and/or gamma-chain ( c) 
cytokine signals transduced via signal transducer and activator of transcription 
(STAT)5 and in the absence of TCR signalling, at the CD4
hiCD8
lo stage (Park et        
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al., 2010; Yu et al., 2003).  Furthermore, the presence of CD8 SPs in the IL7, 
Interleukin-7  receptor   -chain  (IL7r )  and   c-deficient  mice  further  argues 
against a non-redundant instructive role for cytokines in this process (Di Santo 
et al., 1999; Peschon et al., 1994; von Freeden-Jeffry et al., 1995). 
We also found evidence that a CD8 lineage-specific developmental block did 
not  simply  result  from  a  reduction  in  Zap70  function.    SKG  mice  exhibit  a 
reduction-of-function mutation in Zap70 (Sakaguchi et al., 2003), which equally 
affected CD4 and CD8 lineage development (Figure 4.5).  This fits with the 
suggestion that the positive selection signal strength correlates with the overall 
numbers  of  positively  selected  cells  as  opposed  to  influencing  the  lineage 
decision,  which  researchers  have  used  as  evidence  to  support  the  kinetic 
signalling  model  (Bosselut  et  al.,  2001;  Erman  et  al.,  2006).    Indeed,  a 
quantitative instructive model predicts that such a loss of Zap70 function and 
thus  reduction  in  TCR  signal,  would  favour  the  generation  of  an  increased 
frequency of CD8 SPs relative to CD4 SPs.  In this regard, our results oppose 
the quantitative instructive model of CD4/CD8 lineage commitment.  It could be 
argued that the phenotypic progression to the DP3 population in TetZap70 mice 
results  from  lower  Zap70  abundance  exacerbating  a  “break”  in  the  positive 
selection  signal,  thus  lending  support  to  arguments  of  the  kinetic  signalling 
model (Singer et al., 2008).  Therefore our data lends support to aspects of both 
the quantitative and kinetic models of lineage commitment.   
An advance made by our study was to show that during positive selection in WT 
mice, Zap70 underwent a rapid upregulation in positively selecting subsets of        
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DP thymocytes (Figure 4.1 C), which contributed to increased TCR signalling 
sensitivity (Figure 4.2 A-B).  It has been shown that Zap70 abundance is higher 
in thymic SPs relative to total DPs (Chan et al., 1994b; Palacios & Weiss, 2007).  
However,  these  studies  did  not  take  into  account  heterogeneity  of  DP 
population.    As  the  majority  of  DP  thymocytes  are  phenotypically  DP1 
(Chapter 3, Figure 3.4 B), such studies did not permit resolution of the finer 
kinetics of Zap70 regulation in developmentally intermediate populations. 
Whilst we found that Zap70 was progressively upregulated with maturity during 
selection  (Figure 4.1 C),  the  highest  mRNA  expression  was  in  the  positively 
selecting DP2 and DP3 populations (Figure 4.6 A).  This may be necessary as 
selecting cells rapidly upregulate overall Zap70 expression, whereas expression 
levels  are  only  required  to  be  maintained  in  peripheral  cells.    Furthermore, 
completion  of  positive  selection  has  been  correlated  with  the  induction  of 
eukaryotic initiation factor 4E (eIF4E), a protein that increases the efficiency of 
mRNA translation (Nunomura et al., 2000).  Therefore Zap70 levels may be 
maintained in mature SP populations due to increased translation, as opposed 
to requiring transcriptional elevation.  Differences in protein turnover rates in 
positively selected T-cells compared to non-selecting DPs may also contribute 
to the maintenance of higher Zap70 abundance. 
Interestingly  we  saw  a  similar  pattern  of  regulation  with  regards  to  CD5 
expression.    CD5  was  rapidly  increased  in  the  DP2  population  at  the 
transcriptional level, before mRNA expression was reduced in the DP3 and SP 
populations (Figure 4.6 B).  This precisely mirrors CD5 protein expression in        
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the  DP  populations  (Chapter 1,  Figure 3.4).    Furthermore,  mature  SP 
populations have high levels of CD5 expression, relative to non-selecting DPs 
(Azzam et al., 1998).  This is in agreement with findings suggesting that CD5 is 
transcriptionally  regulated  in  the  thymus  by  the  E  protein,  E47  (Yang  et  al., 
2004), a factor that is modulated by TCR positive selection signalling (reviewed 
in (Murre, 2005)).  However, our finding that CD5 is downregulated at the DP3 
stage suggests a further level of developmental regulation.  We found that WT 
DP3  cells  were  actually  more  sensitive  to  TCR  signals  compared  to  DP2s, 
suggesting they should indeed have higher levels of CD5, if expression was 
entirely regulated by TCR signalling (Figure 4.2 A).  An intriguing possibility is 
that  the  developmental  tuning  of  CD5  contributes  to  the  increasing  TCR 
signalling sensitivity of DP3 cells, allowing interpretation of inherently weaker 
MHC-I  mediated  signals.    Further  experiments  will  be  required  to  elucidate 
whether  developmental  modulation  of  E  proteins  directly  contributes  to  the 
regulation of CD5 expression in DP3 thymocytes. 
Nevertheless,  because  both  Zap70  and  CD5  showed  similar  expression 
patterns (with the exception of the DP3 population), and due to the implication 
of TCR signalling in CD5 regulation (Azzam et al., 1998), the evidence was 
certainly suggestive of a direct role for TCR signalling in Zap70 modulation.  To 
further explore this possibility, we undertook a comparative genomics approach 
to  identify  non-coding  ECRs,  which  may  correlate  with  genetic  regulatory 
elements.    We  found  a  number  of  conserved  binding  sites  for  transcription 
factors which themselves are direct targets of TCR signalling, including an Ets,        
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Ebox, NFAT and CREB site (Figure 4.7).  Furthermore, we showed that PMA 
and  ionomycin  treatment  at  a  concentration  known  to  mimic  the  positive 
selection signal, also upregulated Zap70 (Figure 4.8 B-C) (Ohoka et al., 1996). 
In  support  of  the  finding  that  TCR  signalling  may  directly  upregulate  Zap70, 
Chandok  et  al.  recently  found  that  Zap70  is  upregulated  following  antigenic 
stimulation of peripheral T cells (Chandok et al., 2007).  We additionally showed 
that  the  calcineurin  inhibitors  CsA  and  FK506  inhibited  this  upregulation 
suggesting that NFAT activation may be particularly important for this process 
(Figure 4.8 F-H). There is considerable redundancy between NFAT proteins, as 
NFAT1, NFAT2 and NFAT4 are expressed in thymocytes (reviewed in (Macian, 
2005)), and their expression is temporally regulated by the positive selection 
signal  (Adachi  et  al.,  2000).    NFAT4  predominates  in  DP  thymocytes,  and 
interestingly  the Nfat4
-/-  mouse  has  an  apparently  greater  defect  in  the  CD8 
lineage  development  relative  to  the  CD4  lineage,  although  this  was  not 
quantified in a large cohort of mice (Oukka et al., 1998).  If this proved to be the 
case, it is an interesting possibility that this reflects a failure to upregulate Zap70 
during positive selection in these mice.  Further analysis of the Nfat4
-/- mice 
would be required determine if Zap70 was indeed dysregulated during positive 
selection.  In addition, it will be important in future experiments to determine 
whether NFAT directly associates with the Zap70 gene.  ChIP analysis could be 
employed  to  determine  whether  NFAT  binds  to  the  Zap70  locus  directly.  
Furthermore, generation of mice with a mutation of the conserved NFAT binding 
site  will  enable  elucidation  of  the  precise  role  of  this  site  in  Zap70  gene 
regulation.        
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A criticism of the finding that PMA and ionomycin treatment can induce Zap70 
expression  in  DPs,  is  that  whilst  this  treatment  is  known  to  mimic  positive 
selection TCR signalling, it certainly deviates from the physiological signal.  We 
therefore undertook studies in vivo, aimed at investigating the kinetics of Zap70 
upregulation.  First of all we found that I.P. injection of anti-CD3/CD28 induced 
an  upregulation  of  Zap70  in  some  F5 Rag1
-/- b2m
-/-  cells  (Figure 4.9 A).  
Secondly, we showed that F5 Rag1
-/- b2m
-/- cells received a stronger positive 
selection signal following intrathymic transfer to B6 hosts relative to F5 Rag1
-/-- 
hosts, likely resulting from differences in intraclonal competition between the 
host  environments.    Importantly,  we  found  that  increased  kinetics  of  Zap70 
upregulation  in  donor  F5 Rag1
-/- b2m
-/-  thymocytes  correlated  with  stronger 
positive selection signalling (Figure 4.9).  Thus we conclude that the positive 
selection  TCR  signal  is  likely  to  directly  upregulate  Zap70  expression.  
Furthermore,  this  suggests  there  is  a  reciprocal  relationship  between  TCR 
signalling and Zap70, as Zap70 expression is also rate-limiting for TCR signal 
transduction  (Figure 4.1 A).    Intriguingly,  the  finding  that  the  strength  of  the 
TCR  signal  dictates  the  extent  to  which  Zap70  is  upregulated  may  have 
implications on the future homeostatic potential of a selecting cell.  For example, 
cells  with  a  relatively  weak  avidity  TCR  may  not  fully  increase  their  Zap70 
expression levels.  This may impact the antigen sensitivity of a T-cell clone in 
the  periphery.    Furthermore,  because  TCR  signalling  is  necessary  for  naïve 
T-cell  survival  (Ernst  et  al.,  1999;  Polic  et  al.,  2001;  Viret  et  al.,  1999),  the 
lifespan of a low avidity T-cell may be impacted.  How the positive selection        
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signal impacts on the homeostatic potential of a T-cell is investigated further in 
Chapter 5. 
Whilst we find evidence that TCR signals positively upregulate Zap70, Zap70 
itself is likely to be a rate-limiting in TCR signal transduction.  By increasing 
Zap70 expression, the TCR signal may induce a positive feedback loop, which 
further  increases  TCR  signalling  sensitivity.    Such  a  model  is  fitting  with  a 
feedforward-loop, which is an evolutionary conserved signalling network motif, 
commonly  involved  in  discerning  instructive  developmental  signals  over 
background noise (reviewed in (Alon, 2007)).  We suggest that signals through 
the  TCR  augment  TCR  sensitivity.    This  increased  intracellular  sensitivity  in 
conjunction  with  consistent  extracellular  TCR  signalling  instructs  the  lineage 
commitment process.  With regards to the lineage decision itself, it is known 
that  CD4  has  a  higher  affinity  for  Lck  than  does  CD8,  implying  that 
CD4-mediated  signals  are  relatively  stronger  than  those  transduced  by  CD8 
(Ravichandran  &  Burakoff,  1994;  Wiest  et  al.,  1993).    We  would  therefore 
predict that MHC-II restricted T-cells will exhibit a more rapid upregulation of 
Zap70 compared to MHC-I restricted cells.  Such a possibility will require further 
dissection,  by  following  Zap70  expression  in  positively  selecting  DP1 
thymocytes, following intrathymic transfer to b2m
-/- or MHC-II  /  hosts. 
CD4  lineage  cells  develop  with  earlier  timings  than  CD8  lineage  cells 
(Chapter 1).    Therefore,  strong/consistent  MHC-II-mediated  signals  could  be 
resolved  over  weak/intermittent  MHC-I-mediated  signals  through  differential 
kinetics of TCR signalling sensitisation.  Alternatively, because CD4-mediated        
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signals  are  of  a  higher  strength  relative  to  those  mediated  by  CD8,  positive 
selection signal transduction may occur in MHC-II restricted cells when Zap70 is 
more limiting.  Conceivably this may occur independently of Zap70 upregulation 
for  MHC-II-restricted  cells  in  the  DP2  population.    In  contrast,  positive 
upregulation  of  TCR  signalling  strength  may  be  needed  to  discern 
weaker/intermittent signals, a prediction not made by the classical quantitative 
instructive  model.    With  regards  to  the  kinetic  signalling  model,  evidence 
suggests that the CD4
hiCD8
lo coreceptor reversing population correlates with 
increased signalling strength (Correia-Neves et al., 2001; Ohashi et al., 1993; 
Singer et al., 2008) (reviewed in (Hogquist, 2001)).  It could be that coreceptor 
reversal  may  simply  represent  a  mechanism  to  decrease  the  early  signal 
received  by  high  avidity  MHC-I  restricted  cells  (Correia-Neves  et  al.,  2001) 
(reviewed in (He et al., 2010)).  Re-expression of the CD8 coreceptor would 
then permit strong signalling to occur in DP3 cells.  Thus the quantitative and 
kinetic models of thymic development may not be mutually exclusive, however 
the  changes  in  TCR  signalling  threshold  and  kinetic  aspects  of  CD4/CD8 
lineage commitment are crucial to the lineage commitment process. 
Thus we conclude with the following model for the signalling requirements of 
positive  selection  and  the  CD4/CD8  lineage  decision  (Figure  4.10).    We 
suggest that upon transit to the DP2 population, MHC-II cells receive a relatively 
stronger  and  more  consistent  TCR  signal,  permitting  rapid  upregulation  of 
Zap70, in conjunction with lineage commitment.  In contrast, because DP2 cells 
are relatively insensitive to TCR signalling, we suggest that weakly/intermittently        
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signalled MHC-I restricted cells are refractive to lineage specifying signals at 
this  stage.    However,  a  lower  level  of  signalling  permits  the  upregulation  of 
Zap70 and the phenotypic transition to the DP3 population.  DP3 cells are more 
sensitive to receiving TCR signals, and thus this may permit the interpretation of 
MHC-I-mediated TCR signals at this later stage.  Therefore both quantitative 
and  kinetic  aspects  contribute  to  the  CD4  versus  CD8  lineage  decision.  An 
essential feature of such a model is that temporal separation of signals through 
the same receptor can lead to divergent developmental fates.  The temporal 
separation  of  developmental  cues  is  consistent  with  a  permissive  signalling 
threshold model, a conserved developmental mechanism whereby gradients in 
receptor sensitivity permit resolution of temporally distinct signals (reviewed in 
(Freeman & Gurdon, 2002)).  A future goal for developmental biologists will be 
the identification of factors that switch the amenability of a cell between different 
potential fates.  Microarray analysis of the DP2 versus DP3 populations may 
facilliate  the  identification  of  such  factors  in  positively  selecting  thymic 
populations.        
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Figure 4.1 Transgenic Zap70 expression is rate-limiting for TCR signal 
transduction and can influence the developmental fate of thymocytes 
(A) TetZap70 mice were fed dox for two days (red line) and were analysed by 
flow cytometry, along with Zap70
-/- (grey fill) controls.  The left histogram shows 
the expression of HuCD2 on live thymocytes from TetZap70 and Zap70
-/- mice.  
Cells  were  electronically  gated  based  on  expression  of  HuCD2  (1-5,  gate  5 
refers to total Zap70
-/- control thymocytes).  The right hand histogram shows the 
percentage  of  thymocytes  from  gates  1-5  influxing  calcium,  as  a  function  of 
time.  Addition of CD3-crosslinking antibody is denoted as X.  (B-C) TetZap70
on, 
B6  and  Zap70
-/-  (grey  fill)  mice  were  analysed  by  flow  cytometry,  for  the 
expression of Zap70.  (B) The top histogram shows the expression of Zap70 in 
Zap70
-/- controls (grey fill), in addition to HuCD2
+ gated DP1 cells (black line), 
DP2  cells  (red  line)  and  DP3  cells  (blue  line),  from  TetZap70
on  mice.    The 
bottom histogram shows the expression of Zap70 in Zap70
-/- controls (grey fill) 
in addition to TCR
+CD5
+ CD4 SP (red line) and TCR
+CD5
+ CD8 SP cells (blue 
line), from TetZap70
on mice.  Zap70 mean fluorescence intensity (MFI) values 
are  for  indicated  populations  are  shown  next  to  histograms.    (C) The  top 
histogram  shows  the  expression  of  Zap70  in  Zap70
-/-  controls  (grey  fill),  in 
addition to DP1 cells (black line), DP2 cells (red line) and DP3 cells (blue line), 
from B6 mice.  The bottom histogram shows the expression of Zap70 in Zap70
-/- 
controls (grey fill) in addition to TCR
+CD5
+ CD4 SP (red line) and TCR
+CD5
+ 
CD8 SP cells (blue line), from B6 mice.  Zap70 MFI values are for indicated 
populations are shown next to histograms.  Data in (A-C) is representative of  3 
independent experiments.  (D) DP1-3, CD4 SP and CD8 SP populations were        
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sorted to high purity ( 95%) from B6 mice.  Cell populations were lysed and 
protein equivalent to 2x10
5 cells was run on a 10% sodium dodecyl sulphate 
(SDS)-polyacrylamide  gel  electrophoresis  (PAGE)  gel  and  blotted  onto  a 
polyvinylidene difluoride (PVDF) membrane.  The membrane was stained for 
Zap70 (top) or GAPDH (bottom).  Antibody staining was detected by secondary 
incubation  with  a  horseradish  peroxidase  (HRP)-coupled  secondary  antibody 
and  resolution  of  chemiluminescence  following  treatment  with  enhanced 
chemiluminescence  (ECL)  reagent.    Zap70  expression  was  normalised  to 
GAPDH based on the relative chemiluminescence.  Data is representative of 
two independent experiments.        
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Figure 4.2 Defective TCR signalling in TetZap70 DP3 thymocytes following 
CD3 crosslinking 
TetZap70 mice were fed dox for  4 days and were analysed for the expression 
of  CD4,  CD8,  TCR  and  CD5  by  flow  cytometry,  along  with  B6  controls.  
(A-B) Histograms show the percentage of DP1 (thin black line), DP2 (red line), 
DP3 (blue line) and B6 CD8 SP (thick black line) thymocytes influxing calcium 
as a function of time.  Addition of CD3-crosslinking antibody is denoted as X.  
Histograms  represent  DP  populations  from  (A)  B6  and  (B)  TetZap70  mice.  
Data is representative of  3 independent experiments.  (C) DP1 (top row), DP2 
(middle row) and DP3 (bottom row) thymocytes from TetZap70 (red line) and B6 
(black line) mice were analysed by flow cytometry.  Left histograms show the 
percentage thymocytes influxing calcium as a function of time, following addition 
of  ionomycin  (denoted  as  Iono).    Right  histograms  show  Indo1  expression 
following loading and prior to the induction of calcium influx.        
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Figure 4.3 TCR signal-transducing proteins are not dysregulated in 
TetZap70 mice 
TetZap70 mice (red line) were fed dox for  4 days and were analysed by flow 
cytometry, along with B6 controls (black line).  DP1 DP2 and DP3 populations 
were discriminated by staining for CD4 CD8 TCR and CD5 and were further 
analysed  for  the  expression  of  intracellular  Lck,  Fyn,  LAT,  Slp76  or  Erk2.  
Expression  levels  were  compared  to  the  following  negative  controls:    Lck 
expression was compared to Lck
-/- DP1 cells, Fyn and Erk2 expression were 
compared  to  isotype  control  stained  B6  DP1  cells  and  LAT  and  Slp76 
expression  were  compared  to  B6  TCR
-CD5
-CD25
-CD44
-  lymphocytes, 
comprising primarily of B-cells.  Results are representative of  3 independent 
experiments.        
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Figure 4.4 A developmental block between DP3 and CD8 SP populations 
is a consequence of transgenic Zap70 expression 
F5 TetZap70 mice were fed dox for  7 days (F5 TetZap70
on) and were analysed 
for  the  expression  of  CD4,  CD8,  TCR,  CD5  and  HuCD2  by  flow  cytometry, 
along  with  F5
+/- Rag1
-/-  and  F5
+/- Rag1
-/- Zap70
-/-  controls.    (A)  Density  plots 
show  expression  of  CD5  against  TCR  on  DP  gated  thymocytes  and  CD4 
against CD8 on live gated thymocytes (DP gating shown on bottom row, F5 
TetZap70
on  cells  are  additionally  HuCD2
+  gated).    (B)  Bar  charts  show  the 
DP3:DP2 and CD8:DP3 ratio in F5
+/- Rag1
-/- controls (n=2) and F5 TetZap70
on 
mice (n=3).  DP3:DP2: p=ns and CD8:DP3: ** p 0.01 (Student s t-test). 
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Figure 4.5 Reduced Zap70 function affects CD4 and CD8 lineages equally 
SKG mice and BALB/c control thymi and LNs were analysed for the expression 
of CD4, CD8, CD5, TCR and Zap70 by flow cytometry.  (A) Scatter dot plot 
shows total live thymocyte numbers.  p=ns (Student s t-test BALB/c n=10, SKG 
n=10).    (B) Scatter  dot  plot  shows  the  percentage  of  TCR
hiCD5
hi  cells  as  a 
frequency of live thymocytes.  *** p 0.001 (Student s t-test BALB/c n=10, SKG 
n=10).    (C) Density  plots  show  expression  of  CD4  against  CD8  on  live 
thymocytes  (top)  and  CD5  against  TCR  (bottom)  on  DP  gated  thymocytes.  
(D) Scatter dot plot shows total live TCR
+CD5
+ LN cells.  *** p 0.001 (Student s 
t-test BALB/c n=10, SKG n=10).  (E) Density plots show CD4 against CD8 on 
CD25
-CD44
lo (naïve) LN lymphocytes.  (F) Bar charts show the CD4:CD8 ratio 
of TCR
hiCD5
hi mature thymocytes (p=ns, Student s t-test BALB/c n=10, SKG 
n=10) and naïve LN lymphocytes (p=ns, Students t-test BALB/c n=5, SKG n=5).  
(G) Histograms show Zap70 expression in DP1 (grey fill), DP2 (top row, red 
line),  DP3  (top  row,  blue  line),  CD4  SP  (bottom  row,  red  line)  and  CD8  SP 
(bottom row, blue line) populations.  MFI values are indicated to the right of 
histograms.  Data is representative of  3 independent experiments.        
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Figure 4.6 Zap70 and CD5 are transcriptionally regulated during positive 
selection 
DP1, DP2, DP3, CD4 SP and CD8 SP populations were sorted to high purity 
( 95%) from B6 mice.  Cellular mRNA was purified and analysed by RT-qPCR.  
Bar charts show the mean expression of (A) Zap70 and (B) CD5 relative to 
Hprt1.  Analysis was performed in triplicate wells and error bars represent the 
sd.  Data is representative of  3 independent experiments.        
  223 
 
 
 
        
  224 
Figure 4.7 Evolutionary conserved transcription factor binding analysis of 
the region upstream of Zap70 identifies potential regulatory factors 
Comparative  genomic  analysis  was  performed  on  murine  and  human  DNA 
encoding  Zap70  and  ~5-10  kb  proximal  regions  using  the  ECR  browser 
(available  online  at  http://ecrbrowser.dcode.org/,  accessed  September  2010).  
(A) Graphical  output  showing  evolutionary  conserved  regions  (coloured 
histograms) between human and mouse DNA.  The 5  putative Zap70 promotor 
is shown magnified.  Histograms represent evolutionary conserved non-coding 
regions  (red),  transposons  and  simple  repeats  (green),  intronic  regions 
(salmon), coding exons (blue) and untranslated regions (yellow).  (B) Left hand 
graphical output shows evolutionary conserved transcription factor binding sites 
as identified by rVista 2.0 using the TRANSFAC professional V10.2 library for 
vertebrates, with matrix similarity optimised for function.  The right panel shows 
the mouse (top) versus human (bottom) DNA alignment.  Ets (1, black), Ebox 
(2,  red),  NFAT  (3,  blue)  and  CREB  (4,  green)  evolutionary  conserved 
transcription  factor  binding  sites  are  indicated  on  the  left  graphical  output 
(coloured numbers) and the right hand DNA alignment (coloured boxes).        
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Figure 4.8 Mimicking the positive selection signal upregulates Zap70 in 
vitro 
B6 thymocytes were depleted of CD3
+, CD25
+ and CD69
+ cells using magnetic 
beads.    Thymocytes  (5x10
6  cells/mL)  were  cultured  with  PMA  (P)  and 
ionomycin (I) for 14 hours, before being washed and subsequently cultured in 
medium alone for the remaining culture time.  Where indicated, inhibitors were 
added for the entire duration of the culture.  Non-treated cells (NT, grey fill), 
PMA  and  ionomycin  treated  cells  (P+I,  black  line)  or  PMA,  ionomycin  and 
inhibitor  treated  cells  were  washed  and  subsequently  analysed  for  the 
expression  of  CD4,  CD8,  TCR,  CD5,  CD69  and  Zap70  by  flow  cytometry.  
(A) Density plots show expression of CD4 against CD8 and CD5 against TCR 
on  DP  gated  cells,  on  pre-  and  post-depletion  thymocytes.    (B) Cells  were 
cultured with different combinations of PMA and/or ionomycin.  Density plots 
show the expression of CD4 against CD8 at 22 and 44 hours.  (C) Histograms 
show the expression of CD69 and Zap70 in Non-treated cells, cells treated with 
PMA alone (red line), ionomycin alone (blue line) or PMA and ionomycin after 
22 and 44 hours.  (D-H)  Cells were analysed after 22 hours.  (D) Cells were 
cultured in medium alone, with PMA and ionomycin, or with PMA, ionomycin 
and actinomycin D (ActD, red line) or cyclohexamide (Chx, blue line).  Density 
plots show CD4 against CD8 expression on live thymocytes, and the histogram 
shows Zap70 expression in live thymocytes.  (E) Thymocytes were cultured in 
medium alone, with PMA and ionomycin, or with PMA, ionomycin and Kn93 (red 
line)  or  U0126  (blue  line).    The  histogram  shows  Zap70  expression  in  live 
thymocytes.    (F-G) Cells  were  cultured  with  PMA  and  ionomycin  along  with        
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different concentrations of cyclosporin A (CsA).  (F) Density plots show CD4 
against CD8 in live thymocytes.  (G) Histogram shows Zap70 expression on live 
thymocytes.    (H) Histogram  shows  Zap70  on  live  thymocytes  cultured  in 
medium, with PMA and ionomycin or with PMA, ionomycin and FK506 (red line).  
Data is representative of  2 independent experiments.        
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Figure 4.9 Zap70 is regulated by the positive selection TCR signal 
(A-C)  F5  Rag1
-/-  b2m
-/-  mice  were  injected  I.P.  with  50µg anti-CD3  (clone 
H57-597,  eBioscience)  and  5µg anti-CD28  (clone  37.51,  eBioscience)  and 
analysed for the expression of CD4, CD8, TCR and CD5 by flow cytometry after 
24 hours, along with non-injected controls.  (A) Density plots show CD4 against 
CD8 on live thymocytes and CD5 against TCR on DP gated thymocytes (DP 
gating shown on the top row plots).  (B-C) DP1 (black line) and DP2 (red line) 
populations  from  anti-CD3  and  anti-CD28  treated  mice  and  total  DPs  from 
non-injected  mice  (grey  fill)  were  analysed  for  the  expression  of  CD69  and 
Zap70.    Histograms  show  (B) CD69  and  (C) Zap70  expression.    Data 
represents  two  independent  experiments.   ( D-E) F5  Rag1
-/-  b2m
-/-  CD45.2
+ 
thymocytes (1-2x10
6 cells) were intrathymically transferred to B6 CD45.1
+ hosts 
(red line) or F5 Rag1
-/- CD45.1
+ hosts (blue line).  Host and donor thymocytes 
were analysed by flow cytometry 1-5 days following transfer.  (D) Histogram 
shows  CD69  expression  on  live  CD45.2
+  donor  thymocytes  or  B6  DP1  host 
(CD45.1
+) controls (grey fill).  (E) Line graph shows the fold increase of Zap70 
MFI  in  donor  cells  (CD45.2
+)  relative  to  the  host  (CD45.1
+)  mouse  DP1 
population.  The fold increase in Zap70 MFI in CD8 SPs relative to the host DP1 
population is also shown for F5 Rag1
-/- CD45.1
+ (black circle) and B6 CD45.1
+ 
(black square) host thymocytes.  Data represents  2 transfers per timepoint.        
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Figure 4.10 A model for the signalling characteristics directing 
phenotypic progression of positively selecting thymocytes 
Based on the data in chapter 3-4, we have hypothesised the following signalling 
requirements directing the phenotypic progression of MHC-I (blue) or MHC-II 
(orange) restricted positively selecting thymocytes.  All cells initially reside in the 
TCR
loCD5
lo DP1 population (non-selecting, black).  Upon initiation of positive 
selection  through  MHC  recognition,  cells  phenotypically  transit  to  the 
TCR
intCD5
hi DP2 population.  DP2 thymocytes with a TCR restricted to MHC-II 
receive  a  relatively  strong  and  consistent  TCR  signal  due  to  properties 
conferred by the CD4 coreceptor.  This permits lineage commitment, despite the 
fact that DP2 thymocytes are relatively insensitive to receiving TCR signals.  In 
contrast DP2 thymocytes with a TCR restricted to MHC-I receive a relatively 
weak or intermittent TCR signal at the DP2 stage.  This does not permit lineage 
commitment to occur, as DP2 cells are insensitive to receiving TCR signals. 
Instead  cells  phenotypically  progress  to  the  DP3  stage  where  they  increase 
TCR and Zap70 expression and reduce CD5 expression.  This now permits 
strong TCR signalling, despite the weak avidity/intermittent signalling properties 
conferred by the CD8 coreceptor.  A strong TCR signal in the DP3 population 
instructs  CD8  lineage  commitment  and  thus  by  regulating  TCR  signalling 
sensitivity, strong/consistent and weak/intermittent signals can be discerned at 
different timepoints.  Furthermore, positive autoregulation of Zap70 by the TCR 
may further differentiate strong and weak TCR signals. 
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Chapter 5 
The Impact of the Positive Selection Signal 
on Naïve T-cell Homeostasis 
5.1 Introduction 
Lymphocyte numbers are maintained at a constant level, despite continuous 
inputs of new cells and outputs via death or differentiation.  The maintenance of 
cell numbers is achieved through the regulation of homeostatic survival factors, 
which become rate limiting if cell numbers are high or drive generation of new 
cells  if  in  excess.    Thus  lymphocytes  have  the  ability  to  sense  whether  the 
surrounding  environment  is  lymphopenic  or  lymphoreplete.    Essential 
lymphocyte  survival  factors  include  signals  through  the  antigen  receptor  and 
signals mediated by cytokines (reviewed in (Freitas & Rocha, 2000)). 
In the case of T-cells, homeostatic antigen receptor signals are transduced by 
the TCR (Introduced in Chapter 3, section 3.1).  Furthermore gamma chain ( c) 
cytokine signals, and in particular those mediated by IL7 are also essential for 
T-cell  homeostasis  (reviewed  in  (Jameson,  2002)).    The  IL7  receptor  alpha 
chain (IL7r ) is constitutively associated with Janus kinase (JAK)1, whereas the 
 c is associated with JAK3 (reviewed in (Jiang et al., 2005)).  IL7 signals are 
transduced  following  crosslinking  of  the  IL7r   and   c  subreceptors,  thus        
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bringing JAK1 and JAK3 into close proximity with one another, and leading to 
their mutual phosphorylation and activation (Foxwell et al., 1995).  Activated 
JAKs  subsequently  phosphorylate  IL7r ,  providing  docking  sites  to  recruit 
STAT5, which itself is a target of JAK kinase activity.  Phosphorylated STAT 
(pSTAT)5  subsequently  translocates  to  the  nucleus,  where  it  induces  gene 
transcription  (reviewed  in (Jiang  et  al.,  2005)).    A  key  pSTAT5  target  is  the 
antiapoptotic gene B-cell leukaemia/lymphoma 2 (Bcl2), which in part confers 
IL7 induced survival signal (Jiang et al., 2004; Kim et al., 1998b; von Freeden-
Jeffry et al., 1997). 
Whilst ablation of MHC-II and MHC-I leads to a profound block in CD4 and CD8 
lineage development respectively (Koller et al., 1990; Madsen et al., 1999), IL7 
or  IL7r -deficiency  also  leads  to  a  severe  reduction  in  thymopoiesis  of  both 
lineages (Peschon et al., 1994; von Freeden-Jeffry et al., 1995).  Thus TCR and 
IL7 signals control the generation of new peripheral T-cells.  Furthermore, both 
TCR and cytokine signals are necessary to maintain mature T-cell numbers.  
Ablation of peripheral TCR signalling through cre-mediated TCR deletion (Polic 
et al., 2001), or through cessation of Lck expression in tetracycline inducible Lck 
mice leads to a progressive loss of CD4 and CD8 naïve T-cells (Seddon et al., 
2000).  Similarly T-cells do not survive for prolonged periods in IL7-deficient 
hosts (Schluns et al., 2000) and IL7 improves T-cell survival in vitro (Tan et al., 
2001).  In addition, IL7 transgenic mice show increased naïve T-cell numbers, 
suggesting  that  IL7  levels  limit  T-cell  population  size  in  lymphoreplete  hosts        
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(Mertsching et al., 1995).  Hence TCR and IL7 signalling is essential not only for 
the generation of T-cells, but also for persistence of naïve T-cells. 
Similarly to that of T-cells, B-cell homeostasis depends on signals mediated by 
the  B-cell  antigen  receptor  (BCR).    Mice  deficient  in  IgM  heavy  chain 
expression,  a  component  of  the  BCR  on  all  developing  B-cells,  exhibit 
developmentally  arrested  B-cell  development  (Kitamura  et  al.,  1991).  
Furthermore,  mx-cre-induced  deletion  of  the  surface  immunoglobulin  (Ig)  on 
mature B-cells results in a progressive loss of these cells (Lam et al., 1997).  In 
addition  to  BCR  signalling,  B-cells  depend  on  soluble  pro-survival  signals 
mediated by the tumour necrosis factor (TNF)-family member, B-cell activating 
factor (BAFF), that signals through the BAFF-receptor (BAFFR).  Mice deficient 
in BAFF or BAFFR exhibit in a block in B-cell development (Schiemann et al., 
2001; Thompson et al., 2001).  Moreover, recent advances in the understanding 
of B-cell homeostasis suggest there is extensive crosstalk between the BCR 
and BAFFR  signalling  pathways  (reviewed  in (Cancro,  2009)).    BCR  signals 
were found to direct BAFFR upregulation during B-cell development (Smith & 
Cancro, 2003; Walmsley et al., 2003).  In addition, BCR signalling induces the 
upregulation of the NF B protein p100, which is a rate limiting substrate for 
BAFFR  signal  transduction  (Stadanlick  et  al.,  2008).    Thus  BCR  signals 
augment BAFFR signalling.  It has been suggested that when BAFFR is limiting 
in a lymphoreplete environment, this will ensure that BCR-signalled clones are 
more likely to respond to limiting BAFF signals and thus preferentially survive.  
Hence  there  is  crosstalk  between  generalised  and  clonotypic  homeostatic        
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signals  in  B-cells  (reviewed  in  (Cancro  &  Kearney,  2004)).    In  contrast,  the 
relationship between the TCR and Interleukin-7 receptor (IL7R) signals remains 
controversial. 
Recent  findings  suggest  that  modulating  IL7r   expression  could  be  a  key 
control point for integrating TCR and IL7 signals.  Excess IL7 signalling causes 
a downregulation of IL7r , whereas IL7r  expression is upregulated when IL7 is 
limiting  (Park  et  al.,  2004).    Park  et  al.  suggest  that  TCR  signals  block  IL7 
signalling,  leading  to  an  upregulation  of  the  IL7r   that  subsequently  permits 
increased IL7 signalling (Park et al., 2007).  However, it has been suggested 
more recently that TCR signals actually augment IL7R function, by recruiting 
IL7r  and  c subreceptors to lipid rafts (Cho et al., 2010).  Furthermore, in the 
absence  of  peripheral  TCR  signalling  IL7r   expression  was  decreased, 
suggesting  a  complex  homeostatic  relationship  exists  between  the  TCR  and 
IL7r   signalling  pathways  (Takada  &  Jameson,  2009).    Importantly,  the 
molecular and genetic control mechanisms underlying these processes remain 
to be identified. 
During  T-cell  development  IL7r   is  expressed  on  DN  thymocytes,  before 
expression is extinguished at the DP stage.  IL7r  is subsequently re-expressed 
on  positively  selecting  thymocytes,  thus  suggesting  that  the  TCR-mediated 
positive  selection  signals  can  control  IL7r   expression  in  developmentally 
immature  T-cells  (Akashi  et  al.,  1998;  Sudo  et  al.,  1993).    Whilst  factors 
controlling  the  re-expression  of  IL7r   remain  obscure,  studies  in  conditional        
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knockout mice have identified some potential candidates.  For example CD4-
cre-mediated deletion of forkhead box O1 (Foxo1) resulted in defective IL7r  
expression in thymic and peripheral SP populations (Kerdiles et al., 2009).  In 
addition GA-binding protein (Gabp) controlled IL7r  expression in DN cells and 
the thymic lymphoma derived EL4 cell line (Xue et al., 2004).  Interestingly, DP 
cells deficient for both Runx1 and Runx3 failed to upregulate IL7r  following 
positive selection (Egawa et al., 2007).  Runx factors are also essential for CD4 
silencing  and  CD8  lineage  commitment,  suggesting  they  are  functionally 
regulated  during  positive  selection  (Sato  et  al.,  2005;  Taniuchi  et  al.,  2002; 
Woolf et al., 2003).  However, whether positive selection TCR signalling directly 
influences  these  factors,  and  which  of  these  factors  are  necessary  and/or 
sufficient for IL7r  re-expression remains to be determined.  In addition, it is 
unknown if IL7r  is regulated in the same way during thymic development as it 
is in naïve peripheral T-cells. 
Whilst there is evidence that IL7r  expression and/or function is modulated by 
TCR  signalling  in  the  periphery,  the  molecular  mechanisms  of  this  process 
remain to be elucidated.  Furthermore, it is unknown whether developmental 
TCR  signals  can  directly  influence  IL7r   re-expression  following  positive 
selection.  Given that IL7r  is downregulated at the DP stage, and re-expressed 
following positive selection, we sought to investigate the relationship between 
positive selection TCR signalling and IL7r  re-expression.        
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5.2 Results 
5.2.1 Disparate re-expression of IL7r  in CD4 and CD8 SP thymocytes 
In Chapter 1 we identified that CD4 and CD8 lineages develop with temporally 
distinct  kinetics.    Furthermore  there  is  evidence  that  CD4  development  is 
instructed  by  strong/consistent  signalling  whereas  CD8  development  is 
associated with weak/intermittent signals (reviewed in (Hogquist, 2001; Singer 
et al., 2008)).  Therefore, we asked whether IL7r  expression differed in CD4 
and CD8 lineage cells.  We examined IL7r  expression on B6 thymocytes and 
peripheral  LN  T-cells  (LNTs)  by  flow  cytometry.    B6  CD25
-CD44
loTCR
+CD5
+ 
(naïve)  CD4  and  CD8  LNTs  were  found  to  express  similar  levels  of  IL7r  
(Figure 5.1 A).  In the thymus, IL7r  was undetectable on non-selecting DP1 
thymocytes.  In contrast, IL7r  was expressed on SP thymic populations, with 
CD4 SP cells expressing relatively higher levels of IL7r  compared to CD8 SP 
cells (Figure 5.1 B, top).  This suggested that IL7r  re-expression levels in the 
thymus correlated with the positive selection TCR signalling strength in B6 mice. 
5.2.2 Suboptimal positive selection signalling correlates with a defect in 
IL7r  expression 
Based on IL7r  re-expression patterns in B6 thymocytes, we hypothesised that 
the positive selection signal strength instructed IL7r  re-expression levels.  To 
investigate this possibility, we examined IL7r  expression levels in mice that 
exhibit defects in TCR signalling.  We first examined IL7r  expression in SKG        
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mice, which have a W163C mutation in the carboxy-terminal SH2 domain of 
Zap70,  resulting  in  a  reduction  of  Zap70  function  (Sakaguchi  et  al.,  2003).  
These mice exhibit an equal defect in CD4 and CD8 SP lineage development, 
suggesting  that  reduced  TCR  signalling  affected  both  lineages  equally 
(Chapter 3, Figure 4.5).  SKG mice showed a reduction in IL7r  re-expression 
in both CD4 and CD8 SP thymocyte and naïve LNT compartments, compared to 
BALB/c  controls  (Figure 5.1 C).    Typically  IL7r   expression  was  reduced  to 
approximately  60-70%  of  BALB/c  expression,  representing  a  significant 
reduction in both CD4 and CD8 LNT populations (Figure 5.1 D) (CD4: p 0.001, 
CD8:  p 0.001,  Student s  t-test  BALB/c  n=12,  SKG  n=12).    We  found  no 
significant difference between the CD8:CD4 IL7r  MFI ratio, in SKG compared 
to  BALB/c  controls  (p=ns,  Student s  t-test  BALB/c  n=12,  SKG  n=12) 
(Figure 5.1 E),  suggesting  that  the  defect  in  IL7r   expression  was  equal  in 
LNTs of both lineages. 
We  secondly  examined  IL7r   expression  in  TetZap70
on  mice,  which  have  a 
specific defect in TCR signalling in the CD8 lineage relative to a more minor 
defect  in  the  CD4  lineage,  resulting  from  dysregulated  developmental 
expression  of  Zap70  (Chapter 4)  (Saini  et  al.,  2010).    In  these  mice,  both 
thymic and peripheral CD4 and CD8 cells exhibited reduced IL7r  expression 
compared  to  B6  controls  (Figure 5.1 F).    Typically  IL7r   expression  was 
reduced to approximately 70% of B6 levels in the CD4 lineage and 50% of B6 
levels in the CD8 LNTs (CD4: p 0.001, CD8: p 0.001, Student s t-test B6 n=7, 
TetZap70
on  n=7)  (Figure 5.1 G).    Interestingly,  we  found  that  the  CD8:CD4        
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IL7r  MFI ratio was significantly reduced in the LNT populations of TetZap70 
mice (p 0.001, Student s t-test B6 n=7, TetZap70
on n=7) (Figure 5.1 H).  Thus 
peripheral  CD8  SP  cells  from  TetZap70
on  mice  exhibited  a  greater  defect  in 
IL7r   expression  relative  to  CD4  SPs.    Our  results  suggest  that  defective 
positive selection TCR signalling proportionally correlates with a corresponding 
defect in IL7r  re-expression. 
5.2.3 Low avidity TCR transgenic T-cells have a reduced expression of 
IL7r   
SKG and TetZap70
on mice both exhibit defects in TCR signalling at the level of 
Zap70  function/expression.    We  next  investigated  whether  T-cell  clones 
exhibiting a low avidity for spMHC also had reduced IL7r  expression.  To do 
so, we examined IL7r  expression in thymocytes and naïve LNTs from TCR 
transgenic mice that have different avidities for spMHC.  F5 and OT-I T-cells 
express MHC-I restricted TCRs, and therefore on a Rag1
-/- background only 
generate CD8 SP lineage cells (Figure 5.2 A) (Hogquist et al., 1994; Mamalaki 
et  al.,  1993).    We  compared  levels  of  CD5  on  F5 Rag1
-/-  and  OT-I Rag1
-/- 
T-cells,  since  CD5  expression  is  known  to  correlate  with  the  TCR  avidity  to 
spMHC in the periphery (Azzam et al., 2001; Smith et al., 2001).  Whereas B6 
naïve  CD8  SP  cells  showed  a  relatively  broad  range  of  CD5  expression, 
F5 Rag1
-/- cells expressed relatively low levels of CD5.  In contrast OT-I Rag1
-/- 
cells  exhibited  relatively  high  expression  of  CD5  (Figure 5.2 B).    This 
suggested that in the periphery, F5 Rag1
-/- T-cells received weak signals from 
spMHC compared to OT-I Rag1
-/- T-cells.          
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We  next  asked  whether  the  differences  in  TCR:spMHC  avidity  were  also 
reflected  during  positive  selection  of  F5 Rag1
-/-  and  OT-I Rag1
-/-  thymocytes.  
To address this, thymic phenotypes of F5 Rag1
-/- and OT-I Rag1
-/- mice were 
examined by flow cytometry.  The CD4 versus CD8 profile of F5 Rag1
-/- mice 
was  distinct  from  that  of  OT-I Rag1
-/-  mice,  largely  due  to  the  absence  of  a 
CD4
hiCD8
lo population of positively selecting thymocytes (Figure 5.2 C).  It has 
been  suggested  that  the  CD4
hiCD8
lo  population  represents  a  developmental 
intermediate  for  high  avidity  MHC-I-restricted  thymocytes  (reviewed  in 
(Hogquist, 2001)), implying that the OT-I Rag1
-/- thymocytes receive a stronger 
positive selection signal relative to F5 Rag1
-/- thymocytes.  CD5 and CD69 are 
upregulated  on  positively  selecting  thymocytes,  and  correlate  with  positive 
selection signalling strength (Azzam et al., 1998; Swat et al., 1993).  Thus we 
investigated the expression of these factors in B6, F5 Rag1
-/- and OT-I Rag1
-/- 
mice.  B6 DPs exhibited a broad range of CD5 expression, including a shoulder 
of  higher  CD5  expression  that  represents  the  positively  selecting  cells 
(Figure 5.2 D).  Transgenic mice have prearranged TCRs and undergo positive 
selection homogenously, thus the majority of DP thymocytes in transgenic mice 
are CD5
hi (Itano & Robey, 2000; Wong et al., 2000).  However, OT-I Rag1
-/- DPs 
were  found  to  express  higher  levels  of  CD5  relative  to  F5 Rag1
-/-  DPs 
(Figure 5.2 D).  CD69 was absent from B6 DP1 cells, however it was induced 
on  TCR
hiCD5
hi  positively  selecting  DPs.    Furthermore  CD69  expression  was 
highest on B6, intermediate on OT-I Rag1
-/- and low on F5 Rag1
-/- TCR
hiCD5
hi 
DP  thymocytes  (Figure 5.2 E).    Taken  together,  these  data  suggest  that 
OT-I Rag1
-/-  thymocytes  receive  a  stronger  positive  selection  signal  than        
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F5 Rag1
-/-  thymocytes,  which  correlates  with  the  avidity  of  these  cells  for 
spMHC in the periphery. 
Our  next  question  was  whether  the  positive  selection  signal  strength  in  the 
thymus  correlated  with  differences  in  IL7r   re-expression  levels/kinetics.    To 
answer this, we investigated the expression of IL7r  in DP1-3 and in thymic and 
peripheral CD8 SP populations of B6, F5 Rag1
-/- and OT-I Rag1
-/- mice by flow 
cytometry.    IL7r   was  expressed  at  background  levels  in  the  DP1  and  DP2 
populations of B6, F5 Rag1
-/- and OT-I Rag1
-/- mice (Figure 5.2 F, top row).  We 
found that IL7r  was first re-expressed in the DP3 populations of B6 and OT-I 
Rag1
-/- mice, with similar abundance.  In contrast IL7r  expression remained at 
background levels in F5 Rag1
-/- DP3 thymocytes (Figure 5.2 F, second row).  
IL7r  expression was lower on OT-I Rag1
-/- CD8 SPs relative to the equivalent 
B6 population.  Surprisingly, IL7r  expression was undetectable in CD8 SP cells 
from  F5 Rag1
-/-  mice  (Figure 5.2 F,  third  row).    Thus  the  positive  selection 
signal strength correlated well with IL7r  in terms of both thymic re-expression 
kinetics and abundance.  We next examined expression of IL7r  in peripheral 
CD8  SPs  from  B6,  F5 Rag1
-/-  and  OT-I Rag1
-/-  mice.    Interestingly,  despite 
lacking IL7r  expression in the thymus, F5 Rag1
-/- mice did re-express IL-7r , 
albeit at low levels, in CD8 LNTs relative to levels found in B6 CD8 LNTs.  In 
contrast,  OT-I Rag1
-/-  CD8  LNTs  expressed  higher  levels  of  IL7r   than 
F5 Rag1
-/-  CD8  LNTs,  although  this  still  represented  a  slight  reduction 
compared  to  levels  on  WT  CD8  T-cells  (Figure 5.2 F,  bottom  row).    The 
differences  between  F5 Rag1
---  and  OT-I Rag1
-/-  CD8  LNT  IL7r   abundance        
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was cell intrinsic, as differences persist when F5 Rag1
-/- and OT-I Rag1
-/- LNTs 
were  competed  with  B6  T-cells  in  mixed  BM  chimeras  (Sinclair  et  al., 
manuscript submitted).  Thus avidity for spMHC correlated with peripheral IL7r  
expression in TCR transgenic mice. 
We next asked whether differences in IL7r  surface re-expression levels and 
kinetics correlated with Il7r mRNA abundance.  DP2, DP3 and CD8 SP thymic 
populations were purified by cell sorting to high ( 95%) purity from F5 Rag1
-/- 
and  OT-I Rag1
-/-  mice,  before  mRNA  was  isolated.    mRNA  was  additionally 
isolated from total LNTs of these mice.  We found that Il7r mRNA expression 
mirrored protein expression.  Whereas OT-I Rag1
-/- cells expressed high levels 
of Il7r in DP3 thymocytes, Il7r was only expressed at low levels in F5 Rag1
-/- 
cells.    Il7r  was  however  highly  expressed  in  LNTs  of  both  F5 Rag1
-/-  and 
OT-I Rag1
-/-  mice  (Figure 5.2 G).    Taken  together,  these  data  suggests  that 
suboptimal  positive  selection  signalling  results  in  a  failure  to  upregulate  Il7r 
transcription in DP3 and CD8 SP cells from F5 Rag1
-/- mice. 
5.2.4  Runx  expression  precedes  IL7r   expression  in  F5 Rag1
-/- 
thymocytes 
Several transcription factors have been implicated in regulating Il7r transcription 
in a variety of T-cell developmental stages.  We next investigated whether such 
factors were differently regulated in DP2, DP3, CD8 SP and LNT populations 
from  F5 Rag1
-/-  and  OT-I Rag1
-/-  mice.    Mice  with  a  conditional  deletion  of 
Foxo1 at the DP stage showed reduced IL7r  expression levels in both CD4        
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and CD8 SP thymocytes and naïve LNTs (Kerdiles et al., 2009).  Gabp consists 
of alpha and beta subunits, and was shown to regulate IL7r  expression in a 
thymic lymphoma derived cell line (EL4) and primary DN thymocytes (Xue et al., 
2004).  We found that Foxo1 mRNA was progressively upregulated between 
DP2-CD8  LNT  populations  in  both  F5 Rag1
-/-  and  OT-I Rag1
-/-  mice 
(Figure 5.3 A).    GA-binding  protein   -subunit  1  (Gabpb1)  that  encodes  the 
Gabp   -subunit  exhibited  a  contrasting  pattern  of  expression,  as  it  was 
progressively  downregulated  between  DP2-LNT  populations.    However,  we 
again  saw  no  difference  in  expression  between  F5 Rag1
-/-  and  OT-I Rag1
-/- 
populations (Figure 5.3 B). 
Mice with conditional deletions of Runx1 and Runx3 proteins at the DP stage 
show defects in Il7r re-expression in CD4 and CD8 SP lineages respectively 
(Egawa et al., 2007).  We investigated whether Runx factors may be differently 
regulated between F5 Rag1
-/- and OT-I Rag1
-/- mice.  Runx1 was expressed at 
slightly  elevated  levels  in  the  DP2  population  of  F5 Rag1
-/-  relative  to 
OT-I Rag1
-/- mice.  In F5 Rag1
-/- mice, Runx1 was reduced to background levels 
in the DP3 and CD8 SP populations.  In OT-I Rag1
-/- mice Runx1 expression 
was elevated by approximately 2-3 fold between the DP2 and DP3 populations, 
before  falling  to  background  levels  in  the  thymic  and  peripheral  CD8  SP 
populations (Figure 5.3 C).  Runx3 was expressed at similar levels in the DP2 
population of F5 Rag1
-/- and OT-I Rag1
-/- mice.  In F5 Rag1
-/- mice, whilst Runx3 
levels remained low in the DP3 population, Runx3 showed an approximately 
2-fold  increase  between  DP3  and  CD8  SP  populations.    The  CD8  SP  LNT        
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population from F5 Rag1
-/- mice expressed similar levels of Runx3 as the thymic 
CD8  SP  compartment.    In  contrast  Runx3  expression  was  increased  by 
approximately 8-fold between DP2 and DP3 populations of OT-I Rag1
-/- mice.  
Runx3  expression  remained  at  this  elevated  level  in  the  thymic  CD8  SP 
population and was lower in CD8 SP LNTs, where expression was similar to 
that  seen  in  F5 Rag1
-/-  LNTs  (Figure 5.3 D).    Taken  together,  these  data 
indicated that lower expression of Runx1 and Runx3 in the DP3 and CD8 SP 
thymic compartments correlated with reduced IL7r  expression in thymic and 
peripheral T-cell populations in F5 Rag1
-/- relative to OT-I Rag1
-/- mice. 
5.2.5  IL7  not  TCR  signalling  predominantly  modulates  peripheral  IL7r  
expression and function 
Our data thus far correlated reduced TCR signalling during positive selection 
with a reduction in IL7r  re-expression.  In peripheral T cells however, IL7r  is 
upregulated  in  the  absence  of  IL7-mediated  signalling  and  downregulated 
following IL7 signalling (Park et al., 2004).  TCR signalling has been suggested 
to increase IL7R expression by blocking IL7R signal transduction through an 
indirect mechanism (i.e. reducing IL7-mediated signalling) (Park et al., 2007).  
We therefore sought to test whether IL7 or TCR signalling was the predominant 
factor determining IL7r  expression in naïve LNTs.  To do this we transferred 
MHC-I-restricted  TCR  transgenic  lymphocytes  to  different  host  environments 
that  allowed  increased  or  decreased  IL7R  and  TCR  signalling.    We 
hypothesised that T-cell-deficient Rag1
-/- b2m
-/- hosts would have high levels of 
excess IL7, as they lack peripheral T-cells.  However these hosts would not        
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permit TCR signalling for CD8 LNTs as they lack the  2m component of MHC-I.  
In contrast, transfer to Rag1
-/- hosts would permit high levels of both IL7 and 
TCR signalling. TCR transgenic mice are partially lymphopenic and thus have 
intermediate  levels  of  IL7  relative  to  Rag-deficient  and  WT  mice  (Ge  et  al., 
2004).    However,  high  levels  of  intraclonal  competition  exist  in  such  an 
environment, suggesting TCR signals may be limited.  Finally we hypothesised 
that  following  transfer  of  MHC-I-restricted  TCR  transgenic  thymocytes  to  B6 
hosts,  IL7  signals  would  be  rate-limiting,  whilst  a  reduction  in  intraclonal 
competition  would  permit  an  increase  in  TCR  signalling.    The  hypothesised 
relative levels of IL7R and TCR signals are summarised in Table 5.1. 
Table 5.1 Hypothesised TCR and IL7 signals received by donor 
MHC-I-restricted TCR transgenic LNTs in different host environments 
Host  TCR Signalling  IL7 Signalling 
Rag1
-/- b2m
-/-  -  +++ 
Rag1/2
-/- 
- 
+++  +++ 
TCR transgenic 
 
+  ++ 
B6  ++  + 
 
We  first  investigated  the  effects  of  transferring  weak  avidity  F5 Rag1
-/- 
lymphocytes to different host environments.  Total LNTs from F5 Rag1
-/- mice 
were  isolated  and  5x10
6  cells  were  transferred  intravenously  (I.V.)  to 
Rag1
-/- b2m
-/-,  Rag1
-/-,  F5 Rag1
-/-  or  B6  congenically  marked  hosts  for  three        
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days.    F5 Rag1
-/-  donor  cells  were  re-isolated  and  found  to  be  of  a  naïve 
CD25
loCD44
lo  phenotype,  irrespective  of  the  host  strain  (Figure 5.4 A).    We 
next examined the level of CD5 on donor LNTs to determine the level of TCR 
stimulation by spMHC in each host.  Cells transferred to the Rag1
-/- b2m
-/- hosts 
exhibited  low  levels  of  CD5,  suggesting  that  TCR  signalling  was  reduced  or 
absent.  In contrast, F5 Rag1
-/- cells transferred to both Rag1
-/- and B6 hosts 
showed a relative increase in CD5 expression suggesting that TCR signalling 
was  increased  in  these  donors  relative  to  cells  in  F5 Rag1
-/-  controls 
(Figure 5.4 B).  These results fit with the predicted levels of TCR signalling in 
different host environments (Table 5.1). 
We next determined IL7r  expression on donor lymphocytes to see whether 
there  was  any  evidence  for  TCR  signalling  regulating  peripheral  IL7r  
abundance.    F5 Rag1
-/-  donor  LNTs  transferred  to Rag1
-/-  b2m
-/-  and  Rag1
-/- 
hosts expressed similar or slightly reduced levels of IL7r  compared to donor 
LNTs  transferred  to  F5 Rag1
-/-  control  hosts.    In  contrast,  those  donor  cells 
transferred  to  B6  hosts  upregulated  IL7r   expression,  although  it  was  not 
expressed as highly as in endogenous B6 CD8 SP host LNTs (Figure 5.4 C).  
Therefore  IL7r   expression  correlated  better  with  IL7  availability  rather  than 
spMHC availability in vivo.   
Recently,  Cho  et  al.  reported  that  TCR  signalling  augmented  IL7  signalling, 
through  recruitment  of  the  IL7r   and  the   c  to  lipid  rafts  (Cho  et  al.,  2010).  
Consequently, we tested the downstream function of IL7r  on F5 Rag1
-/- donor        
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LNTs transferred to different hosts, by stimulating cells with IL7 for 30 minutes 
and  measuring  the  induction  of  pSTAT5.    pSTAT5  induction  was  found  to 
closely correlate with IL7r  expression levels.  F5 Rag1
-/- donor cells transferred 
to Rag1
-/- b2m
-/-, Rag1
-/- and F5 Rag1
-/- hosts showed relatively low levels of 
pSTAT5 induction, relative to B6 hosts (Figure 5.4 D).  IL7r  function therefore 
correlated with IL7r  expression levels and not previous TCR signalling. 
The  F5 Rag1
-/-  mice  have  a  weak  avidity  for  spMHC  and  may  not  be 
representative of higher avidity clones.  We therefore wanted to confirm that 
peripheral  IL7r   expression  correlated  with  IL7  availability  and  not  spMHC 
availability  in  OT-I Rag1
-/-  mice,  which  have  a  high  avidity  for  spMHC 
(Figure 5.2 A-E) (Ge et al., 2004).  We transferred 5x10
6 OT-I Rag1
-/- donor 
LNTs to congenically marked Rag1
-/- b2m
-/-, Rag2
-/- or B6 hosts, that together 
permitted  different  levels  of  IL7/TCR  signalling.    In  addition,  we  examined 
pre-transferred  OT-I Rag1
-/-  LNTs  as  controls  (Table 5.1).    Similar  to  the 
F5 Rag1
-/- donor LNTs, OT-I Rag1
-/- LNTs were of a naïve phenotype following 
re-isolation  three  days  after  transfer,  irrespective  of  the  host  environment 
(Figure 5.5 A).    Relative  to  pre-transferred  OT-I Rag1
-/-  cells,  OT-I Rag1
-/- 
donors transferred to Rag1
-/- b2m
-/- hosts showed reduced expression of CD5.  
In contrast, those donor cells transferred to Rag2
-/- or B6 hosts showed elevated 
levels of CD5 (Figure 5.5 B).  These findings confirmed our results following 
transfer of F5 Rag1
-/- LNTs to different hosts, in that IL7r  expression inversely 
correlated with IL7 availability in vivo.        
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We next investigated whether IL7r  expression was differently expressed on 
donor OT-I Rag1
-/- LNTs three days after transfer.  We found that relative to the 
intact  OT-I Rag1
-/-  mice,  the  OT-I Rag1
-/-  donor  LNTs  transferred  to 
lymphopenic  Rag1
-/- b2m
-/-  or  Rag2
-/-  hosts  had  relatively  low  levels  of  IL7r  
expression.  In contrast, those cells transferred to B6 mice had similar levels of 
IL7r , relative to the intact OT-I Rag1
-/- mice (Figure 5.5 C).  Once more, IL7r  
expression  was  found  to  correlate  with  IL7  signalling,  as  OT-I Rag1
-/-  LNTs 
transferred to Rag1
-/- b2m
-/- and Rag2
-/- hosts showed lower pSTAT5 induction 
following  30  minutes  of  IL7  treatment,  when  compared  to  intact  OT-I Rag1
-/- 
mice,  or  OT-I Rag1
-/-  donor  cells  transferred  to  B6  hosts.    Thus  results  with 
strong  avidity  OT-I Rag1
-/-  donor  lymphocytes  parallel  results  seen  following 
transfer  of  weak  avidity  F5 Rag1
-/-  lymphocytes.    These  data  suggest  that 
peripheral IL7 signals predominantly modulate IL7r  expression levels in the 
periphery, irrespective of TCR signalling strength. 
5.2.6 Increasing the positive selection signalling strength restores IL7r  
expression in F5 Rag1
-/- thymocytes 
Our results suggested that different mechanisms exist in the thymus and the 
periphery to control IL7r  expression levels.  In the periphery, we found that 
predominantly  IL7  signals  and  not  TCR  signals  control  IL7r   expression  on 
peripheral  naïve  LNTs  (Figure 5.1,  Figure 5.2).    This  contrasted  with  the 
hypothesis that TCR signals influence peripheral IL7r  expression levels (Park 
et al., 2007).  In contrast, the weakly selecting F5 Rag1
-/- thymocytes exhibited 
no detectable IL7r  re-expression, suggesting that IL7 signals were unlikely to        
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be  influencing  this  process  (Figure 5.2 F).    Instead,  these  findings  were 
suggestive that lower IL7r  expression in F5 Rag1
-/- mice was a direct result of 
reduced TCR signalling during thymic development.  Thus we asked whether 
increasing the positive selection signal in F5 Rag1
-/- thymocytes could rescue 
IL7r  expression in F5 Rag1
-/- cells.  In the periphery, reduction of intraclonal 
competition  permitted  increased  TCR  signalling  as  measured  by  CD5 
expression, when F5 Rag1
-/- cells were transferred to B6 hosts (Figure 5.4 B).  
We hypothesised that reducing the clonal competition of F5 Rag1
-/- thymocytes 
during positive selection may increase the positive selection signal strength and 
permit  us  to  investigate  the  effects  on  IL7r   expression.    F5 Rag1
-/- b2m
-/- 
CD45.2
+  thymocytes  are  arrested  at  the  DP1  pre-positively  selecting  stage 
(Chapter 3, Figure  3.8 D).    We  therefore  used  these  mice  as  a  source  of 
clonotypic  TCR  transgenic  DP1  arrested  thymocytes.    We  intrathymically 
transferred  1-2x10
6  F5 Rag1
-/- b2m
-/- CD45.2
+  donor  thymocytes  to 
 2m-sufficient  B6 CD45.1
+  hosts  that  allowed  an  environment  of  low  clonal 
competition, or to F5 Rag1
-/- CD45.1
+ controls.  Following intrathymic injection 
transferred donor thymocytes were re-isolated after 2-5 days and examined by 
flow cytometry.  Analysis of CD4 and CD8 expression revealed modulation of 
coreceptor expression levels on days two and three, which was more apparent 
in those cells transferred to B6 hosts compared to F5 Rag1
-/- hosts.  However, 
on days four and five both B6 and F5 Rag1
-/- host environments permitted the 
development  of  CD8  SPs  (Figure 5.6 A).    Examination  of  TCR  and  CD5 
expression on transferred thymocytes revealed cells underwent a progressive 
phenotypic progression from DP2 > DP3 > CD8 SP, irrespective of the host        
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environment,  and  with  similar  kinetics  as  described  for  B6  thymocytes 
(Chapter 3, Figure 3.8) (Figure 5.6 B). 
We  next  asked  whether  transfer  of  F5 Rag1
-/- b2m
-/-  thymocytes  to  B6  or 
F5 Rag1
-/- hosts impacted on the positive selection signal strength.  Expression 
of the activation marker CD69 on donor thymocytes was therefore determined 
following intrathymic transfer.  Between days two and five, CD69 expression 
was consistently higher on those F5 Rag1
-/- b2m
-/- thymocytes transferred to B6 
hosts, as opposed to F5 Rag1
-/- hosts.  This finding reflected differences in the 
host TCR
hiCD5
hi DP populations, as B6 host thymocytes had higher levels of 
CD69 relative to F5 Rag1
-/- hosts, further suggesting that these differences were 
intrinsic to the host environment (Figure 5.6 C).  Thus, transfer of F5 Rag1
-/-
 b2m
-/-  thymocytes  to  B6  hosts  resulted  in  quantitatively  elevated  positive 
selection  signalling  compared  with  transfer  to  F5 Rag1
-/-  hosts.    These 
differences reflected the comparatively lower levels of intraclonal competition in 
B6 relative to F5 Rag1
-/- host environments. 
Finally  we  wished  to  determine  whether  the  augmentation  of  the  positive 
selection  signal  in  F5 Rag1
-/- b2m
-/-  thymocytes  could  rescue  IL7r  
re-expression  levels  or  kinetics.    IL7r   was  absent  on  F5 Rag1
-/- b2m
-/-
thymocytes  two  days  following  transfer,  irrespective  of  recipient  mouse.  
Interestingly, IL7r  was expressed on donor thymocytes transferred to B6 hosts 
on day three.  We subsequently saw a progressive upregulation of IL7r , so 
that by day five, donor F5 Rag1
-/- b2m
-/- thymocytes expressed similar levels of 
IL7r  compared to the B6 host CD8 SP population.  In sharp contrast, we saw        
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no expression of IL7r  on donor thymocytes in F5 Rag1
-/- hosts by day five, 
reflecting  the  absence  of  IL7r   expression  on  host  F5 Rag1
-/-  thymocytes 
(Figure 5.6 D).    These  data  indicated  that  augmenting  the  positive  selection 
signal  strength  positively  influences  IL7r   re-expression  levels  and  kinetics.  
Such a mechanism may influence the homeostatic survival potential of T-cells, 
as  differences  in  IL7r   expression  are  likely  to  affect  the  ability  of  cells  to 
compete with one another for peripheral IL7 survival signals.        
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5.3 Discussion 
We have described a novel homeostatic mechanism, whereby the strength of 
the positive selection signal dictates IL7r  expression levels.  We first found that 
IL7r  expression was sub-optimally re-expressed in mice exhibiting defects in 
TCR  signalling  machinery,  or  in  transgenic  T-cells  receiving  a  weak  positive 
selection  signal.    The  defect  in  IL7r   re-expression  correlated  with  a 
lower/delayed  expression  of  Runx1  and  Runx3  in  the  low  avidity  TCR 
transgenic F5 Rag1
-/- mice compared to the OT-I Rag1
-/- mice.  In contrast, IL7 
and not TCR signalling predominantly controlled IL7r  expression levels in the 
periphery.  This suggested the control of IL7r  expression by the TCR was a 
distinct and unique property of the positive selection signal.  Finally, we showed 
that reducing clonal competition between positively selecting F5 Rag1
-/- b2m
-/- 
thymocytes not only augmented the positive selection signal, but also restored 
IL7r  re-expression kinetics and abundance in positively selected thymocytes.  
We therefore suggest a mechanism whereby positive selection TCR signalling 
confers  a  greater  survival  potential  to  thymocytes  with  a  strong  avidity  for 
spMHC, by instructing cells to express higher levels of IL7r . 
Positive selection of CD4 SP cells is associated with stronger TCR signalling 
relative to selection of CD8 SP cells (reviewed in (Hogquist, 2001)).  Our finding 
that CD4 SP thymocytes also express higher levels of IL7r  in the thymus led 
us to investigate whether positive selection signal strength impacted on IL7r  
re-expression (Figure 5.1 B).  We found that SKG mice, which have a mutation        
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in Zap70 that reduces TCR signalling, had reduced IL7r  expression in both 
CD4 and CD8 LNTs (Figure 5.1 C-E).  In contrast, TetZap70
on mice showing a 
specific defect in CD8 lineage TCR signalling had a correspondingly greater 
defect in peripheral CD8 SP IL7r  expression (Figure 5.1 F-H).  Similarly the 
low avidity F5 Rag1
-/- mice showed defective IL7r  re-expression relative to the 
high  avidity  OT-I Rag1
-/-  mice,  in  terms  of  mRNA  and  protein  abundance 
(Figure 5.2).  Importantly this defect in IL7r  could be corrected by augmenting 
the  positive  selection  signal,  by  reducing  the  intrathymic  clonal  competition 
(Figure 5.6).  Thus we conclude that relatively weak positive selection signal 
strength confers an IL7r 
lo phenotype to selected T-cells.  It has been described 
that IL7r  is upregulated on positively selecting thymocytes (Akashi et al., 1998; 
Sudo  et  al.,  1993)  and  is  upregulated  after  treatment  of  DP  thymocytes  by 
concentrations of PMA and ionomycin that mimic the positive selection signal 
(Brugnera et al., 2000).  Our results extend these findings, by suggesting that 
IL7r  expression levels are linked to the positive selection signal strength of the 
TCR.  Indeed such a finding is reminiscent of B-cell positive selection, whereby 
decreased BCR signalling strength correlates with reduced BAFFR expression 
(Walmsley et al., 2003). 
In  contrast,  we  found  that  IL7  signals  predominated  over  TCR  signals  in 
controlling  peripheral  IL7r   expression  (Figure 5.4-5.5).    This  supports  the 
argument  that  a  predominating  role  of  TCR  signalling  in  controlling  IL7r  
expression is unique to the positive selection signal.  IL7 signalling has been 
shown to downregulate of IL7r  in the periphery (Park et al., 2004).  However,        
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such  a  mechanism  cannot  account  for  all  of  our  findings.    For  example, 
TetZap70
on  thymocytes  have  a  specific  defect  for  IL7r   expression  the  CD8 
lineage  relative  to  the  CD4  lineage  (Figure 5.1 F-H),  whilst  the  defect  in 
F5 Rag1
-/- T -cells  is  cell  intrinsic,  since  it  is  present  in  mixed  BM  chimeras 
(Sinclair et al. Manuscript submitted).   
A number of recent findings suggest that TCR and IL7 signal integration may be 
complex.  Park et al. have also proposed the concept of coreceptor tuning in 
peripheral CD8 cells, whereby TCR signals block IL7 signalling, thus leading to 
an  upregulation  of  IL7r   (Park  et  al.,  2007).    Consequently  IL7  signalling  is 
increased, which feeds back to downregulate IL7r  and upregulated CD8 , thus 
increasing  TCR  signalling.    In  contrast  TCR  signalling  did  not  affect  CD4 
expression  (Park  et  al.,  2007).    Paradoxically,  Cho  et  al.  have  recently 
described  that  TCR  signalling  actually  increased  IL7  sensitivity,  by  inducing 
IL7r  and  c localisation in lipid rafts (Cho et al., 2010).  Furthermore, loss of 
TCR signalling mediated by transfer of naïve T-cells to MHC-I-deficient hosts 
resulted  in  decreased  IL7r   expression  within  the  CD8  lineage  (Takada  & 
Jameson, 2009).  However, another conflicting finding showed loss of peripheral 
Lck signalling has no effect on IL7r  expression levels (Seddon et al., 2003).  
Hence, the precise relationship between TCR signalling and IL7r  expression is 
unclear.  In addition these studies cannot account for the complete absence of 
IL7r   expression  in  F5 Rag1
-/-  thymocytes  (Figure 5.2 F-G).    That  these  low 
avidity  cells  positively  select  to  the  CD8  lineage  without  re-expressing  IL7r  
suggests that IL7r  expression is indeed sensitive to TCR signalling quantity.         
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This  characteristic  appears  to  contradict  the  proposed  role  of  IL7  signals  in 
instructing  the  CD8  SP  lineage  decision  (see  below) (Brugnera  et  al.,  2000) 
(reviewed  in  (Singer  et  al.,  2008)).    However,  it  remains  to  be  investigated 
whether  F5 Rag1
-/-  thymocytes  are  indeed  completely  insensitive  to  IL7 
signalling, as their apparent lack of IL7r  implies. 
Our  data  imply  that  transcriptional  mechanisms  underlie  differences  in  IL7r  
expression in F5 Rag1
-/- and OT-I Rag1
-/- mice (Figure 5.2 G).  A number of 
transcription  factors  have  been  implicated  in  controlling  IL7r   expression  in 
various cell types (reviewed in (Mazzucchelli & Durum, 2007)), some of which 
we examined.  We found that Foxo1 was similarly expressed in both F5 Rag1
-/- 
and OT-I Rag1
-/- mice (Figure 5.3 A).  Kerdiles et al. found that CD4-Cre driven 
Foxo1 deficiency that deleted Foxo1 at the DP stage resulted in reduced IL7r  
expression in thymic and peripheral SP cells (Kerdiles et al., 2009).  Our results 
suggest that in Foxo1-deficiency may affect maintenance rather than induction 
of  IL7r .    Xue  et  al.  showed  that  Gabp  expression  was  essential  for  IL7r  
expression in DN thymocytes and the EL4 cell line (Xue et al., 2004).  However, 
similar mRNA expression of Gabpb1 in F5 Rag1
-/- and OT-I Rag1
-/- thymocytes 
suggest this factor may not be important for setting IL7r  re-expression levels.  
Alternatively,  Gabp  may  be  regulated  in  DP  thymocytes  by  limiting  the 
abundance of the Gabp  -subunit, the expression levels of which remain to be 
tested in F5 Rag1
-/- and OT-I Rag1
-/- thymocytes.          
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Nevertheless, we did find that reduced IL7r  expression correlated with reduced 
Runx1 and Runx3 expression in F5 Rag1
-/- cells (Figure 5.3 C-D).  This fits with 
data  from  Egawa  et  al.  whereby  CD4-Cre-mediated  deletion  of  Runx1  and 
Runx3  resulted  in  reduced  IL7r   expression  in  CD4  and  CD8  lineages 
respectively  (Egawa  et  al.,  2007).    A  Runx1  binding  site  exists  in  the  IL7r  
promotor region, and mutation of this site in the transformed DP cell line, KKF, 
resulted in reduced IL7r  expression (Lee et al., 2005).  However it remains to 
be determined whether Runx1 and/or Runx3 physically interact with the IL7r  
locus in primary positively selecting T-cells, and whether this is essential for 
IL7r  re-expression.  The recent finding that Runx3 expression is upregulated in 
vitro  following  IL7  treatment  further  complicates  the  correlation  between 
Runx1/3 and IL7r  expression (Park et al., 2010).  Our findings suggest that 
Runx3  upregulation  can  actually  precede  IL7r   induction,  suggesting  Runx3 
also  upregulated  through  IL7-independent  mechanisms  (Figure 5.2 G, 
Figure 5.3 D).    It  would  be  interesting  to  know  whether  Runx  factors  and 
IL7:IL7r  signalling can reciprocally regulate one another.  Furthermore, Runx 
factors  associate  with  the  Brg/Brahma-associated  factors  (BAF)  chromatin 
remodelling  complex  (reviewed  in  (Taniuchi  &  Littman,  2004)),  thus 
comparisons of the chromatin configuration in F5 Rag1
-/- and OT-I Rag1
-/- SP 
thymocytes  will  be  a  future  goal  for  the  lab.    Finally,  it  is  interesting  that 
Runx1/Runx3 gene deletion did not entirely ablate IL7r  re-expression (Egawa 
et  al.,  2007).  Gene  expression  analysis  of  F5 Rag1
-/-  and  OT-I Rag1
-/- 
thymocytes may give insight into additional factors regulating IL7r  expression.  
In  conclusion,  we  have  identified  a  cellular  mechanism  whereby  IL7r         
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expression is set based on the positive selection signalling strength, however 
the genetic mechanism/s remain to be elucidated. 
Following transfer to lymphoreplete B6 hosts, both F5 Rag1
-/- and OT-I Rag1
-/- 
thymocytes  upregulate  IL7r   expression  (Figure 5.4 E,  Figure 5.5 E).    This 
suggests that IL7 is not limiting in these transgenic mouse models.  However, 
IL7 is likely to be limited in lymphoreplete WT mice, as IL7 transgenic mice have 
increased T-cell numbers (Mertsching et al., 1995) and mice lacking either CD4 
or CD8 lineages have similar numbers of T-cells compared to WT (Fung-Leung 
et al., 1991; Rahemtulla et al., 1991).  Our findings lead us to propose a model 
whereby the positive selection signal strength controls IL7r  expression.  Such 
a mechanism would serve to continually refine the peripheral T-cell pool, as 
weakly selected clones would be preferentially lost in conditions where IL7 was 
limiting.    This  could  include  low  avidity  clones,  overrepresented  clonotypes 
exhibiting high intraclonal competition for thymic TCR ligands, and those T-cells 
with  defective  TCR  rearrangements  or  defects  in  TCR-associated  signalling 
molecules.  It remains to be tested whether IL7r 
lo cells will be efficiently purged 
from  a  lymphoreplete  environment  as  compared  with  IL7r 
hi  cells.    Further 
studies will follow the fate of B6 IL7r 
lo and IL7r 
hi post selection thymocytes 
following I.V. transfer to congenic WT hosts.  IL7 has been shown to enhance 
homeostatic proliferation (Tan et al., 2001), so T-cell clones that have received 
a stronger positive selection signal may be more likely to undergo homeostatic 
proliferation during lymphopenia.  Thus we suggest the IL7r  expression levels 
confer a memory of positive selection signal strength to a T-cell.          
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Our  model  suggests  a  mechanism  of  antigen  receptor  and  cytokine  signal 
integration  that  contrasts  with  that  of  B-cells.    BCR  signals  control  the 
expression of BAFFR (Smith & Cancro, 2003; Walmsley et al., 2003), and in 
addition  induce  the  upregulation  of  the  NK- B  substrate  p100,  which  is  rate 
limiting  in  BAFFR  signal  transduction  (Stadanlick  et  al.,  2008).    We  have 
identified  that  TCR  signalling  controls  IL7r  e xpression  levels  during  T-cell 
development.    Although  there  is  no  evidence  that  TCR  and  IL7  signalling 
pathways show signal integration, it would be interesting to investigate whether 
such  integration  may  occur  post-transcriptionally,  perhaps  through  the 
coregulation of early genes induced by TCR and IL7 signalling pathways.  There 
is functional evidence for signal integration, as both IL7 and TCR signals can 
synergise  to  promote  homeostatic  proliferation  (reviewed  in  (Surh  &  Sprent, 
2008)).  
In conclusion, the results presented in this chapter give further insight to T-cell 
homeostatic  control  mechanisms.    Such  findings  may  have  implications  for 
human diseases in which T-cell homeostasis is perturbed.  Administration of 
exogenous  IL7  has  been  trialled  in  acquired  immunodeficiency  syndrome 
(AIDS)  patients  (Levy  et  al.,  2009),  whereas  IL7  administration  has  been 
proposed as a treatment to boost T-cell numbers in elderly patients (reviewed in 
(Aspinall et al., 2007)).  Our findings suggest that such exogenous IL7 treatment 
may permit the continued survival of weaker avidity clones.  It will be interesting 
to determine whether this is indeed the case and if so, whether this impacts on 
the functionality of the reconstituted T-cell pool.        
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Figure 5.1 Peripheral IL7r  expression correlates with the positive 
selection signalling strength 
B6, BALB/c, SKG and TetZap70
on T-cells were analysed for the expression of 
CD4, CD8, TCR, CD5, CD25, CD44 and IL7r  by flow cytometry.  (A) B6 LNs 
were analysed.  Density plot shows CD4 against CD8 expression on naïve LN 
T-cells (CD25
loCD44
loTCR
hiCD5
hi).  Histogram shows IL7r  expression on naive 
CD4 SP (red line) and CD8 SP (blue line) (CD4 and CD8 SP gating is shown in 
left plot).  (B) B6 thymi were analysed.  Density plot shows CD4 against CD8 
expression  on  live  thymocytes.    Histogram  shows  IL7r   expression  on  DP1 
(grey fill), CD4 SP (red line) and CD8 SP (blue line).  Data is representative of 
 3  independent  experiments.    (C) Histograms  show  the  expression  IL7r   on 
naïve CD4 SP T-cells from BALB/c (black line) or SKG (red line) thymi and LNs 
(top row), and naïve CD8 SP T-cells derived from BALB/c (black line) or SKG 
(blue line) thymi and LNs (bottom row).  BALB/c DP1 cells (grey fill) are shown 
as a negative control.  (D) The bar chart shows the mean IL7r  MFI on naïve 
CD4  SP  (red)  and  CD8  SP  (blue)  LNTs  from  a  cohort  of  SKG  mice,  as  a 
frequency  of  the  IL7r   MFI  on  equivalent  populations  from  BALB/c  mice.  
*** p 0.001  (Student s  t-test,  BALB/c  n=12,  SKG  n=12).    (E)  The  bar  chart 
shows  the  CD8:CD4  ratio  of  IL7r   MFI  on  BALB/c  and  SKG  LNTs.  p=ns 
(Student s  t-test,  BALB/c  n=12,  SKG  n=12).    (F) Histograms  show  the 
expression  IL7r   on  naïve  CD4  SP  T-cells  derived  from  B6  (black  line)  or 
TetZap70
on  (red  line)  thymi  and  LNs  (top  row),  and  naïve  CD8  SP  T-cells 
derived from B6 (black line) or TetZap70
on (blue line) thymi and LNs (bottom 
row).  B6 DP1 cells (grey fill) are shown as a negative control.  (G) The bar        
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chart shows the mean IL7r  MFI on naïve CD4 SP (red) and CD8 SP (blue) 
LNTs from a cohort of TetZap70
on mice, as a frequency of the IL7r  MFI on 
equivalent  populations  from  B6  mice.    *** p 0.001  (Student s  t-test,  B6  n=7, 
TetZap70
on n=7).  (H) The bar chart shows the CD8:CD4 ratio of IL7r  MFI on 
B6  and  TetZap70
on  LNTs.  *** p 0.001  (Student s  t-test,  B6  n=7,  TetZap70
on 
n=7). Error bars represent sd.  The data in (F-H) were obtained my Moni Saini        
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Figure 5.2 MHC-I restricted F5 Rag1
-/- transgenic thymocytes receive a 
weak positive selection signal and show a defect in IL7r  re-expression 
(A-B, F) LNs from B6, F5 Rag1
-/- and OT-I Rag1
-/- mice were analysed for the 
expression of CD4, CD8, TCR, CD5, CD25, CD44 and IL7r  by flow cytometry.  
(A) Density  plots  show  CD4  against  CD8  expression  on  naïve  T-cells 
(CD25
loCD44
loTCR
hiCD5
hi).    (B) Histograms  shows CD5  expression  on  CD8 
SPs from OT-I Rag1
-/- (red line), F5 Rag1
-/- (blue line) and B6 controls (black 
dotted line) (gating is shown in (A)).  (C-F) Thymi from B6, F5 Rag1
-/- and OT-I 
Rag1
-/- mice were analysed for the expression of CD4, CD8, TCR, CD5, CD69 
and  IL7r   by  flow  cytometry.    (C) Density  plots  show  CD4  against  CD8 
expression  on  live  thymocytes  and  CD5  against  TCR  expression  on  DP 
thymocytes.    (E) Histogram  shows  CD69  expression  on  TCR
hiCD5
hi  DP 
thymocytes.    (F) Histograms  show  IL7r   expression  in  DP2  (top  row),  DP3 
(second  row)  and  CD8  SP  (third  row)  gated  thymocytes,  and  CD8  SP  LNT 
(bottom row) populations from B6 (dotted black line), F5 Rag1
-/- (blue line) and 
OT-I Rag1
-/-  (red  line)  mice.    B6  DP1  thymocytes  (grey  fill)  are  shown  as  a 
negative control.  (G) DP2, DP3 and CD8 SP populations were sorted to high 
purity  ( 95%)  from  OT-I Rag1
-/-  and  F5 Rag1
-/-  mice.    Cellular  mRNA  was 
purified and analysed by RT-qPCR.  Bar chart shows the mean expression of 
IL7r mRNA relative to Hprt1.  Analysis was performed in triplicate wells and 
error  bars  represent  the  sd.    Data  is  representative  of   3  independent 
experiments.        
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Figure 5.3 The defect in IL7r  re-expression in F5 Rag1
-/- mice correlates 
with reduced Runx mRNA expression 
DP2, DP3 and CD8 SP thymocytes were sorted to high purity ( 95%) or total LN 
cells were isolated from F5 Rag1
-/- and OT-I Rag1
-/- mice.  Cellular mRNA was 
purified and analysed by RT-qPCR.  Bar charts show the mean expression of 
(A) Foxo1,  (B) Gabpb,  (C) Runx1  and  (D) Runx3  relative  to  Hprt1.    Analysis 
was  performed  in  triplicate  wells  and  error  bars  represent  the  sd.    Data  is 
representative of  3 independent experiments.        
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Figure 5.4 Peripheral IL7r  expression is tuned by IL7 signals and not 
TCR signals in F5 mice 
Total LN lymphocytes were harvested from F5 Rag1
-/- CD45.1
+ mice and 5x10
6 
cells  were  parked  in  F5 Rag1
-/- b2m
-/-,  Rag1
-/-,  F5 Rag1
-/-  or  B6  hosts  (all 
CD45.2
+) for three days.  Host LNs were then analysed by flow cytometry for 
the  expression  of  CD4,  CD8,  TCR,  CD5,  CD25,  CD44  and  IL7r .  
(A) Histograms show CD25 against CD44 on donor CD45.1
+TCR
+ gated cells.  
(B) Histograms  show  CD5  expression  on  donor  CD45.1
+TCR
+  gated  cells 
transferred to F5 Rag1
-/- b2m
-/- (blue line, left), Rag1
-/- (blue line, middle), B6 
(blue  line,  right)  and  F5 Rag1
-/-  (grey  fill)  mice.    (C) Histograms  show  IL7r  
expression on donor CD45.1
+TCR
+ gated cells transferred to F5 Rag1
-/- b2m
-/- 
(blue line, left), Rag1
-/- (blue line, middle), B6 (blue line, right) and F5 Rag1
-/- 
(grey  fill)  mice,  in  addition  to  host  B6  CD8  SP  controls  (black  dotted  line).  
(D) Total LN lymphocytes were harvested from F5 CD45.1
+ mice and parked in 
F5 Rag1
-/- b2m
-/-, Rag1
-/-, F5 Rag1
-/- or B6 hosts (all CD45.2
+) for three days.  
Lymphocytes were then re-isolated from host LNs and treated with 10ng/ml IL7 
(blue  line)  or  left  untreated  (grey  fill)  at  37ºC  for  30  minutes.    Cells  were 
immediately  fixed  and  permeablised,  before  intracellular  pSTAT5  expression 
was  examined  by  flow  cytometry.    Histograms  show  pSTAT5  expression  on 
CD45.1
+ gated cells.  Data are representative of  3 independent experiments. 
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Figure 5.5 Peripheral IL7r  expression is tuned by IL7 signals and not 
TCR signals in OT-I mice 
Total  LN  lymphocytes  were  harvested  from  OT-I Rag1
-/-  CD45.2
+  mice  and 
5x10
6  cells  were  parked  in  Rag1
-/- b2m
-/-  CD45.2
+,  Rag2
-/-  CD45.1
+  or  B6 
CD45.1
+ hosts for three days.  Host LNs or control OT-I Rag1
-/- LNs were then 
analysed by flow cytometry for the expression of CD4, CD8, TCR, CD5, CD25, 
CD44  and  IL7r .    (A) Histograms  show  CD25  against  CD44  on  donor 
CD45.1
+TCR
+ gated cells or OT-I Rag1
-/- controls.  (B) Histograms show CD5 
expression on donor CD45.2
+TCR
+ gated cells transferred to Rag1
-/- b2m
-/- (red 
line,  left),  Rag2
-/-  (red  line,  middle),  B6  (red  line,  right)  or  identically  gated 
non-transferred  OT-I Rag2
-/-  controls  (grey  fill).  (C) Histograms  show  IL7r  
expression on donor CD45.2
+TCR
+ gated cells transferred to Rag1
-/- b2m
-/- (red 
line,  left),  Rag2
-/-  (red  line,  middle),  B6  (red  line,  right)  or  identically  gated 
non-transferred OT-I Rag1
-/- controls (grey fill), in addition to host B6 CD8 SP 
controls  (black  dotted  line).    (D) Total  LN  lymphocytes  were  harvested  from 
OT-I Rag1
-/- CD45.2
+ mice and parked in Rag1
-/- b2m
-/-, Rag2
-/- or B6 hosts (all 
CD45.2
+) for three days.  Lymphocytes were then re-isolated from host LNs or 
isolated from intact OT-I Rag1
-/- controls and treated with 10ng/ml IL7 (red line) 
or left untreated (grey fill) at 37ºC for 30 minutes.  Cells were immediately fixed 
and  permeablised,  before  intracellular  pSTAT5  expression  was  examined  by 
flow cytometry.  Histograms show pSTAT5 expression on CD45.1
+ gated cells.  
Data are representative of  3 independent experiments.        
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Figure 5.6 Augmentation of a weak positive selection signal restores 
IL7r  expression levels and kinetics 
F5 Rag1
-/- b2m
-/- CD45.2
+ thymocytes (1-2x10
6) were intrathymically transferred 
to  B6  CD45.1
+,  or  F5  CD45.1
+  hosts.    Host  and  donor  thymocytes  were 
analysed by flow cytometry 2-5 days (d2-5) following transfer.  (A) Density plots 
show CD4 against CD8 expression on total host (CD45.1
+) or CD45.2
+ donor 
thymocytes.  (B) Density plots show CD5 against TCR expression on DP gated 
host (CD45.1
+) or total CD45.2
+ donor thymocytes.  (C) Histograms show CD69 
expression  on  CD45.2
+  donor  thymocytes  transferred  to  B6  (red  line)  or  F5 
(blue line) hosts, in addition to B6 DP1 (grey fill), B6 TCR
hiCD5
hi DP (dotted 
black  line)  and  F5  TCR
hiCD5
hi  DP  (black  line)  host  mouse  controls  (all 
CD45.1
+).    (D) Histograms  show  IL7r   expression  on  CD45.2
+  donor 
thymocytes transferred to B6 (red line) or F5 Rag1
-/- (blue line) hosts, in addition 
to B6 DP1 (grey fill), B6 CD8 SP (dotted black line) and F5 Rag1
-/- CD8 SP 
(black line) host mouse controls (all CD45.1
+).  Data are representative of  2 
replicate mice per timepoint. 
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Chapter 6  
Final Discussion 
The overall aim of this thesis was to study the kinetics of positive selection and 
the  CD4/CD8  lineage  decision.    Furthermore  we  investigated  whether  this 
process  impacted  on  the  future  survival  potential  of  naïve  T-cells.    We  first 
sought to examine the kinetics of the CD4 versus CD8 lineage decision, and 
also to characterise the phenotypic changes associated with this event.  This 
allowed us to gain a better understanding of how a positively selecting T-cell 
can interpret signals from either MHC-II or MHC-I.  In the final results chapter 
we investigated a novel concept, that the nature of the positive selection may 
influence  the  future  homeostatic  survival  capacity  of  a  T-cell.    The  data 
presented in this thesis supports a view that CD4 and CD8 lineage commitment 
occurs  with  temporal  distinction  following  the  initiation  of  positive  selection.  
Intriguingly,  the  CD4  and  CD8  lineages  were  also  found  to  develop  from 
phenotypically  distinct  DP  precursor  populations.    We  provide  evidence  for 
differences in TCR signalling sensitivity between these populations, thus leading 
us to propose a model whereby the temporal regulation of thymic development 
allows for interpretation of the lineage commitment signal at distinct signalling 
thresholds.  Finally our results suggest that positive selection TCR signalling 
does not merely instruct the lineage commitment decision but also determines 
the IL7r  expression levels in the periphery.  Thus by implication, the positive        
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selection signal affects the future capacity of a mature T-cell to survive in the 
peripheral lymphoid organs. 
6.1 The positive selection signal as a developmental process 
Following restoration of positive selection, CD4 lineage commitment could occur 
as early as two days, whereas we saw no CD8 lineage cells until four days after 
positive selection was initiated (Figure 3.2, Figure 3.8).  This finding represents 
a conceptual step forward with regards to our understanding of the CD4/CD8 
lineage decision.  Lucas and Germain first reported that positive selection and 
lineage  commitment  were  temporally  segregated  events  (Lucas  &  Germain, 
1996).  The TetZap70 inducible system enabled us to examine the kinetics of 
positive selection with improved resolution, allowing us to identify that the CD4 
and CD8 lineage commitment events are also temporally distinct.  Furthermore, 
we identified three temporally distinct DP populations based on the expression 
of  TCR  and  CD5,  which  had  different  developmental  potential.    The  DP1 
population was present in TetZap70
off mice that are Zap70-deficient, and thus 
we  conclude  it  was  likely  to  contain  the  DP  cells  yet  to  receive  a  positive 
selection  signal  (Figure 3.4).    In  contrast  the  DP2  population  contained  the 
direct  precursors  of  the  CD4  lineage,  and  indirect  precursors  of  the  CD8 
lineage.  DP2 cells destined to become CD8 SPs had to first transit via the DP3 
population  (Figure 3.8,  summarised  in  Figure 3.12).    We  suggest  that 
subdividing  the  DP  population  into  DP1-3  subpopulations  permits  finer 
resolution of developmentally intermediate populations in WT mice, compared        
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to the commonly employed strategy of gating based on subtle differences in 
coreceptor expression levels (Lucas & Germain, 1996) (reviewed in (Singer et 
al., 2008)).  Hence, our results may warrant a re-examination of mice reported 
previously  to  have  defects  in  positive  selection.    Examination  of  the  DP1-3 
phenotype  of  such  mice  may  give  new  insight  into  the  nature  of  these 
developmental abnormalities. 
We  further  identified  that  WT  selecting  thymocytes  progressively  upregulate 
Zap70 and are likely to tune expression of TCR and CD5, thus modulating their 
TCR  signalling  sensitivity  throughout  development  (Figure 3.2,  Figure 4.1, 
Figure 4.2).    This  may  allow  thymocytes  to  interpret  MHC-II-mediated 
strong/consistent signals at an earlier time point, as these signals will require 
less TCR signalling sensitivity.  In contrast, cells interpret a weak/intermittent 
MHC-I-mediated  signal  at  a  later  time,  when  TCR  signalling  sensitivity  is 
increased.    Thus  we  hypothesise  that  the  timing  of  the  lineage  commitment 
signal  is  critical  to  match  MHC-specificity  to  lineage  choice  (summarised  in 
Figure 4.10).  Our model posits that positive selection resembles a permissive 
signalling  threshold  mechanism:  a  developmental  signalling  network  found 
commonly in eukaryotic lineage specification.  Such a mechanism is typified by 
a  cells  ability  to  make  only  one  developmental  choice  within  a  particular 
temporal  window  (reviewed  in  (Freeman  &  Gurdon,  2002).    Hence  positive 
selection represents two closely linked permissive induction decisions.  Early 
induction of TCR signalling will result in CD4 lineage commitment, whereas later 
induction results in CD8 commitment.  Indeed the process whereby an identical        
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signalling pathway leads to different developmental outcomes depending on the 
temporal context has been reported in Drosophila eye development (Freeman, 
1996), suggesting it may be a convergently evolved developmental strategy.  It 
is likely that temporal networks operate to allow interpretation of the timing of 
developmental  signalling.    Thus  it  will  be  of  interest  to  compare  microarray 
analysis of DP2 and DP3 T-cells, to elucidate potential candidates playing such 
a role. 
A  unique  feature  of  the  CD4/CD8  lineage  decision  made  by  T-cells  is  that 
polyclonal TCRs have different avidities for spMHC ligand.  Thus mechanisms 
have  to  ensure  that  wide-ranging  avidities  for  spMHC  do  not  lead  to 
misinterpretation of the developmental signal.  We hypothesise that redundancy 
exists to ensure that MHC-II versus MHC-I-mediated positive selection signal is 
divergent, and is largely imparted by the different properties of the CD4 or CD8 
coreceptors.  First, the cytoplasmic tail of CD4 binds to Lck with a higher affinity 
than CD8 (Wiest et al., 1993), suggesting that MHC-II signals may be generally 
of a higher avidity.  Second, following positive selection, the CD8 coreceptor is 
downregulated,  suggesting  that  a  CD8:spMHC-I  signal  is  likely  to  be  initially 
transient (reviewed in (Singer et al., 2008)).  Thus aspects of both quantitative 
and kinetic signalling models are likely to contribute to inherent differences in 
coreceptor-mediated recruitment of Lck.   
Data presented herein provide further insight into how such strong/consistent 
versus weak/intermittent signals may be further differentiated.  We find evidence 
for a positive feedback loop, whereby TCR signals directly upregulate Zap70        
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expression in vitro and in vivo (Figure 4.8, Figure 4.9), at the transcriptional 
level  (Figure 4.6).    Failure  to  upregulate  Zap70  resulted  in  a  developmental 
block particularly affecting the CD8 lineage (Figure 4.4) (Saini et al., 2010)).  
We  suggest  that  the  positive  autoregulation  of  Zap70  occurs  as  part  of  a 
feedforward  loop,  a  common  motif  found  in  transcription  factor  networks.    A 
feedforward  loop  commonly  permits  the  resolution  of  developmental  signals 
from  inherent  background  noise  common  to  biological  signalling  pathways 
(reviewed in (Alon, 2007).  Thus regulating Zap70 directly downstream of the 
TCR  may  serve  to  further  enhance  differences  in  signalling,  so  that 
strong/consistent  MHC-II  signals  increase  TCR  signalling  sensitivity  more 
rapidly then weak/intermittent MHC-I signals.   
Paradoxically, the failure to upregulate Zap70 in TetZap70
on mice had only a 
minimal effect on the CD4 lineage (Figure 3.1).  This may be explained if Zap70 
expression  is  not  rate-limiting  in  MHC-II-mediated  TCR  signal  transduction.  
However we found that the CD4 lineage was enriched with cells expressing a 
relatively higher level of Zap70 compared to CD8 lineage cells, suggesting that 
this is not the case for all cells.  It could be that high Zap70 expression early in 
positive  selection  promotes  strong  signalling  associated  with  CD4  SP 
development,  irrespective  of  MHC-restriction  (Figure 4.1).    In  contrast,  we 
showed that lower expression of Zap70 was associated with a developmental 
block at the DP3 stage of development (Figure 4.4).  Critically, a developmental 
increase in TCR sensitivity may be required to progress beyond the DP3 stage, 
thus  providing  an  explanation  for  why  CD8  lineage  cells  appear  to  be  more        
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affected  by  the  loss  of  developmental  Zap70  upregulation  in  TetZap70 
thymocytes. 
It is therefore possible that developmentally dysregulated Zap70 expression in 
TetZap70  mice  leads  to  an  incorrect  lineage  decision,  resulting  in  mature 
MHC-mismatched T-cells.  Whether this is the case could be revealed in mice 
where only MHC-II or MHC-I restricted T-cells are permitted to develop.  Thus, 
future  experiments  in  the  lab  will  examine  positive  selection  of  TetZap70 
thymocytes  on  MHC-II  or  MHC-I-deficient  backgrounds.    It  may  also  be  of 
interest to examine whether lineage misdirection occurs in mouse models where 
TCR or CD5 are perturbed during thymic selection.  For example it has been 
reported in E3 ubiquitin-protein ligase Cbl (c-Cbl)-deficient mice that both TCR 
and CD5 are upregulated in DP thymocytes (Naramura et al., 1998), but it is 
unknown whether this leads to the misinterpretation of the lineage commitment 
signal. 
6.2 Impact of the positive selection signal on naïve T-cell 
homeostasis 
Positive  selection  has  been  thought  of  as  an  isolated  developmental  event, 
functioning for the sole purpose of instructing MHC-II restricted cells to the CD4 
lineage  and  MHC-I  restricted  cells  to  the  CD8  lineage.    However,  we  find 
evidence suggesting that the  quality  of the positive selection will impact on the 
future homeostatic survival potential of T-cells.  We found both in polyclonal 
mouse models with defects in TCR signalling, and in transgenic mouse models        
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with weak spMHC avidity, that IL7r  was suboptimally re-expressed following 
positive selection (Figure 5.1, Figure 5.2).  When we intrathymically transferred 
F5 Rag1
-/- b2m
-/-  TCR  transgenic  T-cells  to  F5 Rag1
-/-  hosts,  donor  cells 
received a weak positive selection signal, but importantly there was no impact 
on  the  kinetics  with  which  lineage  commitment  progressed  (Figure 5.6 A-B, 
lower rows).  Thus, signalling was sufficient to permit lineage commitment, but 
inadequate to allow for IL7r  re-expression.  In contrast, improving the positive 
selection signalling strength by transferring F5 Rag1
-/- b2m
-/- cells to B6 hosts 
increased  both  the  positive  selection  signal  strength  as  measured  by  CD69 
expression,  and  also  restored  IL7r   expression  (Figure 5.6).    Such  a 
mechanism would result in T-cells retaining a memory of their positive selection 
signalling strength.   
TCR and IL7 signals have partially redundant function in naïve T-cell survival 
(Seddon  &  Zamoyska,  2002a).    We  have  not  only  found  evidence  that  the 
positive  selection  signal  tunes  IL7r   abundance,  but  also  that  Zap70  was 
expressed  with  lower  abundance  in  F5 Rag1
-/- b2m
-/-  thymocytes  receiving  a 
suboptimal positive selection signal (Figure 4.9).  Hence the positive selection 
signal  apparently  affects  both  TCR  and  IL7r   signalling  sensitivity  in  weakly 
signalled  cells.    Such  a  model  is  reminiscent  of  B-cell  positive  selection 
signalling (reviewed in (Cancro & Kearney, 2004)).  Walmsley et al. have shown 
that B-cells deficient in Rac1 or Rac2 during positive selection have defective 
upregulation of BAFFR (Walmsley et al., 2003).  Furthermore, BCR signals are 
required to induce synthesis of the NF B substrate p100, essential for BAFFR        
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signal transduction (Stadanlick et al., 2008).  It remains controversial whether 
TCR  signals  augment  IL7r   signalling  in  mature  T-cells,  or  indeed  whether 
physiological differences in the positive selection signal strength affect mature 
BCR signal transduction. 
An implication of our findings is that T-cell clones receiving a strong positive 
selection signal are more likely to survive in the periphery, as they will be able to 
outcompete cells for survival factors.  Boursalian et al. reported that IL7r  was 
progressively  upregulated  over  approximately  two  weeks  following  thymic 
egress,  on  both  CD4  and  CD8  naïve  T-cells  (Boursalian  et  al.,  2004).    An 
alternative  interpretation  of  these  findings  would  be  that  IL7r 
lo  cells  were 
progressively lost over this period.  Indeed we are currently investigating this 
hypothesis,  by  comparing  the  survival  potential  of  WT  IL7r 
hi  and  IL7r 
lo 
thymocytes transferred to congenic hosts.  A further question arising from our 
data  is  why  such  a  preference  for  strong  spMHC  recognition  during  thymic 
development would be beneficial to naïve T-cells?  Such a mechanism would 
certainly be favourable in eliminating any T-cells that escape positive selection 
with defects in TCR structure or associated signalling machinery.  However, it is 
not clear whether such cells exist in the periphery given the strong competition 
during positive selection in WT mice.  A mechanism whereby IL7r  expression 
is lower on weakly selected cells could alternatively favour clonal diversity, as it 
may reduce intraclonal competition.  For example, we found that by reducing 
intraclonal competition between selecting F5 Rag1
-/- b2m
-/- thymocytes, Zap70 
and IL7r  expression was restored (Figure 4.9, Figure 5.6).  However, TCR        
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transgenic mice are likely to represent an extreme case.  Even in the low avidity 
F5 Rag1
-/- mice, approximately 1x10
7 cells can be sustained in the peripheral 
lymph  nodes  (Mamalaki  et  al.,  1993),  approximately  20-25%  of  the  total 
numbers residing in WT lymph nodes (Figure 4.5).  Thus it is unclear whether 
the  availability  of  spMHC  would  be  rate  limiting  for  intraclonal  competition.  
Furthermore,  T-cells  are  likely  to  be  cross-reactive  for  identical  self-peptides 
(reviewed in (Mason, 1998)), so such a mechanism may result in a loss of naïve 
T-cell repertoire diversity via outcompetition of weaker avidity clones. 
An  attractive  hypothesis  as  to  why  T-cells  with  strong  spMHC  avidities  are 
favoured is that spMHC recognition is also likely to be required during T-cell 
activation.    The  absence  of  self-recognition  has  been  shown  to  impair  the 
activation of both naïve and memory T-cells (Kassiotis et al., 2002; Stefanova et 
al., 2002).  Furthermore, it has been shown that a single foreign peptide antigen 
displayed  in  the  context  of  MHC  (pMHC)  interaction  can  elicit  a  calcium 
response  in  T-cells  provided  that  additional  TCR:spMHC  interactions  are 
aggregated into a signalling complex (Irvine et al., 2002).  Thus the continual 
refinement  of  the  adaptive  immune  system  through  preferential  loss  of  low 
avidity  clones  and  continual  input  from  thymic  development  may  ensure  a 
progressive accumulation of higher avidity clones, which are most likely to elicit 
an immune response.  It will be interesting to investigate whether IL7r 
hi and 
IL7r 
lo naïve T-cells from WT polyclonal mice show a different propensity for 
activation, following an immune challenge.        
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6.3 Future perspectives 
The  results  presented  in  this  thesis  expand  on  the  existing  knowledge  of 
positive selection and CD4/CD8 lineage development.  Furthermore, our results 
raise a number of questions about this process.  For example, the CD4 SP 
population in TetZap70 mice is enriched with cells expressing a relatively high 
level of Zap70 compared to the CD8 SP population (Figure 4.1 B).  It would be 
interesting to address whether MHC-II restricted cells with low levels of Zap70 
are redirected to the CD8 lineage, and likewise whether MHC-I-restricted cells 
with high Zap70 expression are redirected to the CD4 lineage.  Such a question 
could  be  addressed  in  a  system  where  b2m
-/-  and  MHC-II  /   hosts  were 
reconstituted with TetZap70 BM.  These BM chimeras could be induced with 
dox but would only permit the development of MHC-II or MHC-I restricted cells 
respectively,  and  thus  would  enable  the  identification  of  mismatched  lineage 
development. 
We have also identified that the branch point between CD4 and CD8 lineages 
occurs at the DP2 stage.  Thus the DP2 population comprises both MHC-II and 
MHC-I-restricted  thymocytes.    It  is  not  known  whether  there  is  homeostatic 
competition  between  MHC-II  and  MHC-I-restricted  thymocytes  undergoing 
positive selection.  We hypothesise that if no cross-competition existed, the sum 
of  the  DP2  population  frequencies  in  b2m
-/-  and  MHC-II  /   mice  should 
approximately  equal  the  WT  DP2  frequency.    Interestingly,  upon  gross 
examination of the thymic phenotype, the DP2 frequencies appear to be larger 
than expected in b2m
-/- and/or MHC-II  /  mice (Figure 3.6 B), suggesting that        
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the  homeostasis  of  DP2  cells  is  indeed  impacted  by  cells  selecting  to  an 
alternative  lineage.    Due  to  the  potentially  complex  population  dynamics 
involved, a mathematical modelling approach could be used to identify whether 
interclonal  competition  exists  between  MHC-II  and  MHC-I-restricted  DP2 
thymocyte populations.  Such an approach has been successful elsewhere to 
model  the  dynamics  of  homeostatic  proliferation,  revealing  that  a  seemingly 
complex cellular process could be predicted using a relatively simple stochastic 
single-division model (Yates et al., 2008).  Mathematical modelling of DP subset 
homeostasis would be further aided by analysing the development of MHC-II 
and  MHC-I-restricted  cells  independently,  as  would  be  possible  using  a  BM 
chimeric system where b2m
-/- and MHC-II  /  host mice were reconstituted with 
TetZap70 BM. 
Finally,  we  find  that  different  levels  of  Zap70  and  IL7r   expression  are 
apparently set by the positive selection signal.  Furthermore the upregulation of 
Zap70  is  critical  for  this  process.    For  example,  failure  to  upregulate  Zap70 
results in a specific defect in CD8 lineage development (Figure 4.4) (Saini et 
al., 2010).  Thus it is of interest to investigate the genetic elements controlling 
these processes.  This could involve characterisation of chromatin modifications 
during positive selection, in addition to identification of transcription factors that 
directly bind the Zap70 or Il7r loci.  The eventual aim of such studies would be 
to generate mice with mutated genetic regulatory elements, to study their role 
during T-cell development and/or naïve T-cell differentiation.        
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6.4 Conclusions 
The CD4/CD8 lineage decision employs sophisticated regulatory mechanisms 
to  ensure  the  accurate  coupling  of  MHC-restriction  to  lineage  choice.    This 
process  has  served  as  a  model  system  in  which  to  study  haematopoietic 
differentiation.    Our  data  represents  a  conceptual  step  forward  from  current 
models  of  CD4/CD8  development.    We  show  that  further  to  the  temporal 
separation of positive selection and lineage commitment, development of CD4 
and CD8 lineages is also temporally distinct.  In addition, our results identify that 
kinetic  changes  in  TCR  signalling  sensitivity  underlie  this  developmental 
process,  and  may  be  crucial  for  the  resolution  of  MHC-II  versus 
MHC-I-mediated  selection  signals.    Finally,  we  argue  that  the  lineage 
commitment  decision  is  not  simply  an  isolated  process,  but  rather  confers 
differing  survival  capabilities  to  T-cells,  based  on  the  quality  of  the  positive 
selection  signal.    This  has  far  reaching  consequences  on  the  naïve  T-cell 
repertoire,  as  not  all  T-cells  surviving  positive  selection  are  equally  likely  to 
persist in the peripheral lymphoid organs.        
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